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Cornell University 2015 
Listeria monocytogenes is of particular concern in ready-to-eat (RTE) food product. It is 
able to survive and grow in RTE foods from low numbers to potentially hazardous levels. With 
the aim of developing control strategies that prevent or reduce growth of this pathogen in RTE 
food products, I combined both applied and basic research approaches to perform phylogenetic, 
phenotypic and transcriptomic characterizations of RTE food associated L. monocytogenes, 
enabling a better understanding of L. monocytogenes population genetics, biological capacities, 
as well as the mechanisms that it uses to survive and grow in food matrices. 
First, we used a 10-gene multilocus sequence typing scheme to investigate the diversity 
and phylogenetic distribution of 124 L. monocytogenes strains with various genetic backgrounds. 
Our data show that 10-gene MLST allows for high level of discrimination of L. monocytogenes 
and demonstrated the distinct ability of growth of L. monocytogenes under nutrient limited 
conditions between some of the subgroups of L. monocytogenes. 
 Second, we quantify the effects of organic acids, nisin, and their combinations on 
controlling 18 strains (individually) of L. monocytogenes growing on the RTE seafood, cold-
smoked salmon (CSS), and in modified BHI broth (MBHIB) at 7oC. The combination of 
potassium lactate and sodium diacetate, and the combination of potassium lactate and nisin, were 
identified as the most effective bacteriostatic treatment and bactericidal treatment against L. 
monocytogenes, respectively. We also observed that the quantitative prediction of the variability 
	  	  
	  
of growth parameters in a food matrix such as CSS by using a laboratory medium could only be 
achieved for lineage II strains but not lineage I strains.  
 RNA-seq was used to understand the transcriptional landscape of L. monocytogenes 
strain H7858 grown on cold-smoked salmon (CSS, water-phase salt 4.65%, pH 6.1) relative to in 
modified brain heart infusion broth (MBHIB, water-phase salt 4.65%, pH 6.1) at 7oC. We found 
that genes encoding proteins involved in cobalamin biosynthesis as well as ethanolamine and 
1,2-propanediol utilization have significantly higher transcript levels in H7858 grown on CSS 
compared to in MBHIB. Our data identify specific transcriptional profiles of L. monocytogenes 
growing on vacuum-packaged CSS, which may provide targets for development of novel and 
improved strategies to control L. monocytogenes growth on this RTE food.  
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CHAPTER 1  
INTRODUCTION 
 
Listeria monocytogenes is an opportunistic foodborne pathogen that causes a severe life-
threatening disease, listeriosis, particularly in neonates, pregnant women, elderly people and 
other immunologically-susceptible persons. It is estimated to cause approximately 1600 illnesses 
annually with a high case fatality rate of 20 ~30% in the United States (1). Characterization of L. 
monocytogenes isolates by multiple subtyping methods (2-4) has shown that strains can belong 
to one of four distinct genetic lineages (5, 6) with apparent differences in virulence (7, 8), growth 
under adverse conditions (9, 10) and gene expression related to virulence and stress response (11, 
12). Lineage I strains are associated with most human listeriosis outbreaks, lineage II strains are 
predominant in foods, environments, animal listeriosis cases and sporadic human clinical cases, 
whereas lineage III and IV are mainly from animal sources (13). Among the 13 known serotypes 
of L. monocytogenes, three serotypes including 4b, belonging to lineage I, as well as 1/2a and 
1/2b, belonging to lineage II, are most commonly associated with human illnesses (14). Using 
molecular typing method such as multilocus sequence typing to place L. monocytogenes isolates 
with various genetic backgrounds into clonal framework will facilitate a better understanding of 
(i) whether particular clusters of L. monocytogenes isolates are more virulent and have higher 
epidemic potential, and (ii) which phenotypic characters, if any, are linked to L. monocytogenes 
more likely to be associated with outbreaks than the others. In addition, these genetic variations 
of L. monocytogenes clearly illustrate the importance of using strains representing different 
genetic backgrounds in studies on L. monocytogenes stress survival and virulence as well as in 
validation studies for L. monocytogenes control strategies. 
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L. monocytogenes is ubiquitously prevalent in the environment and almost exclusively 
transmitted by food (15, 16). It has been identified as of particular concern to the ready-to-eat 
(RTE)-meat and -seafood industries due to its ability to grow at temperatures as low as -0.4oC 
and salt contents as high as 25% (at 4oC) (17-19), which elevate the risk of food contamination 
and transmission of this pathogen through RTE foods to humans. Cold smoked salmon (CSS), a 
RTE seafood, represents a typical food product that can support the growth of L. monocytogenes 
from low numbers to potentially hazardous levels (20-25). Consequently, this product has been 
identified as having a high risk per serving for listeriosis (22, 23). The heat treatment applied 
during processing of CSS, as well as the typical product characteristics of CSS including pH, 
water activity, salt, sodium nitrite, and phenolic components are not sufficient to control the 
growth of L. monocytogenes (24, 25). Therefore, it is critical to develop control strategies that 
prevent or reduce growth of this pathogen in RTE food including the RTE seafood cold-smoked 
salmon. 
One potential method to control L. monocytogenes in RTE food is the use of bactericidal or 
bacteriostatic antimicrobial agents, such as nisin, potassium lactate and sodium diacetate. Nisin 
(NI), a bacteriocin produced by Lactococcus lactis, is known to reduce the population of L. 
monocytogenes in various food products, including cold-smoked salmon (26-29). Salts of 
organic acids, such as potassium lactate (PL) and sodium diacetate (SDA), are also widely used 
in the RTE meat industry as antimicrobial agents (30), and have also been evaluated for use in 
CSS (23, 31). Meanwhile, combining antimicrobial agents in a food system can often enhance 
antimicrobial action against pathogenic and/or spoilage organisms (32-34). As challenge studies 
in food matrices can be costly and time-consuming, there is potential to utilize antimicrobial 
efficacy data generated from studies in laboratory medium to predict efficacy in food matrices. 
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Strong correlations would allow data generated from laboratory medium to be used as an 
effective and rapid initial screen for antimicrobial efficacy. 
On the other hand, with the aim of developing control strategies that prevent or reduce 
growth of this pathogen in RTE seafood products, there is a need for better understanding of the 
mechanisms that L. monocytogenes uses to survive and grow in food matrices. Changes in gene 
expression in response to various environments can be used to determine the physiological state 
of L. monocytogenes under different conditions, and identify the metabolic pathways that are 
important for survival and growth of L. monocytogenes in food products. This will allow the 
identification of new compounds that could specifically interfere with these metabolic pathways 
and thereby control the growth of L. monocytogenes (35). However, the majority of data from 
previous studies are based on exposure of L. monocytogenes to specific stresses in laboratory 
medium, providing information about specific stress responses in a controlled environment. This 
information may not provide the full extent of stress responses in a more complex environment, 
such as a food matrix, as a previous study has demonstrated that L. monocytogenes may react 
differently to stress in a food matrix (e.g., growth on CSS) as compared to in a laboratory setting 
(e.g., growth in brain heart infusion broth), especially for lineage I strains of L. monocytogenes 
(36), indicating the importance of the investigation of L. monocytogenes transcriptome in a real 
food matrix.  
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CHAPTER 2  
CLONAL CLUSTERING USING 10-GENE MULTILOCUS SEQUENCE TYPING REVEALS 
AN ASSOCIATION BETWEEN GENOTYPE AND LISTERIA MONOCYTOGENES 
MAXIMUM GROWTH RATE IN DEFINED MEDIUM 
Published in: Foodborne Pathogens and Disease 
 
ABSTRACT 
We used a 10-gene multilocus sequence typing (10G-MLST) scheme to investigate the 
diversity and phylogenetic distribution of 124 L. monocytogenes strains across major lineages, 
major serotypes, and seven epidemic clones (ECs) that have been previously associated with 
outbreaks. The 124 isolates proved to be diverse, with a total of 81 sequence types (10G-STs) 
belonging to 13 clonal complexes (CCs), where all STs of the same CC differ from one another 
in up to three of the ten alleles (named as 10G-triple-locus-variant-clonal-complexes [10G-TLV-
CCs]). Phenotypic characterization for 105 of the 124 strains showed that L. monocytogenes had 
variable maximum growth rate (µmax) in a defined medium at 16oC, and classification by lineage 
or serotype was not able to reflect the genetic basis for the difference of this phenotype. Among 
the six major 10G-TLV-CCs, 10G-TLV-CC4 that included lineage I strains had significantly 
lower µmax (Tukey HSD adjusted (adj.) P < 0.05) compared to 10G-TLV-CC1 and 10G-TLV-
CC3 that both comprised lineage II strains, indicating a distinct difference in growth of these L. 
monocytogenes isolates under nutrient limited conditions among some of the CCs. However, the 
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other three (10G-TLV-CC2, 6 and 10) of the six major 10G-TLV-CCs containing either lineage I 
or lineage II strains did not show significantly different µmax compared to the others (adj. P < 
0.05). Our findings highlighted the importance of using molecular typing methods that can be 
used in evolutionary analyses as a framework for further understanding the phenotypic 
characteristics of subgroups of L. monocytogenes. 
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INTRODUCTION 
Listeria monocytogenes is an opportunistic foodborne pathogen that poses a particular 
risk for pregnant women, neonates, elderly people and other immunologically-susceptible 
persons. It is ubiquitous in the environment and almost exclusively transmitted by food (1, 2). L. 
monocytogenes isolates have been differentiated into four genetic lineages (I ~ IV) (3, 4) and 13 
known serotypes (5). Despite having similar prevalence in food and environment samples, 
lineage I and II strains are more likely to be associated with human hosts and non-human (e.g., 
animal, food and environment) sources, respectively (6), whereas lineage III and IV are mainly 
from animal hosts (3). Serotypes 4b, 1/2a and 1/2b are most commonly associated with human 
illnesses (5). Phenotypic characterization of L. monocytogenes isolates has shown apparent 
differences among lineages and serotypes in virulence (7, 8) and growth under various conditions 
(9-11). However, with the aim of developing control strategies that prevent L. monocytogenes 
outbreaks, further study is needed to investigate (i) whether particular genetic subtypes of L. 
monocytogenes are more persistent in environment or food, potentially increasing human 
exposure to these strains, and (ii) which phenotypic characteristics, if any, are linked to L. 
monocytogenes that are more likely to be associated with outbreaks.  
Multi-virulence-locus sequence typing (MvLST) (12, 13) together with pulsed-field gel 
electrophoresis (PFGE) (14), have been used to define epidemic clones (ECs) of L. 
monocytogenes, where isolates that are genetically related but implicated in temporally- and 
geographically-distinct outbreaks are classified in one EC (12, 15-17). Multilocus sequence 
typing (MLST) (18) which targets seven housekeeping genes (7G-MLST) has been used to 
define the clonal complexes (CCs) of L. monocytogenes (19, 20). Cantinelli et al. (21) recently 
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confirmed the correspondence between ECs and CCs in terms of phylogenetic clustering and 
discriminatory power. In this study, we used 10-gene MLST (10G-MLST) (22) to investigate the 
phylogenetic diversity of L. monocytogenes strains. Further, we compared the available 
classification results based on these previously described typing schemes (CCs and ECs 
identified by using 7G-MLST and MvLST scheme, respectively) to the one we used (10G-MLST 
scheme), to understand the correlations among them and enable cross-referencing between the 
phylogenetic classification results of these schemes.  
The ability to persist at low temperatures and in nutrient limited food processing 
environments elevates the risk of food contamination and transmission of this pathogen through 
foods to humans (23, 24), thus possibly representing one of the important phenotypes to identify 
the L. monocytogenes isolates with greater potential to spread through the food supply. Since 
Lineage III and VI of L. monocytogenes are rarely isolated from human related cases or from 
food, we focused on Lineage I and II, and compared the maximum growth rates (µmax) of L. 
monocytogenes isolates growing in a chemically defined medium (DM) at 16oC by lineage (I & 
II) and 10G-MLST defined CCs (where all STs of the same CC differ from one another in three 
or fewer of the ten alleles). This will facilitate better understanding of the correlation between 
phenotype and genotype of L. monocytogenes. 
MATERIALS AND METHODS 
Isolates. For measurement of µmax in DM, a group of 105 isolates was assembled from 
our collection [the Cornell University Food Safety Laboratory (CUFSL)] (Table S2.1) to 
represent isolates from a wide range of sources (Table 2.1, 2.2) and diverse genetic backgrounds 
based on ribotype data (Table S2.1). For 10G-MLST analysis, we (i) sequenced the MLST genes 
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for 89 of the 105 isolates, and (ii) extracted MLST gene sequences for the remaining 16 isolates 
from the public sequence repositories. Second, in addition to these 105 isolates, 19 isolates with 
full genome sequence data available were included in the 10G-MLST analysis by extracting 
MLST gene sequences from the public sequence repositories (Table S2.1). The whole isolate set 
included (i) 24 human and food isolates from 15 outbreaks, (ii) 64 human and food isolates from 
non-outbreak cases, (iii) 12 animal isolates, and  (iv) 18 environmental isolates, for a total of 124 
L. monocytogenes isolates representing lineages I, II, III, and IV, as well as seven of the ECs. 
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Table 2.1. Lineage I isolates used for 10-gene multilocus sequence typing (10G-MLST) analysis  
Strain IDa Source 10G-STb 
10G-
SLV
-CCc 
10G-
TLV-
CCd 
7G-
STe 
7G-
CCf 
µmaxg 
[log(OD600/
ml)/day] 
FSL	  J1-­‐0220	  	   1979, human, Boston vegetable 
outbreak 2	   2	   2	   NA
h NA 0.047 
FSL	  J1-­‐0225	  	   1983, human, Massachusetts milk 
outbreak 9	   2	   2	   290 2 0.058 
FSL	  R2-­‐0583	  	   1983, human, Massachusetts milk 
outbreak 9	   2	   2	   NA 2 0.039 
FSL	  R2-­‐0578	  	   1983, human, Massachusetts milk 
outbreak 38	   2	   2	   NA 2 0.05 
FSL	  J1-­‐0020	  	   1987, human, Philadelphia multiple 
foods outbreak 9	   2	   2	   NA 2 0.052 
FSL	  J1-­‐0129	  	   1988-1989, human, UK pate outbreak 2	   2	   2	   NA 2 0.046 
FSL	  R2-­‐0585	  	   1988-1990, food, UK pate outbreak 2	   2	   2	   NA 2 0.021 
FSL	  R2-­‐0589	  	   1988-1990, food, UK pate outbreak 36	   2	   2	   NA 2 0.041	   
FSL	  J1-­‐0116	  	   1988-1990, human, UK pate outbreak 2	   2	   2	   2 2 0.062 
HPB2262 1997, Italian gastroenteritis outbreak 2	   2	   2	   2 2 NA 
FSL	  F2-­‐0091	  	   1999, human, sporadic 2	   2	   2	   NA NA 0.055 
FSL	  M2-­‐0042	  	   1999, human, sporadic 37	   2	   2	   NA NA 0.041 
FSL	  F2-­‐0656	  	   2001, human, sporadic 2	   2	   2	   NA NA 0.041 
FSL	  F2-­‐0661	  	   2001, human, sporadic 2	   2	   2	   NA NA 0.041 
FSL	  S4-­‐0848	  	   2002, environment (sidewalk floor) 39	   2	   2	   2 2 0.034 
ATCC 19117 animal (sheep), sporadic 2	   2	   2	   2 2 NA 
SLCC 2755 1967, animal (chinchilla) 47	   5	   4	   66 3 NAh 
FSL	  R2-­‐0502	  	   1994, food, Illinois chocolate milk 
outbreak 1	   5	   4	   3 3 0.04 
FSL	  R2-­‐0598	  	   1994, human, Illinois chocolate milk 
outbreak 1	   5	   4	   NA 3 0.06 
FSL	  N1-­‐0017	  	   1998, food 21	   5	   4	   3 3 0.033 
FSL	  M1-­‐0006	  	   1998, human, sporadic 19	   Si	   4	   NA NA 0.012 
FSL	  F2-­‐0369	  	   2000, food (RTE pasta salad) 1	   5	   4	   NA NA 0.043 
FSL	  R2-­‐0154	  	   2001, food (smoked seafood) 1	   5	   4	   NA 3 0.055 
FSL	  L3-­‐0051	  	   2002,food (RTE salmon) 1	   5	   4	   NA 3 0.034 
FSL	  F6-­‐0386	  	   2007, food (smoked salmon) 20	   5	   4	   NA NA 0.049 
FSL	  J1-­‐0049	  	   human sporadic 1	   5	   4	   3 3 0.028 
FSL J1-0194 1997, human, sporadic 30	   3	   5	   88 S 0.036 
FSL	  F2-­‐0521	  	   2000, food (smoked fish salad) 31	   3	   5	   NA NA 0.048 
FSL R8-5459 2010, environment (floor) 32	   3	   5	   NA NA 0.05 
FSL	  N1-­‐0260	  	   human 33	   3	   5	   NA NA 0.031 
FSL R2-0557 human, sporadic 34	   3	   5	   NA NA 0.033 
FSL	  F6-­‐0366	  	   1998-1999, food (meat), US hot dog 
outbreak 4	   6	   6	   6 6 0.034 
FSL	  N1-­‐0225	  	   1998-1999, human, US hot dog 
outbreak 29	   6	   6	   6 6 0.05 
FSL	  N1-­‐0061	  	   1998, food (salmon brine) 27	   6	   6	   NA NA 0.053 
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aIsolates are listed in numerical order of the “Lineage”, and then in “10G-TLV-CC”  .  
b10G-ST, sequence type (ST) identified by using 10G-MLST scheme. 
c10G-SLV-CC, single-locus-variant-clonal complex identified by using 10G-MLST scheme and 
eBURST algorithm, where all STs in the clonal complex (CC) differ from one another in one of 
the ten alleles. 
d10G-TLV-CC, triple-locus-variant-clonal complex identified by using 10G-MLST scheme and 
eBURST algorithm, where all STs in the same CC differ from one another in no more than three 
of the ten alleles. 
e7G-ST, ST identified by using 7-gene multilocus sequence typing (7G-MLST) scheme. 
Table 2.1 (Continued) 
FSL	  E1-­‐0201	  	   2001, environment (soil) 4	   6	   6	   NA NA 0.053 
FSL	  N3-­‐0780	  	   2002, animal (bovine feces) 4	   6	   6	   6 6 0.055 
FSL	  N3-­‐0692	  	   2002, environment (soil) 4	   6	   6	   6 6 0.054 
FSL	  R2-­‐0763	  	   2002, human, Northeastern states 
sliced deli meat outbreak 4	   6	   6	   6 6 0.044 
FSL	  F3-­‐0950	  	   2005, human, sporadic 4	   6	   6	   NA 6 0.049 
FSL	  F6-­‐0095	  	   2005, human, sporadic 28	   6	   6	   NA NA 0.055 
FSL	  F2-­‐0699	  	   2002, human, sporadic 14	   7	   7	   NA NA 0.049 
FSL	  F3-­‐0757	  	   2002, human, sporadic 14	   7	   7	   NA NA 0.028 
FSL	  H5-­‐0804	  	   2006, environment (deli floor drain) 59	   7	   7	   NA NA 0.052 
FSL	  J1-­‐0175	  	   environment (water) 58	   7	   7	   87 S 0.052 
FSL	  J1-­‐0108	  	   1981, human, Halifax coleslaw 
outbreak 8	   8	   8	   1 1 0.059 
FSL	  J1-­‐0126	  	   1983-1987, human, Switzerland 
cheese outbreak 8	   8	   8	   1 1 0.033 
FSL	  J1-­‐0110	  	   1985, food, Mexican-style cheese 
outbreak 8	   8	   8	   1 1 0.052 
FSL	  C1-­‐0122	  	   1998, human, sporadic 22	   8	   8	   1 1 0.043 
SLCC 2378 poultry 45	   8	   8	   73 1 NA 
FSL	  J2-­‐0045	  	   1992, animal (sheep), clinical 25	   10	   9	   NA NA 0.044 
FSL	  F2-­‐0018	  	   1999, human, sporadic 24	   S	   9	   NA NA 0.047 
FSL	  F2-­‐0366	  	   2000, human, sporadic 26	   10	   9	   NA NA 0.042 
FSL	  S4-­‐0643	  	   2002, environment (bench) 11	   9	   12	   NA 4 0.052 
L312 food (cheese) 11	   9	   12	   4 4 NA 
07PF0776 human (myocardial abscess), sporadic  42	   9	   12	   4 4 NA 
FSL	  J1-­‐0169	  	   1996, human, sporadic 7	   S	   Si	   5 5 0.051 
FSL	  E1-­‐0041	  	   2000, animal (sheep), clinical 41	   S	   S	   NA NA 0.051 
FSL	  F2-­‐0493	  	   2000, food (raw chunk beef patties)  35	   S	   S	   NA NA 0.047 
FSL	  R2-­‐0501	  	   2000, human, North Carolina cheese 
outbreak 40	   S	   S	   558 S 0.043 
FSL	  R2-­‐0182	  	   2001, food (smoked seafood) 7	   S	   S	   NA 5 0.061 
FSL	  F2-­‐0693	  	   2001, human, sporadic 60	   S	   S	   NA NA 0.036 
FSL	  S4-­‐0440	  	   2002, environment (sidewalk floor) 23	   S	   S	   379 NA 0.049 
FSL S10-630 2010, environment (produce farm) 43	   S	   S	   NA NA 0.048 
SLCC 2540 1956, human, sporadic 46	   S	   S	   617 3 NA 
	  	  
	  
16	  
f7G-CC, CC identified by using 7G-MLST scheme, where all ST in the same CC differ from one 
another in one of the seven alleles. 
gµmax, the growth parameter, maximum growth rate, of L. monocytogenes isolates growing in 
defined medium (DM) at 16oC. 
hNA, not available. 
iS, singleton, (i) for 10G-SLV-CCs and 10G-TLV-CCs, singletons were defined as STs differing 
from all of the other STs in more than one or more than three of the ten alleles, respectively, (ii) 
for 7G-CCs, singletons were defined as STs differing from all of the other STs in more than one 
of the seven alleles. 
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Table 2.2. Lineage II isolates used for 10-gene multilocus sequence typing (10G-MLST) 
analysis  
Strain IDa Source 10G-STb 
10G-
SLV-
CCc 
10G-
TLV
-CCd 
7G-
STe 
7G-
CCf 
µmaxg 
[log(OD
600/ml)/
day] 
FSL	  R2-­‐0559	  	   1998, food, sporadic 5	   1	   1	   11 11 0.054 
FSL	  J1-­‐0101	  	   1998, human, sporadic 5	   1	   1	   86 11 0.04 
FSL	  C1-­‐0111	  	   1998, human, sporadic 77	   Sh	   1	   NAi NA 0.037 
FSL	  F2-­‐0237	  	   1999, food (smoked salmon) 18	   S	   1	   NA NA 0.045 
FSL	  F2-­‐0141	  	   1999, human, sporadic 5	   1	   1	   NA NA 0.055 
FSL	  F2-­‐0048	  	   1999, human, sporadic 70	   1	   1	   NA NA 0.063 
FSL	  R2-­‐0011	  	   2000, food (RTE deli salad) 16	   1	   1	   NA NA 0.057 
FSL	  F6-­‐0154	  	   2000, food, US turkey deli meat outbreak 5	   1	   1	   86 11 0.053 
FSL	  F2-­‐0516	  	   2000, human, sporadic 16	   1	   1	   NA NA 0.02 
FSL	  F2-­‐0405	  	   2000, human, sporadic 71	   1	   1	   NA NA 0.054 
FSL	  R2-­‐0499	  	   2000, human, US turkey deli meat outbreak 76	   1	   1	   11 11 0.059 
FSL	  T1-­‐0073	  	   2001, food (raw Norweigan) 81	   S	   1	   NA NA 0.065 
FSL	  R2-­‐0487	  	   2001, food (RTE bagged salad) 74	   1	   1	   NA NA 0.059 
FSL	  L3-­‐0123	  	   2002, environment (floor drain) 72	   1	   1	   NA NA 0.061 
FSL	  F3-­‐0566	  	   2003, human, sporadic 73	   1	   1	   NA NA 0.066 
FSL	  F3-­‐0995	  	   2006, human, sporadic 18	   S	   1	   NA NA 0.055 
FSL R8-0879 2008, environment (floor drain) 75	   S	   1	   NA NA 0.061 
FSL	  X1-­‐0001	  	   1987, human, sporadic 69	   4	   3	   85 7 0.047 
FSL	  F2-­‐0194	  	   1999, human, sporadic 68	   S	   3	   7 7 0.063 
FSL	  L4-­‐0100	  	   2002, environment (fish processing floor mat) 49	   4	   3	   NA NA 0.059 
FSL	  L4-­‐0096	  	   2002, environment (fish processing plant drain) 50	   4	   3	   NA NA 0.059 
FSL	  F3-­‐0744	  	   2002, human, sporadic 3	   4	   3	   NA NA 0.058 
FSL	  F3-­‐0631	  	   2003, human, sporadic 3	   4	   3	   NA NA 0.048 
FSL	  F6-­‐0084	  	   2004, human, sporadic 3	   4	   3	   NA NA 0.055 
FSL R6-0896 2007, environment (floor drain) 3	   4	   3	   NA 7 0.064 
SLCC 5850 1924, animal (rabbit) 3	   4	   3	   12 7 NA 
FSL	  F2-­‐0539	  	   1924 animal (rabbit) 6	   11	   10	   35 9 0.044 
SLCC 2372 1935, human, sporadic 13	   11	   10	   122 9 NA 
SLCC 2479 1966, human, sporadic 6	   11	   10	   9 9 NA 
FSL	  J1-­‐0022	  	   human sporadic 13	   11	   10	   NA 9 0.052 
FSL	  G2-­‐0003	  	   human, reference strain 61	   S	   10	   210 9 0.034 
FSL	  J1-­‐0125	  	   human, sporadic 6	   11	   10	   NA 9 0.039 
FSL	  R2-­‐0561	  	   human, sporadic 6	   11	   10	   9 9 0.053 
FSL	  R2-­‐0089	  	   2000, food (RTE deli salad) 62	   12	   13	   NA NA 0.047 
FSL	  F2-­‐0515	  	   2000, food (RTE turkey deli meat) 15	   12	   13	   NA NA 0.039 
FSL	  L4-­‐0151	  	   2002, environment (raw salmon room floor 
drain) 15	   12	   13	   NA NA 0.044 
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Table 2.2 (Continued) 
SLCC 7179 1986, food (cheese) 51	   S	   S	   91 NA NA 
FSL	  J2-­‐0003	  	   1993,  animal (bovine), clinical 79	   S	   S	   89 NA 0.048 
FSL	  J2-­‐0054	  	   1993, animal (sheep), clinical 48	   S	   S	   412 S 0.061 
Finland1998 1998, Finland butter outbreak 10	   S	   S	   155 NA NA 
FSL	  C1-­‐0051	  	   1998, human sporadic 10	   S	   S	   NA NA 0.054 
FSL	  C1-­‐0115	  	   1998, human, sporadic 80	   S	   S	   370 S 0.047 
FSL	  F2-­‐0032	  	   1999, food (smoked whitefish) 66	   S	   S	   NA NA 0.054 
FSL	  F2-­‐0216	  	   1999, human, epidemic 10	   S	   S	   NA NA 0.054 
FSL	  F2-­‐0039	  	   1999, human, sporadic 63	   S	   S	   NA NA 0.049 
FSL	  E1-­‐0154	  	   2001, environment (soil) 65	   S	   S	   NA NA 0.048 
FSL	  R2-­‐0493	  	   2001, food (RTE deli salad) 64	   S	   S	   NA NA 0.018 
FSL	  L4-­‐0396	  	   2002, environment (finished product area 
drain) 67	   S	   S	   NA NA 0.048 
FSL	  N3-­‐0165	  	   2002, environment (soil) 78	   S	   S	   90 90 0.057 
08_5578 2008, Canadian deli meat outbreak 17	   S	   S	   292 8 NA 
08_9523 2008, Canadian deli meat outbreak 17	   S	   S	   120 8 NA 
aIsolates are listed in numerical order of the “Lineage”, and then in “10G-TLV-CC”  .  
b10G-ST, sequence type (ST) identified by using 10G-MLST scheme. 
c10G-SLV-CC, single-locus-variant-clonal complex identified by using 10G-MLST scheme and 
eBURST algorithm, where all STs in the clonal complex (CC) differ from one another in one of 
the ten alleles. 
d10G-TLV-CC, triple-locus-variant-clonal complex identified by using 10G-MLST scheme and 
eBURST algorithm, where all STs in the same CC differ from one another in no more than three 
of the ten alleles. 
e7G-ST, ST identified by using 7-gene multilocus sequence typing (7G-MLST) scheme. 
f7G-CC, CC identified by using 7G-MLST scheme, where all ST in the same CC differ from one 
another in one of the seven alleles. 
gµmax, the growth parameter, maximum growth rate, of L. monocytogenes isolates growing in 
defined medium (DM) at 16oC. 
hS, singleton, (i) for 10G-SLV-CCs and 10G-TLV-CCs, singletons were defined as STs differing 
from all of the other STs in more than one or more than three of the ten alleles, respectively, (ii) 
for 7G-CCs, singletons were defined as STs differing from all of the other STs in more than one 
of the seven alleles. 
iNA, not available 
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MLST. All of the 124 isolates were characterized using a previously described 10G-
MLST scheme (22), which includes DNA sequences of partial open reading frames for ten genes: 
ldh, lmo0490, prs, sigB, polC, rarA, lmo1555, pbpA, addB, and lmo2763 (22). This method was 
selected as it was designed to be used for the majority of Listeria species, not just 
monocytogenes, and has the potential to be more discriminatory with the inclusion of 10 genes 
rather than 7. The 10G-MLST data for the isolates from our collection (CUFSL, Table S2.1) can 
be found on Food Microbe Tracker (http://www.foodmicrobetracker.com). Sequence types based 
on 10G-MLST (10G-STs) (Table 2.1, 2.2) were determined by using DnaSP v.5 (25). For each 
10G-MLST locus, an allele number was given to each distinct sequence variant, and a distinct 
10G-ST number was attributed to each distinct combination of alleles at the ten genes. 10G-ST 
numbers were initially based on highest frequency for the 10G-STs, and were subsequently 
increased arbitrarily. 
The eBURST V3 (26) algorithm was used for the classification of single-locus-variant-
clonal complexes (10G-SLV-CCs) and triple-locus-variant-clonal complexes (10G-TLV-CCs). 
All 10G-STs assigned to the same 10G-SLV-CC and 10G-TLV-CC share identical alleles at nine 
and seven of ten loci, respectively. Singletons were accordingly defined as 10G-STs having at 
least two and four allelic mismatches with all other 10G-STs (Fig S2.1, Table 2.1, 2.2) for 10G-
SLV-CCs or 10G-TLV-CCs, respectively. The central 10G-ST of a clonal complex (CC) was 
defined as the ST that differed from the largest number of other STs at only a single locus or at 
three loci for 10G-SLV-CCs or 10G-TV-CCs, respectively. The goeBURST 1.2.1 (27) algorithm 
was used to visualize the relationship of the 10G-STs by generating a full minimum spinning tree 
with PHYLOViZ (www.phyloviz.net) (Fig. 2.1).  
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Figure 2.1. Ten major 10G-TLV-CCs and the minimum spanning tree generated by goeBURST 
for all 10G-STs  
Ten major 10G-TLV-CCs and the minimum spanning tree generated by goeBURST for 
all 10G-STs. 10G-TLV-CCs were identified by using 10G-MLST scheme and eBURST 
algorithm, where all 10G-STs of the same 10G-TLV-CC differ one another in no more than three 
of the ten alleles. Ten major 10G-TLV-CCs (defined as the 10G-TLV-CCs containing more than 
2 10G-STs) are depicted by red (lineage I) and green (lineage II) circles. Seven ECs and the 7G-
CCs are designated next to their corresponding 10G-TLV-CCs and specifically pointed to the 
group founder 10G-STs. The identified group founder 10G-STs are represented by light-green 
elements, and the other 10G-STs are represented by blue. The size of each element reflects the 
number of isolates within a 10G-ST. Locus variant levels (level 1-10) are shown on links 
between 10G-STs.  
.  
	  	  
	  
21	  
For 60 of the 124 isolates, CC (defined as 7G-CC in present study) were assigned to each 
strain based on sequence types (ST) (defined as 7G-ST in present study) (Table 2.1, 2.2) 
presented in the Pasteur MLST database 
(http://www.pasteur.fr/recherche/genopole/PF8/mlst/Lmono.html) and in the studies of Ragon et 
al. (20) and Cantinelli et al. (21). All 7G-STs assigned to the same 7G-CC share identical alleles 
at six of seven loci, and singletons were accordingly defined as 7G-STs having at least two 
allelic mismatches with all other 7G-STs (Table 2.1, 2.2). This scheme includes DNA sequences 
of partial open reading frames for seven genes including abcZ, bglA, cat, dapE, dat, ldh, and 
lhkA (20). There is one gene (ldh) in common between the 7G-MLST and10G-MLST scheme. 
Maximum growth rate in defined media. To simulate a nutrient-limited (e.g., food 
processing) environment for L. monocytogenes growth, we measured µmax of 105 L. 
monocytogenes isolates using a DM specific to L. monocytogenes (28) at 16oC, with 25 mM 
glucose as the carbon source. For growth prior to inoculation in DM, we followed the approach 
previously described by Stasiewicz et al. (29). In the DM, OD600 readings were taken from hour 
0~3 as time point 0 (started from the first detectable OD600 value of each sample), and at every 6 
or 12 hours after time point 0 until stationary phase (up to 96 hours). The four-factor modified 
logistic growth model described by Baranyi and Roberts (30) was used to calculate the growth 
parameter µmax, [log(OD600/ml)/day], for each strain. Regression was carried out by using the 
NLStools package (v 0.0-5) in R v2.6.2. For growth in DM, each strain was tested once; multiple 
strains per CC were considered replicates. 
Association of growth rates. One-way analysis of variance (ANOVA) were used to 
determine if µmax was significantly different between lineages and among 10G-TLV-CCs for the 
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105 strains tested (Fig. 2.1), where the values of the µmax served as the response. The linear 
model used for the ANOVA was: Y(µmax) = lineage or 10G-TLV-CC + strain + E(error). Strain 
was treated as a random effect. Significant difference between a given pair of lineages or 10G-
TLV-CCs was identified by the Student’s T test and Tukey HSD method (α = 0.05; JMP 7, SAS 
Institute, Inc., Cary, NC), respectively. Student’s T test p-value (P) and Tukey HSD adjusted p-
values (adj. P) are reported as significant when < 0.05. 
RESULTS AND DISCUSSION 
Ten-gene MLST allows for a high level of discrimination of L. monocytogenes. Based 
on 10G-MLST, the 124 isolates were found to represent a total of 81 10G-STs (Fig S2.1, Table 
2.1, 2.2). Four 10G-STs, 10G-ST1, 2, 3, and 4 predominated, with five or more isolates 
belonging to each of the 4 STs, and cumulatively account for 21% isolates (26/124). Among 
them, 10G-ST1, 2 and 4 belong to lineage I, and 10G-ST3 belongs to lineage II. Overall, lineage 
I (39 STs, 64 isolates) contains more STs than lineage II (34 STs, 51 isolates). All 10G-STs 
containing more than one isolate originated from more than one source, which is consistent with 
the finding of Haase et al. (6). The 10G-STs, 10G-ST1, 2 and 3, all included outbreak related 
isolates and correspond to 7G-ST3, 7G-ST2, and 7G-ST6, respectively. Interestingly, despite that 
two isolates from the US hot dog outbreak FSL F6-0366 (H7858) and FSL N1-0225 (H7550) 
were both assigned as 7G-ST6 previously, they were differentiated into two distinct 10G-STs 
(10G-ST4 and 10G-ST29). The 10G-MLST showed a higher discriminatory power (D = 0.9842) 
(31) compared to 7G-MLST (D= 0.9774), indicating that, although with some exceptions, 10G-
MLST is generally more discriminatory than 7G-MLST (Table 2.1, 2.2). This suggests that 10G-
MLST is an effective approach for characterizing L. monocytogenes DNA sequence 
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polymorphism with a higher resolution compared to the 7G-MLST scheme. 
While 10G-MLST shows increased discrimination over 7G-MLST, most likely these 
methods will be replaced with whole genome sequencing (WGS) (32), which is being adopted by 
public health agencies for routine surveillance (33, 34), including an MLST-based approach to 
analyze genome sequence data (wgMLST) (35). However, interpreting genetic variation will 
present new challenges to investigation using WGS or wgMLST, whereas the use of smaller 
number of genes for clustering may still be useful and efficient to define genetically distinct 
groups with phenotypic differences. In addition, 7G- or 10G-MLST data will be easily 
comparable with genome based data, since the necessary sequences can be easily extracted from 
WGS data. 
eBURST clustered 124 isolates into 12 10G-SLV-CCs and 13 10G-TLV-CCs. We 
used the eBURST algorithm to identify 12 10G-SLV-CCs and 42 singletons from 81 10G-STs, 
where all 10G-STs belonging to the same 10G-SLV-CCs share identical alleles at nine of the ten 
loci. Two 10G-SLV-CCs, 10G-SLV-CC1 (12 isolates, 8 STs) and 10G-SLV-CC2 (16 isolates, 6 
STs), predominated and accumulatively accounted for 23% isolates (28/124), and 17% of the 
10G-STs (14/81); they belong to lineage II and lineage I, respectively. Overall, lineage I (8 10G-
SLV-CCs, 11 singletons) contains more 10G-SLV-CCs than lineage II (4 10G-SLV-CCs, 22 
singletons). A large proportion of the outbreak-associated isolates were classified into 10G-SLV-
CC2, accounting for 42% of the outbreak-associated isolates (10/24). Overall, isolate 
classifications into 10G-SLV-CCs and 7G-CCs were consistent for the majority of the clonal 
complexes (Table 2.1, 2.2) with some exceptions, for instance, isolates FSL J1-0169 and FSL 
R2-0182 assigned as 7G-CC5 were differentiated by 10G-MLST into two singletons. 
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A less stringent approach allowing three-locus variants between members identified 13 
10G-TLV-CCs and 31 singletons among the 124 isolates (Table 2.1, 2.2). This approach allowed 
more isolates to be clustered into CCs, and reduced the number of singletons, facilitating a better 
understanding of the relationship between isolates. Among the 13 10G-TLV-CCs, ten CCs that 
each contain more than two 10G-STs were highlighted in Fig. 2.1, and account for 69% isolates 
(85/124) and 60% of 10G-STs (49/81) (Table 2.1, 2.2). The 26 outbreak-associated isolates were 
distributed in six of the 13 distinct 10G-TLV-CCs, including five of the 10G-TLV-CCs that each 
represent one EC (Fig. 2.1, Table S2.1). Among them, each of the ECs only reciprocally 
corresponds to one 10G-TLV-CCs , showing a consistency between the classification into ECs 
and 10G-TLV-CCs, which is similar to the findings of Cantinelli et al. (21) that MLST based 
CCs correspond to the EC classification. 
Growth rates show considerable differences between lineages and between 10G-
TLV-CCs. Our data showed that L. monocytogenes had highly variable µmax across the 105 
isolates in DM at 16oC, ranging from 0.012 to 0.066 log(OD600/ml)/day (Table 2.1, 2.2). More 
specifically, a one-way ANOVA model with lineage effect (two levels: lineage I and II) for the 
growth parameter µmax showed a significant effect (P = 0.0059) of lineage on µmax (Table 2.3). 
Lineage I isolates had significantly lower (P < 0.05) average µmax [0.045 ± 0.010 
log(OD600/ml)/day] compared to lineage II isolates [0.052 ± 0.011 log(OD600/ml)/day] (Table 
2.3). In contrast, Bergholz et al. (10) demonstrated that lineage I strains had significantly higher 
growth rate than lineage II strains in brain heart infusion broth (BHIB) with 6% salt at 37oC. 
Moreover, our previous study on L. monocytogenes growth on cold smoked salmon and in 
modified BHIB with 4.65% salt at 7oC showed that, there was no significant difference between 
the average µmax of lineage I and lineage II strains under either of the growth conditions (11). 
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Possible explanations for these observed differences include the high salt content and the 
difference of the incubation temperatures, while the DM used in the present study simulated a 
nutrient limited food-processing environment, usually with relatively low temperatures (about 
16oC). Similarly to our finding, Bruhn et al. (36) found that lineage II strains outcompeted 
lineage I strains in selective enrichment media. However, based on the findings of Haase et al. (6) 
that environmental and food isolates are equally distributed between lineage I and II, it is not 
likely that the ability of lineage II strains to grow faster in non-host environments (especially 
nutrient limited food processing environments) can increase the prevalence of all lineage II 
strains in environmental and food samples. Our observation, combined with the findings of 
Haase et al. (6), may suggest that it is more likely that just some of the subgroups of lineage II 
strains can grow faster than lineage I strains in such environments. 
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Table 2.3. Lineage-specific effects and 10G-TLV-CC-specific effects on maximum growth rate 
of L. monocytogenes isolates grown in defined medium at 16oC  
Lineage (no. isolates) 
µmaxa 
[log(OD600/ml)/day] 
10G-TLV-CCb (no. isolates) µmax [log(OD600/ml)/day] 
Lineage I (57) 0.045 ± 0.010c Ad CC2 (14) 0.046 ± 0.011 AB 
CC4 (9) 0.040 ± 0.015 B 
CC6 (9) 0.050 ± 0.007 AB 
   
   
Lineage II (44) 0.052 ± 0.011 B CC1 (17) 0.054 ± 0.012 A 
CC3 (8) 0.057 ± 0.006 A 
CC10 (5) 0.045 ± 0.009 AB 
aµmax, the growth parameter, maximum growth rate, of L. monocytogenes isolates growing in 
defined media (DM) at 16oC. 
b10G-TLV-CC, triple-locus-variant-clonal complex identified by using 10-gene multilocus 
sequence typing (10G-MLST) scheme and eBURST algorithm, where all sequence types in the 
same clonal complex (CC) differ from one another in no more than three of the ten alleles. 
cResults are summarized by means ± standard deviations for strains of each category, each strain 
was tested once. 
dMeans within a given column with the same letter are not statistically different from each other 
(overall α = 0.05, Tukey's correction). 
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To further compare the growth rate of subgroups of lineage I and lineage II strains, a one-
way ANOVA model with 10G-TLV-CC effect (six levels: 10G-TLV-CC1, 2, 3, 4, 6, 10, each 
having at least five isolates) for the growth parameter µmax was conducted, and showed 
significant effect  (P = 0.0087) of 10G-TLV-CCs on µmax (Fig. 2.2, Table 2.3). The 10G-TLV-
CC4 showed the lowest average µmax (0.040 ± 0.015 log(OD600/ml)/day) and was significantly 
lower (adj. P < 0.05) than 10G-TLV-CC1 (0.053 ± 0.011 log(OD600/ml)/day) and 10G-TLV-CC3 
(0.057 ± 0.006 log(OD600/ml)/day) (Fig. 2.2, Table 2.3). The average µmax of each of the 10G-
TLV-CC2 (7G-CC2), 10G-TLV-CC 6 (7G-CC6) and 10G-TLV-CC10 (7G-CC9) was not 
significantly different (adj. P > 0.05) from the others (Fig. 2.2, Table 2.3). The 10G-TLV-CC4, 
representing partial lineage I strains, corresponds to 7G-CC3. The 10G-TLV-C1 and 10G-TLV-
C3, representing partial lineage II strains, correspond to 7G-CC11 and 7G-CC7 (Table S2.1). 
Interestingly, it has been reported that 7G-CC3 (10G-TLV-CC4) ranked among the 4 most 
common clones (7G-CC2, 7G-CC1, 7G-CC3, 7G-CC9) in the world, and is one of the most 
highly prevalent 7G-CCs (7G-CC1, 7G-CC2 and 7G-CC3) in lineage I (Chenal-Francisque et al., 
2011). According to our result, it seems that the majority of the most prevalent 7G-CCs 
aforementioned, do not have a significant higher growth rate in DM as compared to the less 
prevalent 7G-CCs.  
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Figure 2.2. Boxplots of the distribution of L. monocytogenes growth parameter µmax for six 
major 10G-TLV-CCs 
Boxplots of the distribution of L. monocytogenes growth parameter µmax for six major 
10G-TLV-CCs (defined as each has five or more isolates) in defined media at 16 °C. 10G-TLV-
CC1, 3, and 10 represent lineage II strains, and 10G-TLV-CC2, 4 and 6 represent lineage I 
strains. The horizontal bar indicates the median for each treatment. Boxes represent the 25th to 
75th percentile of the values; whiskers represent the 10th and 90th percentiles. Filled circles 
represent values outside the 10th to 90th percentiles. Boxplots with the same letter are not 
statistically different from each other (overall α = 0.05, Tukey HSD correction).  
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We also assessed whether the source or serotype of isolates may influence µmax in DM. However, 
a one-way ANOVA model with source effect (human, food, environment and animal as four 
levels of this effect) or serotype (1/2a, 1/2b and 4b as three levels of this effect) for the growth 
parameter µmax did not show significant effect (P > 0.05) on µmax. Although various studies have 
characterized L. monocytogenes isolates to probe for phenotypic differences between L. 
monocytogenes lineages or serotypes (8, 10, 11, 29, 37), our data suggest that it is necessary to 
compare between L. monocytogenes CCs, which are defined by sequence typing methods such as 
10G-MLST, when studying the phenotypes of L. monocytogenes, as classification by lineage or 
serotype may not be able to reflect the genetic basis for phenotype difference between different 
phenotypes of L. monocytogenes clusters. 
CONCLUSION 
Our findings demonstrated that the 124 L. monocytogenes isolates are genetically diverse, 
and the outbreak-associated isolates were wide-spread through the diversity of L. monocytogenes. 
We also identified that, among the 105 isolates tested, there was considerable variation in 
maximum growth rate in a nutrient limited growth condition. We found that certain genetic 
subgroups of lineage II strains could grow faster than some genetic subgroups of lineage I strains 
under this nutrient limited condition, which may facilitate their persistence in non-host 
environments, thus leading to a higher risk of food contamination and transmission of this 
pathogen through foods to humans. Our data highlighted the importance of using molecular 
typing methods that are amenable to evolutionary analysis for a further understanding of the 
phylogenetic distribution of L. monocytogenes isolates and for the phenotypic characterization of 
genetic subgroups of L. monocytogenes. Classification of L. monocytogenes based on DNA 
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sequence polymorphism, in the long term, may facilitate the surveillance, detection, and control 
of L. monocytogenes strains that are more likely to cause outbreaks and sporadic listeriosis cases. 
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CHAPTER 3  
EFFICACY OF DIFFERENT ANTIMICROBIALS ON INHIBITION OF LISTERIA 
MONOCYTOGENES GROWTH IN LABORATORY MEDIUM AND ON COLD-SMOKED 
SALMON 
 
Published in: International Journal of Food Microbiology 165:265-275 
 
ABSTRACT 
L. monocytogenes is of particular concern in cold-smoked fish products as it can survive 
curing and cold-smoking, and can subsequently grow from low numbers to potentially hazardous 
levels during refrigerated storage. The purpose of this study was to (i) quantify the effects of 
organic acids, nisin, and their combinations on controlling L. monocytogenes growth on cold-
smoked salmon at refrigeration temperatures, (ii) identify synergistic interactions of binary 
combinations of these antimicrobials, and (iii) determine if results from laboratory growth media 
can predict antimicrobial efficacy on cold-smoked salmon. Strains representing the genetic 
diversity of L. monocytogenes lineages I and II were grown in brain heart infusion (BHI) broth as 
well as on the surface of commercially produced wet-cured, cold-smoked salmon slices at 7oC. 
BHI broth and cold-smoked salmon were supplemented with sodium diacetate (SDA, 0.14% 
water phase (w.p.)), potassium lactate (PL, 2% w.p.), nisin (NI, 50 ppm), and binary 
combinations of inhibitors at the same levels. Cell densities of L. monocytogenes were measured 
over time and used to calculate growth parameters, including initial cell density (N0), lag phase 
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(λ), maximum growth rate (µmax), and maximum cell density (Nmax) for each antimicrobial 
treatment. N0 was significantly lowered by addition of NI with a similar average reduction on 
salmon (2.02 ± 0.99 log(CFU/g)) and in BHI (1.51 ± 0.83 log(CFU/ml)). Among all 
antimicrobial treatments, the combination of PL and SDA led to the greatest increase in λ both 
on salmon (7.1 ± 3.6 days) and in BHI (9.7 ± 3.8 days) when compared to the controls. The 
combination of PL and SDA had synergistic effects on increasing λ and lowering Nmax both in 
BHI and on salmon. Among all the treatments tested, the combination of NI and PL led to the 
greatest reductions in Nmax on salmon. We observed positive correlations between the growth 
parameters obtained from BHI broth and cold-smoked salmon, indicating that growth of L. 
monocytogenes in broth, to some extent, qualitatively reflected characteristics of growth on cold-
smoked salmon under antimicrobial stresses. Results from BHI could quantitatively predict the 
variability of growth parameters obtained from salmon for lineage II strains, but not for lineage I 
strains. Although results from laboratory growth medium may not provide exact predictions of 
antimicrobial efficacy on cold-smoked salmon, they could be used to rapidly identify effective 
combinations for further examination on cold-smoked salmon.  
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INTRODUCTION 
Listeria monocytogenes is an opportunistic foodborne pathogen that causes a severe life-
threatening disease, particularly in neonates, pregnant women, elderly people and those with a 
compromised immune system. L. monocytogenes can be found in many environments and is 
capable of surviving under diverse environmental conditions, including those encountered during 
food processing and refrigerated storage (1). The ability to grow at low temperatures elevates the 
risk of food contamination and transmission of this pathogen through ready-to-eat (RTE) foods 
to humans. Characterization of L. monocytogenes isolates by multiple subtyping methods (2-4) 
has shown that strains can belong to one of four distinct genetic lineages (5, 6) with apparent 
differences in virulence (7, 8), growth under adverse conditions (9, 10) and gene expression 
related to virulence and stress response (11, 12). While strains in lineage I are widely distributed 
in foods as well as animals, in many countries this lineage is overrepresented among isolates 
from sporadic and epidemic cases of human listeriosis, and shows a greater pathogenic potential 
than lineage II strains (7, 13). Lineage II strains, on the other hand, are most commonly isolated 
from food and the environment (7, 14), possibly because strains from this lineage can 
outcompete lineage I strains in some selective media and isolation protocols (15). These genetic 
variations of L. monocytogenes clearly illustrate the importance of using strains representing 
different lineages in studies on L. monocytogenes stress survival and virulence as well as in 
validation studies for L. monocytogenes control strategies. 
L. monocytogenes has been identified as of particular concern in RTE smoked fish products 
including cold-smoked salmon (16-18) because the heat applied during processing is not 
sufficient to inactivate L. monocytogenes. In addition, typical product characteristics of cold-
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smoked seafood including pH, water activity, salt, sodium nitrite, and phenolic components are 
not sufficient to control the growth of L. monocytogenes (19, 20). L. monocytogenes can multiply 
from low numbers to potentially hazardous levels in vacuum-packed cold-smoked salmon during 
long-term refrigerated storage, consequently, this product has been identified as having a high 
risk per serving for listeriosis (17, 21). During processing and post-smoking handling, cross 
contamination from the processing plant environment to the product can occur (22, 23). While 
improved sanitation measures can reduce L. monocytogenes contamination (24), complete 
elimination of L. monocytogenes from cold-smoked fish processing environments has been 
impossible (25). Therefore, it is critical to develop control strategies that prevent or reduce 
growth of this pathogen in RTE seafood products, including cold-smoked salmon. 
One potential method to control L. monocytogenes in RTE seafood is the use of bactericidal 
or bacteriostatic antimicrobial agents, such as nisin, potassium lactate and sodium diacetate. 
Nisin (NI), a bacteriocin produced by Lactococcus lactis, is known to reduce the population of L. 
monocytogenes in various food products, including cold-smoked salmon (26-29). Nisin uses 
Lipid II as a docking molecule to form pores in the bacterial cell membrane. Lipid II is the 
membrane-bound peptidoglycan precursor that is essential for bacterial cell-wall biosynthesis. 
The specific recognition and binding of Lipid II by nisin results in effective permeabilization of 
the cytoplasmic membrane of vegetative cells and the inhibition of cell wall biosynthesis. This 
leads to leakage of intracellular fluids, disruption of the proton motive force, and eventually the 
death of the cell (30, 31). Salts of organic acids, such as potassium lactate (PL) and sodium 
diacetate (SDA), are widely used in the RTE meat industry as antimicrobial agents (32), and 
have also been evaluated for use in cold-smoked salmon (21, 33). Organic acids cross the cell 
membrane in the undissociated form and dissociate in the cytoplasm causing a decrease in 
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intracellular pH (34), which has significant impacts on cell metabolism, resulting in reduced 
growth (35, 36). 
Combining antimicrobial agents in a food system can often enhance antimicrobial action 
against pathogenic and/or spoilage organisms (37-39). Studies in laboratory media (40, 41) and 
studies in food products (21, 33, 42) have been conducted to evaluate the efficacies and identify 
synergistic effects of antimicrobials. As challenge studies in food matrices can be costly and 
time-consuming, there is potential to utilize antimicrobial efficacy data generated from studies in 
laboratory medium to predict efficacy in food matrices. The efficacy of and potential synergy 
between NI and PL or NI and SDA on L. monocytogenes growth in BHI broth or on cold-smoked 
salmon has rarely been evaluated quantitatively, and potential correlations between growth of L. 
monocytogenes in laboratory medium and in the food matrix treated with antimicrobials are 
currently unknown. Strong correlations would allow data generated from laboratory medium to 
be used as an effective and rapid initial screen for antimicrobial efficacy. 
Building on our previous study demonstrating the synergistic inhibitory effects of PL and 
SDA on growth of L. monocytogenes in laboratory medium (40), the purpose of this study was to 
validate NI, PL and SDA, used alone or in binary combinations, as effective antimicrobials 
against L. monocytogenes in modified BHI broth and on vacuum packed cold-smoked salmon at 
7oC. Antimicrobials were tested using strains from lineages I and II to assess efficacy across 
genetic diversity. We were interested in identifying i) significant effects of antimicrobials on L. 
monocytogenes growth parameters in BHI and/or on salmon, ii) significant differences in the 
effect of antimicrobial on growth parameters dependent on genetic lineage of L. monocytogenes, 
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iii) if synergies existed between antimicrobials when used in combination, and (iv) the 
correlation between antimicrobial efficacies in BHI broth and on cold-smoked salmon. 
MATERIAL AND METHODS 
Strains and inoculum preparation. L. monocytogenes isolates (Table 3.1) were streaked 
from frozen stocks of BHI culture stored at -80oC in 15% glycerol onto BHI agar plates and 
incubated at 37oC for 24 h. Single colonies of each strain were individually inoculated into 5 ml 
of BHI broth (in 16 mm tubes), and were incubated at 37oC, with shaking (230 rpm) for 18 h 
(Series 25 Incubator, New Brunswick Scientific, Edison, NJ ). After 18 h, 50 µl BHI culture was 
inoculated into 5 ml chemically defined medium (DM) (43) and grown to stationary phase in 
DM at 16oC statically, as described previously (40).  
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Table 3.1. Subtype and source information for Listeria monocytogenes strains used in this study 
Strain Lineagea Serotypea Ribotypea MLSAb Sourcea References 
FSL J1-194 I 1/2b 1042B 9 Human, sporadic (44) 
FSL F2-693 I 1/2b 1042B 29 Human, sporadic (45) 
FSL L3-051 I 1/2b 1042C 30 RTE salmon (45) 
FSL L4-060 I 1/2b 1043A 1 Smoked fish plant drain (24) 
FSL L4-400 I 1/2b 1052A 1 Smoked fish plant drain (24) 
FSL J1-110 I 4b 1038B 5 Cheese, epidemic (46) 
FSL R2-501 I 4b 1042B 27 Human, epidemic (46) 
FSL J1-126 I 4b 1042B 5 Human, epidemic (46) 
FSL N1-061 I 4b 1044A 7 Salmon brine (16) 
FSL F6-366 I 4b 1044A 6 RTE meat, outbreak (47) 
FSL T1-073 II 1/2a 1023C 46 Raw salmon (48) 
FSL X1-001 II 1/2a 1030A 41 Human, skin lesion (49) 
FSL F2-039 II 1/2a 1030B 39 Human, sporadic (44) 
FSL L4-396 II 1/2a 1039C 31 Smoked fish plant drain (24) 
FSL C1-111 II 1/2a 1039E 48 Human, sporadic (44) 
FSL F2-032 II 1/2a 1045B 45 RTE smoked whitefish (45) 
FSL R2-559 II 1/2a 1053A 51 RTE meat (47) 
FSL L4-151 II 1/2a 1062A 38 Smoked fish plant drain (24) 
FSL F2-237 II 1/2a 1062D 47 RTE smoked salmon (45) 
FSL F2-194 II N/D 1030A 42 Human, sporadic (13) 
aSubtyping and source information can be found in Food Microbe Tracker, available at: 
http://www.foodmicrobetracker.com 
bMLSA (Multi-locus Sequence Analysis) data was collected using the methods described by den 
Bakker et al. (50)  
	  	  
	  
43	  
Growth and enumeration of L. monocytogenes in BHI broth. BHI broth was modified to 
have 4.65% waterphase (w.p.) NaCl, pH 6.1 to simulate the levels typically present in 
commercially processed cold-smoked salmon (40) and supplemented with SDA (Macco 
Organiques, Inc., Valleyfield, Quebec, Canada), PL (PURASAL Hi Pure P-Plus, PURAC 
America, Inc.), NI (Nisaplin, contains approximately 2.5% nisin, Danisco, Inc., Denmark) or 
combinations of two antimicrobials. Growth of L. monocytogenes was specifically assessed in 
BHI broth with seven different treatments including (i) no added inhibitors (CTRL), (ii) 0.14% 
w.p. SDA, (iii) 2% w.p. PL, (iv) 50 ppm w.p. NI, (v) PLSDA (2% PL + 0.14% SDA), (vi) 
NISDA (50 ppm NI + 0.14% SDA), or (vii) NIPL (50 ppm NI + 2% PL). As the pKa values are 
constants for PL (3.79) and diacetate (4.79, the pKa for acetate, the base anion of diacetate) (41), 
the concentrations of undissociated lactate and acetate in a pH 6.1 solution are 0.71 and 0.39 
mM/kg for solutions containing PL and/or SDA, respectively. For the remainder of this article, 
we refer to the water-phase percentages for consistency with recent work evaluating these 
antimicrobials in food products. For each strain and treatment, 75 ml fresh medium was 
aseptically aliquoted into sterile, 300-ml Erlenmeyer shake flasks with metal caps (Bellco Glass 
Co., Vineland, NJ). After chilling to 7oC, the treatment media were inoculated with stationary-
phase cells, grown in DM, for a target population of approximately 1 x 106 CFU/ml, followed by 
incubation at 7°C. To monitor L. monocytogenes growth, cell density was determined every day, 
starting from day 0, until growth initiated, and then every other day until entry into stationary 
phase; measurement was stopped after three time points were taken during stationary phase. For 
all samples, cultures were diluted with phosphate-buffered saline (PBS) and spiral-plated in 
duplicate onto both BHI agar and Oxford agar plates (Becton Dickinson, Sparks, MD #222530 
and Oxford, Cambridge, UK, SR0140) using an Autoplate 4000 (Spiral Biotech, Inc., Norwood 
	  	  
	  
44	  
MA). BHI plates were incubated at 37 oC for 24 h, and Oxford agar plates were incubated at 30 
oC for 48 h, before colonies were counted with the Colony Counter (Spiral Biotech, Inc.). 
Growth and enumeration of L. monocytogenes on cold-smoked salmon.  Commercially 
produced wet-cured cold-smoked salmon fillets were stored at -20 oC and thawed at 4°C 
overnight. A mixture of natural hardwood and fruitwood was used to cold smoke the salmon. 
The physicochemical characteristics of the salmon fillets have been described by Kang et al. (51). 
Salmon slices were weighed (25 ± 0.5g each) and transferred into sterile petri dishes. For each 
treatment, 700 µl of concentrated PL, SDA, and/or NI solutions were added on the surface of 
each sample to achieve the same concentration of antimicrobials as used in BHI broth, and 
spread with sterile plastic cell spreaders. The treated salmon slices were stored for 15 min in a 
biosafety cabinet to allow the treatment solutions to be absorbed. The treated surface was 
inoculated with stationary-phase DM cultures diluted in 0.1% sterile peptone water, for a target 
population of approximately 1 x 104 CFU/g. Inoculated salmon slices were then stored in a 
biosafety cabinet for another 15 min before being transferred into storage bags (oxygen 
permeability 38.10 cc/m2 - 40.50 cc/ m2 at 23°C dry/24 hrs) and packaged using a commercial 
vacuum sealer (FoodSaver, model V2244). All samples were stored at 7°C. L. monocytogenes 
numbers were enumerated at different time points, based on treatment, including (i) day 0, 1, 2, 7, 
12, 17, 23, and 28 for CTRL treatment; (ii) 0, 1, 2, 8, 14, 20, 26, and 32 for SDA treatment; (iii) 
day 1, 2, 3, 8, 14, 20, 26, and 32 for NI, NISDA and NIPL treatment; and (iv) day 0, 1, 5, 11, 17, 
23, 29, 35, and 41 for PL and PLSDA treatment. Vacuum-packed salmon samples were 
aseptically opened and stomached for 30 s at high speed setting (Seward, Stomacher 400, UK) 
with 50 to 100 ml of 0.1% sterile peptone water transferred into each bag. Salmon homogenates 
were spiral-plated on Oxford agar using the Autoplate 4000. Un-inoculated salmon samples were 
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spiral-plated onto Oxford agar to confirm the absence of L. monocytogenes. Oxford agar plates 
were incubated at 30 oC for 48 h, before colonies were counted with the Colony Counter (Spiral 
Biotech, Inc.). The background microbiota (mainly lactic acid bacteria) of the salmon slices used 
in the present study has been tested (by using nitrite-actidione-polymyxin agar) and discussed by 
Kang et al (51). 
Monitoring of incubation temperatures. Incubator temperature was recorded every 20 min 
by an automated thermal recorder during the storage of both BHI broth cultures and cold-smoked 
salmon samples. The average recorded incubation temperature was 7.0 ± 0.5°C.  
Growth model and statistical analysis. Measurements of L. monocytogenes cell density 
over time in BHI broth and on cold-smoked salmon were fitted with a three-phase linear model 
described by Buchanan et al. (52) using the NLStools package (v0.0-11) in R v 2.13.0. Four 
growth parameters including lag phase (λ, [day]), maximum growth rate (µmax, [log(CFU/ml/)day] 
for BHI, [log(CFU/g)/day] for salmon), initial cell density (N0, [log(CFU/ml)] for BHI, 
[log(CFU/g)] for salmon) and maximum cell density (Nmax, [log(CFU/ml)] for BHI, [log(CFU/g)] 
for salmon) were calculated for each strain for each treatment from this model. For each 
treatment in BHI broth and on salmon, each strain was tested once; multiple strains per lineage 
were considered replicates. 
To better characterize the bactericidal effect of treatments on L. monocytogenes, the 
differences between N0 of CTRL and each antimicrobial treatment were calculated for each 
strain as a new growth parameter: N0 reduction (Nr). The Nmax reduction (Nmaxr) was calculated 
from the difference between Nmax of CTRL and the antimicrobial treatments for each strain to 
standardize the effect of antimicrobial treatments on Nmax reduction. Further, predicted time for 1 
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log L. monocytogenes growth (Tlog) for each treatment and each strain was calculated from the 
Buchanan model with the formula Tlog = λ + 1/µmax. 
Two-way analysis of variance (ANOVA) was used to determine if the effect of antimicrobial 
treatments, genetic lineage, as well as the interaction between treatment and lineage, were 
significant for each parameter from growth in broth and on salmon, respectively, where the 
values of the growth parameters served as the response. The linear model used for the ANOVA 
was: 
Y (growth parameter) = treatment︱lineage + strain + E(error)  
where “︱” indicates a full factorial model of the grouped parameters, and strain was treated as a 
random effect. Significant difference between a given pair of antimicrobial treatments were 
identified by the Tukey HSD method (α = 0.05; JMP 7, SAS Institute, Inc., Cary, NC). Tukey 
HSD adjusted p-values (adj. P) are reported as significant when < 0.05. To determine if there 
were significant differences between the responses of lineage I strains and lineage II strains for 
each antimicrobial treatment, the student’s t test was used to compare the values of each growth 
parameter between lineages within each treatment. To examine the synergistic effects of 
combinations of the antimicrobials on growth of L. monocytogenes, a two-way ANOVA model 
on the interaction between PL and SDA, NI and SDA, as well as NI and PL, were carried out. In 
each ANOVA model, the two antimicrobials tested were taken as fixed effects with two levels: 
presence or absence of the antimicrobial. The linear model used for the ANOVA was: 
Y (growth parameter) = A1︱A2 + lineage + strain + E(error) 
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where “︱” indicates a full factorial model of the tested parameters, A1 and A2 indicates a pair 
of two different antimicrobials among PL, SDA and NI. Lineage was treated as a fixed effect and 
strain was treated as a random effect. To investigate the correlation between the antimicrobial 
efficacies in BHI and on salmon, we used linear regression to describe the relationship between 
growth parameters from salmon and those from BHI. Growth parameters from salmon were 
fitted with a linear equation as a function of those from BHI using the procedure of linear 
regression model (JMP 7, SAS Institute, Inc., Cary, NC). The mathematical equation of the 
fitting is: 
Growth Parameter (salmon) = α + β × Growth Parameter (BHI). 
where α is the intercept, and β is the estimated coefficient (slope). As the correlations varied 
among lineages and treatments with or without NI, we split the data into two groups, one with 
parameters from treatments with organic acid salts only (PL, SDA, PLSDA), the other with 
parameters from treatments with NI (NI, NISDA, NIPL); and we analyzed the data by lineage 
within each group. Since organic acid salts did not show any effect on Nr, this parameter was not 
included in the analysis for organic acid treatments; the growth parameters λ, µmax, Tlog, Nmax and 
Nmaxr were examined. For treatments with NI, we focused on the growth parameters Nr, Nmax and 
Nmaxr, which described the bactericidal effect of NI. 
RESULTS 
We quantified the effects of antimicrobials on growth of 20 L. monocytogenes strains 
representing diverse genetic backgrounds in BHI broth and on cold-smoked salmon (Table 3.1) 
Strains FSL T1-073 and FSL X1-001 did not show obvious growth for most of the treatments on 
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salmon. Hence, the analyses reported here were based on 20 strains for BHI (10 strains in lineage 
I and 10 strains in lineage II) and 18 strains for salmon (10 strains in lineage I and 8 strains in 
lineage II).  
Treatments with NI significantly reduced initial cell density. Among the six 
antimicrobial treatments, ANOVA indicated that the growth parameter Nr for SDA, PL, and 
PLSDA was not significantly different from zero (adj. P > 0.05); while all treatments containing 
NI had Nr that were significantly greater than zero across L. monocytogenes genetic lineages (adj. 
P < 0.05), both in BHI and on salmon (Table 3.2; Fig. 3.1A, B). Nr caused by treatments with NI 
(alone or in combination) ranged from 0.34 to 3.82 log(CFU/ml) in BHI and from 0.08 to 4.00 
log(CFU/g) on salmon. In BHI, a comparison of Nr between lineages within each treatment using 
student’s t test revealed that Nr of lineage II strains were significantly greater in the presence of 
NI, as compared to lineage I strains (Table 3.2; Fig. 3.1A; student’s t test: P < 0.05). As shown in 
Table 3.2 and Fig. 3.1A, the average Nr of lineage II strains in BHI for NI, NISDA and NIPL 
were all more than half log(CFU/ml) higher than those of lineage I strains. On salmon, a lineage-
dependent effect of NI on Nr was observed (Table 3.2; student’s t test: P < 0.05), opposite of that 
in BHI, where average Nr of lineage I strains was more than half log(CFU/ml) greater than that 
of lineage II strains. In BHI, NI and PL in combination increased Nr compared to using NI alone 
or NI combined with SDA (adj. P < 0.05). However, the average Nr of NIPL was not 
significantly different from that of NI on salmon (adj. P > 0.05). Adding SDA to NI led to an 
antagonistic effect on Nr compared to using NI alone on salmon, which was identified by a 
significant interaction effect (P < 0.05) for a two-way ANOVA between treatments with NI and 
treatments with SDA. Taken together, these data indicate that addition of SDA or PL to NI did 
not significantly increase the bactericidal efficacy of NI on salmon.  
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Table 3.2. Antimicrobial treatment effects and lineage-specific effects on maximum growth rate 
and initial cell density reduction for Listeria monocytogenes at 7oC 
Treatment 
BHI  Salmon 
Total Lineage I   Lineage II  Total Lineage I   Lineage II 
 
Nr: Broth [log(CFU/ml)]; Salmon [log(CFU/g)] 
 
SDA 0.02 ± 0.09a Ab -0.02 ± 0.09 c = d 0.06 ± 0.09  0.01 ± 0.08 A 0.01 ± 0.10 = 0.01 ± 0.05 
PL  0.10 ± 0.15 A 0.08 ± 0.13 = 0.12 ± 0.17  0.04 ± 0.08 A 0.05 ± 0.09 = 0.02 ± 0.07 
PLSDA 0.15 ± 0.20 A 0.15 ± 0.21 = 0.16 ± 0.22  0.01 ± 0.09 A 0.00 ± 0.12 = 0.03 ± 0.05 
            
NI 1.51 ± 0.83 B 1.20 ± 0.70 < 1.82 ± 0.90  2.02 ± 0.99 C 2.30 ± 1.14 > 1.67 ± 0.68 
NISDA 1.43 ± 0.78 B 1.17 ± 0.78 < 1.69 ± 0.76  1.45 ± 0.79 B 1.51 ± 0.89 = 1.38 ± 0.69 
NIPL 2.01 ± 0.95 C 1.69 ± 0.99 < 2.32 ± 0.90  2.22 ± 0.82 C 2.40 ± 1.08 = 1.99 ± 0.23 
 
µmax: Broth [log(CFU/ml)/day]; Salmon [log(CFU/g)/day] 
 
CTRL 0.38 ± 0.07 A  0.36 ± 0.05  = 0.39 ± 0.09  0.32 ± 0.08 AB 0.33 ± 0.06 = 0.30 ± 0.10 
            
SDA 0.33 ± 0.05 ABC 0.30 ± 0.03 = 0.36 ± 0.06  0.23 ± 0.07 BCD 0.24 ± 0.06 = 0.22 ± 0.08 
PL  0.28 ± 0.07 CD 0.27 ± 0.09 = 0.29 ± 0.06  0.15 ± 0.06 CD 0.14 ± 0.07 = 0.16 ± 0.04 
PLSDA 0.17 ± 0.11 E 0.18 ± 0.14 = 0.16 ± 0.09  0.09 ± 0.04 D 0.10 ± 0.02 = 0.09 ± 0.06 
            
NI 0.37 ± 0.05 AB 0.34 ± 0.05 = 0.39 ± 0.04  0.47 ± 0.31 A 0.59 ± 0.36 > 0.33 ± 0.13 
NISDA 0.31 ± 0.06 BCD 0.27 ± 0.06 < 0.34 ± 0.05  0.32 ± 0.21 AB 0.39 ± 0.24 > 0.22 ± 0.10 
NIPL 0.27 ± 0.03 D 0.27 ± 0.02 = 0.27 ± 0.04  0.32 ± 0.23 ABC 0.44 ± 0.24 > 0.17 ± 0.04 
aResults are summarized by means ± standard deviations for 20 strains for BHI (10 strains in 
lineage I and 10 strains in lineage II) and 18 strains for salmon (10 strains in lineage I and 8 
strains in lineage II), each strain was tested once (n = 20 for BHI per treatment, n = 18 for 
salmon per treatment). 
bMeans within a given column with the same letter are not statistically different from each other 
(overall α = 0.05, Tukey’s correction). 
cData are separated into lineage I and II for each treatment due to the significant lineage-
dependent effect on initial cell density reduction and on maximum cell density both in BHI broth 
and on cold smoked salmon according to student’s t test results. 
dComparison results between lineage I and II for CTRL, treatments with organic acid salts and 
treatments with nisin from student’s t test. An equal symbol indicates no significant difference 
between the two lineages for the treatment, while a < or > indicates that lineage I had a 
significantly lower, or significantly higher, average value for the treatment compared to lineage 
II.  
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Figure 3.1. Boxplots of the distribution of L. monocytogenes growth parameters for each growth inhibitor treatment in modified brain heart 
infusion broth and on cold smoked salmon at 7oC  
(A, B) Initial cell density reduction (C, D) lag phase, (E, F) maximum growth rate, (G, H) maximum cell density reduction, and (I, J) 
time for growth of 1 log(CFU/ml) for BHI broth, 1 log(CUF/g) for cold smoked salmon, from initial cell density. Data are separated into lineage I 
and II for A, B, E and F due to the significant lineage-dependent effect on initial cell density reduction and maximum growth rate for treatments 
with NI. The horizontal bar indicates the median for each treatment. Boxes represent the 25th to 75th percentile of the values; whiskers represent 
the 10th and 90th percentiles. Filled circles represent values outside the 10th to 90th percentiles. Results are from 20 strains for BHI (10 strains in 
lineage I and 10 strains in lineage II) and 18 strains for salmon (10 strains in lineage I and 8 strains in lineage II), each strain was tested once (n = 
20 for BHI per treatment, n = 18 for salmon per treatment).  
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The combination of PL and SDA significantly extended lag phase. Among the six 
antimicrobial treatments, NISDA, NIPL and PLSDA showed significantly longer λ compared to 
CTRL in BHI (Table 3.3; Fig. 3.1C; adj. P < 0.05), but only PLSDA was observed to 
significantly extend λ of L. monocytogenes on salmon (Table 3.3; Fig. 3.1D; adj. P < 0.05). 
Beyond the comparisons of growth parameter means from each treatment, ANOVA results 
showed a significant interaction of PL and SDA on extending λ in BHI (P < 0.0001) and on 
salmon (P < 0.001), indicating a synergistic effect. SDA or PL alone had little effect on λ (adj. P 
> 0.05), but addition of SDA to PL significantly increased average λ to 10 days in BHI and 7 
days on salmon as compared to CTRL (Table 3.3; adj. P < 0.05). Due to rapid onset of L. 
monocytogenes growth on cold-smoked salmon treated with NI, we were unable to calculate λ 
for some of the NI, NISDA and NIPL treatments, and defined those as λ = 0 day. For treatments 
with NI, average lag times were much shorter in salmon than in BHI (Table 3.3; Fig. 3.1C, D). 
Additionally, an antagonistic effect on λ of NI and PL was observed for growth on salmon, 
identified by a significant interaction effect (P < 0.05) for a two-way ANOVA between 
treatments with PL and treatments with NI. NI alone did not have any effect on λ, but adding NI 
to PL antagonistically shortened the average λ of PL by more than 1 day (P < 0.01). This effect 
was not observed in BHI.  
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Table 3.3. Antimicrobial treatment effects on lag phase, maximum cell density reduction, and 
predicted time for growth of one log for Listeria monocytogenes at 7oC 
Treatment 
λa   Nmaxr   Tlog 
Broth (days) Salmon (days)   Broth [log(CFU/ml)] 
Salmon 
[log(CFU/g)]   Broth (days) 
Salmon 
(days) 
CTRL 2.2 ± 0.6 Ab 0.2 ± 0.4 A  0.00 ± 0.00 A 0.00 ± 0.00 A  4.9 ± 0.5 A 3.6 ± 1.1 A 
  
SDA 2.6 ± 0.5 AB 1.6 ± 0.8 A  0.05 ± 0.16 AB 0.12 ± 0.42 A  5.7 ± 0.6 AB 6.2 ± 1.2 A 
  
PL 4.7 ± 1.5 AB 1.9 ± 2.1 A  0.57 ± 0.19 C 1.41 ± 0.44 BC  8.5 ± 1.72 B 9.9 ± 4.7 B 
  
NI 4.1 ± 2.6 AB 0.4 ± 0.8 A  0.13 ± 0.24 AB 1.00 ± 1.13 B  6.9 ± 2.9 AB 3.2 ± 2.0 A 
  
NISDA 5.3 ± 3.1 B 1.6 ± 2.5 A  0.30 ± 0.41 B 0.92 ± 1.08 B  8.7 ± 3.8 B 5.8 ± 3.2 A 
  
NIPL 9.2 ± 5.3 C 0.6 ± 1.4 A  0.91 ± 0.44 D 2.75 ± 1.04 D  13.0 ± 5.5 C 5.4 ± 2.8 A 
  
PLSDA 9.7 ± 3.8 C 7.1 ± 3.6 B  0.86 ± 0.35 D 2.10 ± 0.45 C  17.4 ± 5.9 D 19.5 ± 5.0 C     
aResults are summarized by means ± standard deviations for 20 strains for BHI (10 strains in 
lineage I and 10 strains in lineage II) and 18 strains for salmon (10 strains in lineage I and 8 
strains in lineage II), each strain was tested once (n=20 for BHI per treatment, n=18 for salmon 
per treatment). 
bMeans within a given column with the same letter are not statistically different from each other 
(overall α = 0.05, Tukey’s correction). 
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PL and PLSDA significantly lowered the maximum growth rate of L. monocytogenes. 
Average µmax across L. monocytogenes genetic lineages was significantly lowered by PL PLSDA, 
NISDA and NIPL in BHI, but only by PL and PLSDA on salmon (Table 3.2; Fig. 3.1E, F; adj. P 
<0.05). ANOVA models with lineage effect for the growth parameter µmax showed significant 
differences in µmax across all treatments dependent on lineage for BHI (P < 0.05) and salmon (P 
< 0.01). At the same time, analysis using student’s t test comparing µmax of lineages within each 
treatment revealed that µmax of lineage II strains was significantly greater in BHI treated with 
NISDA (student’s t test: P < 0.05), but significantly lower on salmon treated with NI, NISDA 
and NIPL (student’s t test: P < 0.05), as compared to lineage I strains (Table 3.2; Fig. 3.1E, F). In 
contrast, there was no difference between lineages for treatments containing only organic acid 
salts in BHI or on salmon (Table 3.2; Fig. 3.1E, F). In addition to the lineage-specific effects on 
µmax for treatments containing NI, significantly greater variance of µmax in the presence of NI 
(alone and in combination) was observed on salmon as compared to BHI (Bartlett’s test, P < 
0.0001 (NI), P < 0.0001 (NISDA) and P < 0.0001 (NIPL)). SDA alone did not have a significant 
effect on µmax, but when combined with PL, the combination had an additive effect that led to a 
significantly lower average µmax in BHI, as compared to using PL or SDA alone (Table 3.2; adj. 
P < 0.05). While the average µmax of PLSDA was significantly lower than CTRL on salmon (adj. 
P < 0.05), the binary combination was not more effective than using PL or SDA alone in 
reducing the average µmax (adj. P > 0.05). This could be due to the large variation of µmax values 
for those two treatments, especially for lineage I strains on salmon (Fig. 3.1F).3.4. Treatments 
with NI and PL significantly decreased maximum cell density 
PL, NISDA, NIPL and PLSDA lowered Nmax in BHI and on salmon, while NI lowered Nmax 
on salmon only (Table 3.3; Fig. 3.1G, H; adj. P < 0.05). As shown in Table 3.3, NIPL and 
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PLSDA had the greatest Nmaxr in BHI, with a maximum Nmaxr exceeding 1 log(CFU/ml); while 
only NIPL had the greatest Nmaxr on salmon, with a maximum Nmaxr exceeding 3 log(CFU/g). In 
BHI, SDA or NI alone did not have any effect on Nmaxr. Combining SDA with NI achieved a 
average Nmaxr 1.41 log(CFU/g) on salmon which was significantly greater than zero (adj. P < 
0.05) but was not significantly different from using SDA or NI alone (Table 3.3; Fig. 3.1G; adj. 
P >0.05). SDA synergistically enhanced the effect of PL on increasing Nmaxr both in BHI (P < 
0.05) and on salmon (P < 0.0001), which was identified by a significant interaction effect for a 
two-way ANOVA between treatments with PL and treatments with SDA. NI and PL had an 
additive effect on salmon, where combining NI and PL caused a significantly higher Nmaxr, as 
compared to using NI or PL alone (Table 3.3, Fig. 3.1H; adj. P < 0.05). Significantly greater 
variance of Nmaxr was observed on salmon (Fig. 3.1H) as compared to BHI (Fig. 3.1G) for most 
of the antimicrobial treatments (Bartlett’s test: P < 0.001 (SDA), P< 0.001 (PL), P < 0.0001 (NI), 
P < 0.001 (NISDA) and P < 0.001 (NIPL), except PLSDA (P > 0.05)). This suggests a greater 
variation of the final cell density among different strains under antimicrobial treatment stresses 
for L. monocytogenes on salmon, as compared to BHI. 
PL and PLSDA significantly extended predicted time for growth of 1 log while NI 
antagonistically shortens predicted time for growth of 1 log when added to PL. The 
calculated Tlog parameter combines the influence of λ and µmax on early exponential phase growth, 
and is thus a better indicator of the antimicrobial efficacy of the treatments. In BHI, PL, NISDA, 
NIPL and PLSDA all significantly extended Tlog as compared to CTRL (Table 3.3; Fig. 3.1I; adj. 
P < 0.05); while on salmon, only PL and PLSDA significantly extended Tlog (Table 3.3; Fig. 3.1J; 
adj. P < 0.05). PLSDA was most effective in preventing L. monocytogenes to achieve growth of 
1 log with an average Tlog exceeding 17 days in BHI and 19 days on salmon. ANOVA results 
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indicate that SDA or NI alone did not have an effect on Tlog. However, adding SDA to PL 
synergistically extended average Tlog of PL by about 9 days both in BHI (P < 0.0001) and on 
salmon (P < 0.001), as compared to using PL alone. On the other hand, addition of NI to PL 
showed an antagonistic effect on Tlog on salmon (P < 0.01), shortening average Tlog from 10 days 
to 5 days as compared to using PL alone. Although the combination of NI and SDA significantly 
extended average Tlog in BHI to about 9 days compared to CTRL (adj. P < 0.05), it did not lead 
to significant difference from using SDA or NI alone or show any effect on Tlog on salmon (adj. 
P > 0.05). 
Correlation of growth parameters from BHI broth to those from cold smoked salmon 
were lineage-dependent. Multivariate analysis showed positive correlations between a growth 
parameter from BHI and the same parameter from salmon, indicating that the growth of L. 
monocytogenes in BHI, to some extent, reflected the characteristics of growth on salmon under 
antimicrobial stress. As the correlations varied among lineages and treatments with or without 
nisin, we split the data into two groups, one with parameters from treatments with organic acid 
salts only (SDA, PL, PLSDA), the other with parameters from treatments with NI (NI, NISDA, 
NIPL), and analyzed the data by lineage within each group. Coefficients (intercept and slope) 
and coefficients of determination (R2) for the fitted linear equations describing a growth 
parameter from salmon as a function of its corresponding parameter from BHI are presented in 
Table 3.4. R2 for parameters for lineage II strains were higher than those for lineage I strains. 
This indicates that those growth parameters from BHI had a relatively stronger correlation with 
those from salmon for lineage II strains.  
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Table 3.4. Coefficients and coefficients of determination of linear regression for L. 
monocytogenes growth parameters in BHI and on cold-smoked salmon 
Growth 
parametera 
  
R2 
  Intercept (α)   Slope (β) 
    Estimate Std Error P   Estimate 
Std 
Error P 
Treatments with Organic acid salt (SDA, PL, PLSDA) 
Lineage I 
λ  0.26  0.53 1.24 0.6719  0.64 0.20 0.0038 
µmax  0.11  0.10 0.04 0.0154
b  0.25 0.14 0.0779 
Tlog  0.37  4.05 2.19 0.0752  0.78 0.19 0.0003 
Nmax  0.33  -3.49 2.73 0.2115  1.21 0.33 0.001 
Nmaxr  0.25  0.82 0.22 0.001  1.05 0.35 0.0052 
Lineage II 
λ  0.58  0.62 0.57 0.2845  0.42 0.08 <0.0001 
µmax  0.26  0.06 0.04 0.1557  0.37 0.13 0.0109 
Tlog  0.61  3.74 1.63 0.0319  0.72 0.12 <0.0001 
Nmax  0.75  -8.67 1.87 0.0001  1.80 0.22 <0.0001 
Nmaxr  0.66  0.11 0.19 0.5769  1.83 0.28 <0.0001 
Treatments with nisin (NI, NISDA, NIPL) 
Lineage I 
Nr  0.03  1.80 0.38 <0.0001  0.24 0.42 0.3459 
Nmax  0.06  1.26 3.75 0.7383  0.60 0.45 0.1908 
Nmaxr  0.27  1.03 0.27 0.0007  1.36 0.42 0.0033 
Lineage II 
Nr  0.51  0.80 0.20 0.0008  0.50 0.10 <0.0001 
Nmax  0.64  -9.77 2.55 <0.0009  1.87 0.30 <.00001 
Nmaxr   0.58   0.55 0.26 0.0458   2.03 0.37 <0.0001 
aGrowth parameters from salmon were fitted with a linear equation as a function of those from 
BHI for treatment with organic acid salts only (PL, SDA, PLSDA) and treatment with nisin (NI, 
NISDA, NIPL) per lineage. 
b P values showing significant effects were bolded, α=0.05 
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Overall, across antimicrobial treatments, we found that the relatively high R2 values  (Table 
3.4) for lineage II strains make it possible to predict the variability of these growth parameters 
from salmon by data from BHI, while the variability of growth parameters of lineage I strains 
were relatively unpredictable. For treatments with organic acid salts, R2 for lineage I strains 
indicates that only 33% of the variance in Nmax from salmon was accounted for by change in Nmax 
from BHI compared to 75% for lineage II (Table 3.4), where salmon and BHI parameter pairs for 
lineage I strains were distributed much more randomly compared to lineage II strains (Fig. 3.2). 
The bacteriostatic effects of organic acids were more pronounced in BHI than on salmon for 
lineage II strains. The slope parameter in the regression showed that λ from salmon was a factor 
of 0.42 of that from BHI for lineage II strains treated with organic acid salts (P < 0.0001), the 
intercept was not significantly different from zero (P > 0.05). This suggests that the organic acid 
treatments in BHI are approximately 2.38 times as effective as on salmon in extending λ (R2 = 
0.58). Both the intercept (P < 0.05) and slope (P < 0.0001) of Tlog were significantly different 
from zero (Table 3.4), which means we can predict 61% (R2 = 0.61) of the variability of Tlog of 
salmon by Tlog of BHI using the equation Tlog(salmon) = 3.74 + 0.72 × Tlog(BHI). Nmaxr from 
salmon was a factor of 1.83 of it from BHI (P < 0.0001), the intercept of it was not significantly 
different from zero (P > 0.05), indicating that the organic acid treatments on salmon are 
estimated to be 1.83 times as effective in BHI in reducing the Nmax (R2 = 0.66). As the R2 for µmax 
was very low for both lineages, µmax was relatively unpredictable for both lineages (Table 3.4).  
	  	  
	  
58	  
 
 
 
 
 
 
Figure 3.2. Linear fit of Nmax values from cold smoked salmon by Nmax values from modified 
brain heart infusion broth for treatments with organic acid salts 
Data for lineage I and II strains are presented separately due to significant differences in 
correlations dependent on lineage.  
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For antimicrobial treatments containing NI, both the intercept and slope for Nr and Nmaxr were 
significantly different from zero (Table 3.4), and the R2 was 0.51 and 0.58 (Table 3.4), 
respectively. This means that we can predict 51% of the Nr and 58% of the Nmaxr of salmon by 
those parameters of BHI using the equations Nr(salmon) = 0.80 + 0.50 × Nr(BHI) and 
Nmaxr(salmon) = 0.55 + 2.03 × Nmaxr(BHI). The equation of Nmaxr shows that, the Nmaxr of salmon 
was at least 0.55 log(CFU/g) higher that it of BHI, indicating a better effect of treatments with 
NI on increasing Nmaxr. 
Although the positive correlation coefficients from multivariate analysis and the positive 
slope parameters from the linear regression both indicate similarities between L. monocytogenes 
growth characteristics under antimicrobial stress in BHI and on salmon, quantitative prediction 
of the performance of antimicrobials on salmon was only possible for lineage II strains, but not 
for lineage I strains of L. monocytogenes. 
DISCUSSION 
We investigated the effects of the antimicrobials SDA, PL, NI, singly and in combination, on 
the growth of strains representing two evolutionary lineages of L. monocytogenes in modified 
BHI broth and on cold-smoked salmon at 7oC. Statistical analysis of the growth parameters λ, 
µmax, N0, Nmax, Nr, Nmaxr and Tlog showed that most of the binary combinations of antimicrobials 
had greater effects on inhibiting growth of L. monocytogenes, as compared to use of a single 
antimicrobial alone. Although treatments with NI effectively reduced the initial contamination 
level of L. monocytogenes, the combination of PL and SDA was most effective on inhibiting 
growth of L. monocytogenes during the length of refrigerated storage. Among the binary 
combinations, some exhibited synergistic effects, indicating that the antimicrobial effect of the 
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combination is greater than the sum of the effects of the individual antimicrobials, such as the 
synergistic effects identified between PL and SDA on extending λ and Tlog. Significant lineage-
dependent effects were identified for some antimicrobial treatments. NI had lineage-dependent 
effects on µma as well as on Nr. Correlations between growth parameters in BHI and on salmon 
revealed that the variability of bactericidal effects of treatments with NI and bacteriostatic effects 
of treatments with organic acid salts on salmon could be partly predicted by data from BHI broth 
only for Listeria monocytogenes lineage II strains, but not for lineage I strains. 
Bactericidal effects of NI on L. monocytogenes are highly strain dependent. Our data 
showed that treatment with NI alone or combined with PL or SDA caused significant, but highly 
variable, reduction of initial cell populations for L. monocytogenes strains in BHI and on salmon 
at 7oC. The high variation in Nr indicates that the response of an individual strain of L. 
monocytogenes might lead to an inappropriate estimate of efficacy of NI on cold-smoked salmon, 
highlighting the importance of genetic diversity in validating antimicrobials in a food system. 
While multi-strain cocktails of L. monocytogenes strains have been used in previous studies on 
the bactericidal efficacy of NI in food matrices (29, 53, 54), we individually investigated 18 
distinct L. monocytogenes isolates from a wide range of sources and diverse genetic backgrounds 
for their susceptibility against NI applied to cold-smoked salmon. The difference between the NI 
sensitivities of any two L. monocytogenes strains tested was up to 4 log(CFU/g). A large 
variation in sensitivity to NI was also observed by Rasch and Knøchel (55), who examined a 
collection of 381 L. monocytogenes strains on Tryptic soy agar containing NI, although the 
concentrations of NI used were, in general, lower than those used here. For example, they found 
two strains that were able to grow weakly on 500 IU/ml (12.5 ppm), and while 1% of strains 
could not grow at 10 IU/ml (0.25 ppm), the majority of strains were able to grow at 100 IU/ml 
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(2.5 ppm). Ukuku and Shelef (56) also demonstrated that sensitivity of L. monocytogenes to NI 
at pH 5.0, 6.0 and 7.0 was strain dependent. 
PLSDA inhibits L. monocytogenes growth during extended refrigerated storage. Based 
on comparisons of λ and Tlog among different treatments, PLSDA was the most effective for 
controlling L. monocytogenes during extended refrigerated storage. PLSDA completely inhibited 
L. monocytogenes growth for up to 2 weeks on cold-smoked salmon and 1 log growth was 
achieved after 11 ~ 29 days. Synergistic effects of PL and SDA on extending λ, Tlog and lowering 
Nmax of L. monocytogenes were observed both on cold-smoked salmon and in BHI broth. These 
results are in agreement with previous studies demonstrating the bacteriostatic effect of organic 
acids against L. monocytogenes and the synergistic effect between potassium lactate and sodium 
diacetate in controlling L. monocytogenes on RTE foods, including frankfurters (57, 58), turkey 
products (39), sausages (37, 59), ham (60) and cold-smoked salmon (21, 33). As the 
contamination level of L. monocytogenes on cold-smoked salmon is normally low (61), and 
controlling the growth of L. monocytogenes is important in lowering the risk of infection, 
addition of PLSDA during processing could be an effective control strategy against L. 
monocytogenes on cold-smoked salmon. 
Addition of organic acids does not increase the bactericidal effect of nisin. NIPL and 
NISDA had similar effects on Nr of L. monocytogenes as NI alone on salmon, indicating that the 
bactericidal effect of NI was not enhanced by addition of an organic acid. Similar results have 
been reported for the combination of NI and organic acids (or their salts) on reducing initial 
densities of L. monocytogenes on products such as turkey frankfurters (62), sausages, ham (63-
65), and cold-smoked fish products (29). In these reports, addition of organic acid did not 
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significantly increase the initial reduction in cell density achieved by NI alone. Some studies 
have demonstrated that NI can significantly increase the length of lag phase and reduce the 
growth rate of L. monocytogenes on cold-smoked fish products (42) and ham (66) when used in 
conjunction with lactate, compared to NI or lactate alone. In many cases, the combination of NI 
and an organic acid lead to overall lower L. monocytogenes numbers after the duration of 
refrigerated storage compared to use of organic acid alone, as demonstrated on ham and sausage 
(63-65). Here we show that NI works additively with PL in lowering Nmax. While the maximum 
cell density was reduced by the addition of PL to NI, the predicted time for L. monocytogenes to 
grow 1 log on cold smoked salmon was significantly shorter for the combination of NI and PL 
compared to the combination of PL and SDA, indicating that the combination of organic acids 
and nisin may not be as effective at controlling growth of this pathogen as combinations of 
organic acids alone.  In summary, the addition of organic acids did not enhance the bactericidal 
effect of NI, and NI had negative effects on the bacteriostatic effects of the organic acid salt PL. 
The bactericidal effect of NI is lineage-dependent. Lineage-dependent effects were 
observed for antimicrobial treatments with NI in BHI, where lineage I strains were more resistant 
to NI than lineage II strains. In addition, after the initial decrease in cell density due to NI 
exposure, lineage I strains tended to grow faster than lineage II strains on salmon treated with NI. 
Since this difference in growth was not observed in BHI for all the treatments with NI, growth 
data from BHI broth could not fully predict the lineage-dependent inhibitory effect of NI on L. 
monocytogenes strains on salmon. While the effects of L. monocytogenes lineage on differences 
in nisin resistance have not been assessed previously, variation among lineages for other stress 
resistance phenotypes has been reported. For example, lineage II strains were more sensitive to 
gastric stress in a dynamic gastric system compared to lineage I strains (67), and lineage I and III 
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strains were more resistant to salt stress compared to lineage II strains (68). The presence of 
lineage-dependent differences in stress resistance phenotypes also depends on the type of stress L. 
monocytogenes experiences. For example, lineage I and lineage II strains had similar D-values 
when exposed to heat stress at 55°C (9). In this study, we found that the effect of genetic lineage 
was minor on low temperature growth of L. monocytogenes in the presence of organic acids, 
both on cold-smoked salmon and in BHI broth. This result is in agreement with Stasiewicz et al. 
(40) who found no significantly differences for growth parameters (λ, µmax, N0, Nmax) between L. 
monocytogenes lineage I and II when antilisterial efficacies of organic acids were tested in BHI 
broth at 7oC. Taken together, these studies highlight that lineage-dependent differences in L. 
monocytogenes stress resistance can be significant for many types of stresses, including NI stress. 
It is necessary to include the effect of lineage into analyses of antimicrobial efficacies against L. 
monocytogenes. 
Correlations of antimicrobial effects on L. monocytogenes growth inhibition in BHI 
broth and on cold smoked salmon are lineage-dependent. We identified overall positive 
correlations between L. monocytogenes growth parameters in modified BHI broth and on cold-
smoked salmon. In general, all of the slope parameters from the fitted linear equation for each 
growth parameter were positive, indicating that growth of L. monocytogenes in BHI, to some 
extent, reflects the characteristics of growth on salmon under antimicrobial stress. This suggests 
that BHI broth with the same pH and salt concentration as cold smoked salmon can be used to 
rapidly identify effective single antimicrobial or combinations for further examination on cold-
smoked salmon. However, quantitative prediction of the performance of antimicrobials on 
salmon was only possible for lineage II strains rather than lineage I strains of L. monocytogenes. 
The unpredictability of the antimicrobial efficacies for lineage I strains make it difficult to use 
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data from BHI broth to accurately predict the variability of the antimicrobial efficacies against 
overall L. monocytogenes strains on cold smoked salmon. 
For many growth parameters, the variation in parameters from BHI broth was much lower 
than the variation in parameters from cold smoked salmon, especially for lineage I strains. In 
most cases, antimicrobials appeared to have a greater effect on growth inhibition in BHI 
compared to on salmon. For example, for lineage II strains, the approximately 1:2 ratio in λ from 
salmon to that from BHI indicates that organic acid treatments in BHI were approximately twice 
as effective as on salmon in extending λ of L. monocytogenes. Similarly, Vogel et al. (33) 
reported a more pronounced antilisterial effect of identical concentrations of PL (2%) and SDA 
(0.14%) in salmon homogenate and salmon juice. They found that PLSDA completely inhibited 
the growth of L. monocytogenes for over 28 days in cold-smoked salmon juice and 27 days in 
cold-smoked salmon homogenate, compared to the results from the present study (up to 18 days 
in BHI, 14 days on salmon). We directly applied the antimicrobials on the surface of cold-
smoked salmon slices, in comparison to this, Vogel et al. (33) added antimicrobials into salmon 
homogenate or juice. We speculate that a more homogenous distribution of antimicrobials, when 
used in liquid based evaluation systems, such as the BHI broth used in this study, and the salmon 
juice used by Vogel et al., leads to a broader and longer interaction between antimicrobials and 
target cells, which could reduce variability in the bacterial response to the antimicrobial.   
In addition to the distribution of antimicrobials, other physicochemical factors of the food 
matrix could contribute to increased variability in antimicrobial efficacy. For example, Jung et al. 
(69) reported a decrease in NI efficacy in food containing fat . It was suggested that fat could 
exert a negative impact on NI activity by binding NI via hydrophobic sites thereby making it 
	  	  
	  
65	  
unavailable for bacterial inhibition (69, 70). Our data suggest that the fat content of salmon does 
not affect the efficacy of nisin, as the salmon used had a high content of lipids, ranging from 7.4 
- 10.4%, and we did not observe a decrease in NI efficacy on salmon compared to in BHI. 
However, as phenolic compounds are important for the preservation properties of smoked 
products (71), one may speculate that the phenolic compounds obtained from smoking process 
(about 184.21 mg GAE/100g for the salmon in the present study; (51)) might have interacted 
with NI, exerting a better inhibitory effect against L. monocytogenes and overcoming the 
negative impact of salmon fat. It is also important to note that the complex nature of phenolic 
compounds in the cold-smoked salmon could be influenced by the type of wood used for 
smoking (72, 73). While interactions between NI and phenolic compounds against L. 
monocytogenes have rarely been studied in smoked seafood products, synergistic effects between 
them have been observed for growth of L. monocytogenes in carrot juice (74) as well as for the 
survival of Pediococcus pentosaceus NCDO 813 in wine by Knoll et al. (75). Thomas and Isak 
(76) also demonstrated synergy between NI and the herb rosemary containing high levels of 
antioxidant phenolic diterpenes against L. monocytogenes and Bacillus cereus in chicken soup, 
meat and cheese pasta sauces. Therefore, phenolic compounds can potentially be a significant 
factor influencing the antimicrobial effects on cold smoked salmon compared to in BHI broth. 
Additionally, competition from background microbiota in a food matrix, which would be mainly 
lactic acid bacteria on cold smoked salmon, may need to be taken into consideration when 
comparing the effect of antimicrobials in BHI broth and on cold-smoked salmon. Antimicrobials 
may influence the growth of background microbiota thereby changing the potential interaction 
between the background microbiota and L. monocytogenes. Overall, to fully understand the 
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mechanism of antimicrobials in a food matrix, further study is needed to investigate the impact 
of antimicrobials on the native microbiota as well as the pathogen. 
CONCLUSION 
Data presented here suggest that strain variability, genetic lineage and matrix (BHI versus 
cold-smoked salmon) can significantly affect the efficacy of NI and organic acids against L. 
monocytogenes. While not quantitatively predictive, data from BHI broth can be used to 
efficiently identify possible additive, synergistic, or antagonistic interactions between 
antimicrobials on cold-smoked salmon. Correlations between the characteristics of the growth of 
L. monocytogenes in BHI and on salmon treated with antimicrobials are strong for lineage II 
strains but weak for lineage I strains, revealing that data from BHI broth cannot accurately 
predict the variability of antimicrobial effects on cold smoked salmon for all L. monocytogenes 
strains. Growth parameter data collected in the present study, when combined with genetic and 
cellular level studies, could provide an improved mechanistic understanding of the cellular 
response and resistance development of L. monocytogenes to different antimicrobials. 
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CHAPTER 4 
TRANSCRIPTOMIC ANALYSIS OF LISTERIA MONOCYTOGENES ADAPTATION TO 
GROWTH ON VACUUM-PACKED COLD SMOKED SALMON 
Published in:	  Applied and Environmental Microbiology 
ABSTRACT 
The foodborne pathogen Listeria monocytogenes is able to survive and grow in ready-to-
eat foods, where it is likely to experience a number of environmental stresses due to refrigerated 
storage and the physicochemical properties of the food. Little is known about the specific 
molecular mechanisms underlying survival and growth of L. monocytogenes under different 
complex conditions on/in specific food matrices. RNA-seq was used to understand the 
transcriptional landscape of L. monocytogenes strain H7858 grown on cold-smoked salmon (CSS, 
water-phase salt 4.65%, pH 6.1) relative to in modified brain heart infusion broth (MBHIB, 
water-phase salt 4.65%, pH 6.1) at 7oC. Significant differential transcription of 149 genes was 
observed (FDR<0.05, fold change ≥ 2.5), and 88 and 61 genes were up- and down regulated in 
H7858 grown on CSS relative to in MBHIB. In spite of these differences in transcriptomes under 
these two conditions, growth parameters for L. monocytogenes were not significantly different 
between CSS and MBHIB, indicating that the transcriptomic differences reflect how L. 
monocytogenes is able to facilitate growth under these different conditions. Differential 
expression analysis and Gene Ontology enrichment analysis indicated that genes encoding 
proteins involved in cobalamin biosynthesis as well as ethanolamine and 1,2-propanediol 
utilization, have significantly higher transcript levels in H7858 grown on CSS compared to in 
MBHIB. Our data identify specific transcriptional profiles of L. monocytogenes growing on 
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vacuum-packaged CSS, which may provide targets for development of novel and improved 
strategies to control L. monocytogenes growth on this RTE food.  
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INTRODUCTION 
Listeria monocytogenes is a psychrotolerant foodborne pathogen that causes a potentially 
severe disease, listeriosis. This pathogen is of particular concern to the ready-to-eat (RTE)-meat 
and -seafood industries due to its ability to grow at temperatures as low as -0.4°C and salt 
contents as high as 25% (at 4°C) (1-3). Cold smoked salmon (CSS), a RTE seafood, represents a 
typical food product that can support the growth of L. monocytogenes from low numbers to 
potentially hazardous levels (4-9). The heat treatment applied during processing of CSS is not 
sufficient to inactivate microbes present on the raw material, including L. monocytogenes (10, 
11). In addition, RTE food products, including CSS, can be contaminated with L. monocytogenes 
from environmental sources in processing facilities (10-13). Importantly, typical product 
characteristics of CSS including pH, water activity, salt, and phenolic components do not seem 
to be sufficient to control the growth of L. monocytogenes if it is present (8, 9). 
With the aim of developing control strategies that prevent or reduce growth of this pathogen 
in RTE seafood products, there is a need for a better understanding of the mechanisms that L. 
monocytogenes uses to survive and grow under the complex conditions on/in specific food 
matrices. Characterization of bacterial gene expression patterns in different environments can be 
used to characterize the physiological state of L. monocytogenes under different conditions, and 
to help identify the metabolic pathways that are important for survival and growth of L. 
monocytogenes in food products. This will facilitate identification of new compounds that could 
specifically interfere with these metabolic pathways and thereby control the growth of L. 
monocytogenes (14). Extensive studies on the transcriptome of L. monocytogenes have been 
conducted to assess how it responds to physical, chemical, or biological stresses that it may 
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encounter on/in food matrices (15-22). The majority of data from these experiments are based on 
exposure of L. monocytogenes to specific stresses in laboratory medium, providing information 
about specific stress responses and transcriptional profiles in a controlled environment. This 
information may not provide the full extent of the bacterial transcriptional landscape in a more 
complex environment, such as a food matrix. 
We characterized the transcriptome of late-log-phase L. monocytogenes strain H7858 (a 
serotype 4b lineage I strain) grown on CSS and the same strain grown to late-log-phase in 
modified brain heart infusion broth (MBHIB, water-phase (w.p.) salt 4.65%, pH 6.10). While the 
two conditions chosen here are distinct, they do facilitate characterization of the L. 
monocytogenes transcriptional landscape in a real food as well as comparisons against commonly 
used reference conditions. Our approach is similar to studies that provided significant insights 
into the pathogen transcriptional landscape in human or animal hosts, which also, by necessity, 
must choose reference conditions (e.g., growth in rich media) that differ by a multitude of factors 
from complex host-associated environments (e.g., presence in intestinal lumen or human blood). 
For example, previous characterization of the L. monocytogenes transcriptome in BHI 
(designated as the “reference condition” by the authors) and physiologically relevant conditions 
(e.g. stationary phase, low temperature) as well as in the intestinal lumen of infected mice and 
inoculated human blood provided crucial knowledge of the L. monocytogenes transcriptional 
landscape under various conditions that this pathogen may experience during transmission (23). 
In the present study, we demonstrate the use of RNA-seq technology to study global gene 
expression of L. monocytogenes in a RTE seafood product. We overcame the technical 
difficulties associated with isolating high quality bacterial RNA from the seafood matrix, and 
took advantage of the probe- and annotation-independence of RNA-seq technology to explore 
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the genome-wide transcriptional landscape of L. monocytogenes grown under the complex 
conditions on this food matrix. 
MATERIALS AND METHODS 
Bacterial strain and inoculum preparation. L. monocytogenes strain H7858 was used 
in this study (24). H7858 is a lineage I, serotype 4b strain (representing epidemic clone II), 
isolated from RTE meat and was linked to a multistate listeriosis outbreak from 1998 to 1999 (24, 
25). We selected H7858 for this study as we have studied the phenotypic and transcriptomic 
responses of this strain to a number of stresses relevant to food products, including organic acids 
and bactericidal additives, and know that it can grow to high levels on cold smoked salmon (26-
28). L. monocytogenes H7858 was streaked from frozen BHI stock stored at -80°C in 15% 
glycerol onto a BHI agar plate, followed by incubation at 37°C for 24 h. A single colony was 
subsequently inoculated into 5 ml of BHIB (in 16 mm tubes), followed by incubation at 37oC 
with shaking (230 rpm) for 18 h (Series 25 Incubator, New Brunswick Scientific, Edison, NJ). 
After 18 h, 50 µl BHI culture was inoculated into 5 ml chemically defined medium (DM) (29) 
and grown to stationary phase in DM at 16°C statically, as described previously (30). This 
culture was used to inoculate CSS and MBHIB as detailed below. DM was used to approximate 
a nutrient-limited environment (e.g., food processing plants) that L. monocytogenes may 
encounter before contaminating food. 
Growth conditions in BHI and on salmon. BHIB was modified to have 4.65% w.p. NaCl 
and pH 6.1 to simulate the levels typically present in commercially processed CSS (30). The 
stationary-phase DM culture was used to inoculate 100 ml of MBHIB in 300-ml Erlenmeyer 
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culture flasks with metal caps (Bellco Glass Co., Vineland, NJ), with an initial population of 
approximately 1 x 106 CFU/ml, followed by static incubation at 7°C.  
Commercially produced wet-cured CSS fillets were stored at -20°C and thawed at 4°C 
overnight. A mixture of natural hardwood and fruitwood had been used to cold smoke the 
salmon. The background microbiota (mainly lactic acid bacteria) and physico-chemical 
characteristics of the untreated salmon slices used in the present study have been described 
previously by Kang et al. (31). All CSS samples were from the same batch of product. The 
concentration of lactic acid bacteria on un-inoculated CSS was ~ 4 log(CFU/g) on day 0, ~ 6 
log(CFU/g) on day 5, and ~7 log(CFU/g) on day10 during incubation of the vacuum-packaged 
slices at 7°C. For the un-inoculated CSS, the pH was ~ 6.18, water activity (aw) was 0.96, 
moisture content was ~63.58%, fat content was ~8.87% (31). Un-inoculated salmon samples 
were plated onto Oxford agar and incubated at 30 °C for 48 h to confirm the absence of L. 
monocytogenes.  
Salmon slices were weighed (10 ± 0.5 g each) and transferred into sterile petri dishes. Both 
sides of the salmon slice were inoculated with 500 µl stationary-phase cultures from DM that 
were diluted in 0.1% sterile peptone water to a target population of approximately 1 x 106 CFU/g, 
and spread with sterile plastic cell spreaders. Inoculated salmon slices were then stored in a 
biosafety cabinet for 15 min to dry the surface before being transferred into storage bags (oxygen 
permeability 38.10 cc/m2 - 40.50 cc/ m2 at 23°C dry/24 hrs) and packaged using a commercial 
vacuum sealer (FoodSaver, model V2244). All samples were stored at 7°C. Incubator 
temperature was recorded every 20 min by an automated thermal recorder during the storage of 
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both MBHIB cultures and CSS samples. The range of recorded incubation temperature was 7.0 ± 
0.5°C. 
Determination of exponential-phase sampling points. To monitor L. monocytogenes 
growth, cell density was determined every day, starting from day 0, until log-phase cells were 
collected for RNA extraction on day 7; another three time points were taken on day 10, 11 and 
12 after RNA extraction to determine the maximum cell density. For MBHIB samples, cultures 
were diluted with 0.1% sterile peptone water and spiral-plated in duplicate onto BHI agar using 
an Autoplate 4000 (Spiral Biotech, Inc., Norwood, MA). BHI plates were incubated at 37oC for 
24 h before colonies were counted with the Q- Count Colony Counter (Spiral Biotech). For 
salmon samples, 2 vacuum-packed samples were aseptically opened for each time point and 
stomached for 30 s at high speed setting (Stomacher 400, Seward, West Sussex, UK) with 40 ml 
of 0.1% sterile peptone water transferred into each bag. CSS homogenates were spiral-plated on 
Oxford agar (cat. no. 222530, BD; cat. no. SR0140, Oxoid, Ltd., Hampshire, UK) using the 
Autoplate 4000.  
Measurements of L. monocytogenes cell density over time in MBHIB and on CSS were 
fitted with a three-phase linear model described by Buchanan et al. (32) using the NLStools 
package (v0.0-11) in R v 2.13.0. Four growth parameters including lag phase (λ, [day]), 
maximum growth rate (µmax, [log(CFU/ml or g/)day]), initial cell density (N0, [log(CFU/ml or g]) 
and maximum cell density (Nmax, [log(CFU/ml or g)]) were calculated. Extracted RNA was 
considered to be qualified for downstream processing and analysis if it had a RNA integrity 
number (RIN) ≥ 7 (33). Pilot experiments showed that L. monocytogenes cell density on CSS 
needed to be at least 8 log(CFU/g) to obtain total RNA with RIN ≥ 7; at this cell density H7858 
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was still in log phase. To predict the time point for RNA isolation (TRNA-extraction) (when L. 
monocytogenes cell density reaches 8 log(CFU/ml or g)), we obtained the growth parameters by 
fitting growth data collected from day 0 to 5 as described earlier and calculated TRNA-extraction 
using the equation derived from Buchanan model (32): TRNA-extraction = λ + (1 x 108 CFU/g – N0) ÷ 
µmax. The real Nmax of each growth experiment was confirmed by sampling on day 10, 11 and 12 
after RNA extraction to ensure accuracy of the prediction. The time points for RNA extraction 
fell on day 7 for all four replicates of both CSS and BHI samples. 
RNA isolation, integrity and quality assessment. Similar procedures were used to extract 
RNA from L. monocytogenes growing in MBHIB and on CSS. For MBHIB, a total of 7 ml of 
RNA Protect reagent (Qiagen, Valencia, CA) was added to 7 ml samples in 14 ml Sarstedt tubes 
(Sarstedt, Nümbrecht, Germany), followed by vortexing vigorously for 10 s to mix well; for CSS, 
17 ml of RNA Protect reagent was added to 10 g samples, followed by massaging the sample bag 
to mix well. The mix was incubated at room temperature for 10 min to ensure that the bacterial 
RNA was stabilized. For CSS samples, the liquid part of the mix was then filtered out with a 
207-ml filter bag (cat. no. B01385WA, Whirl-Pak bag, Nasco, Fort Atkinson, WI) to remove 
salmon particles. Cells were pelleted by centrifugation (4,637 × g, 15 min) at 4oC and suspended 
in nuclease free water with proteinase K (12.5 mg/ml) and lysozyme (25 mg/ml), followed by 
incubation at 37oC for 30 min. TRI reagent (Ambion, Austin, TX) was then added to each 
sample (in screw cap tubes with 3 ml of 0.1-mm acid-washed zirconium beads), followed by 
mechanical lysis for 5 min in a Mini-Beadbeater-8 (BioSpec Products, Inc., Barlesville, OK) and 
subsequent RNA extraction according to manufacturer’s recommendations. Total RNA was 
incubated with RQ1 DNase (Promega, Madison, WI) in the presence of RNasin (Promega) to 
remove remaining DNA. Subsequently, RNA was purified using two phenol-chloroform 
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extractions and one chloroform extraction, followed by RNA precipitation and suspension of the 
RNA in RNase free TE (10 mM Tris, 1 mM EDTA; pH 8.0; Ambion). UV spectrophotometry 
(Nanodrop, Wilmington, DE) was used to quantify and assess purity of the RNA. Efficacy of the 
DNase treatment was assessed by TaqMan qPCR analysis of DNA levels for the housekeeping 
gene rpoB (34). qPCR was performed using Taq-Man One-Step RT-PCR Master Mix Reagent 
and the ABI Prism 7000 Sequence Detection System (all from Applied Biosystems, Foster City, 
CA). All samples showed Ct values > 35 for rpoB, indicating negligible levels of DNA 
contamination. As a final step, RNA integrity was assessed using the 2100 Bioanalyzer (Agilent, 
Foster City, CA). All experiments were performed in four biological replications. 
Preparation of cDNA fragment libraries and RNA-Seq. Preparation of cDNA fragment 
libraries was performed using the ScriptSeq Complete Kit (Bacteria)-Low Input Kit (Epicentre, 
Madison, WI). To remove 16S and 23S rRNA from total RNA and enrich for mRNA, 1µg total 
RNA was treated with Ribo-Zero rRNA Removal Reagents (Bacteria)-Low Input and Magnetic 
Core Kit-Low Input according to the manufacturer’s protocol. Enriched mRNA samples were 
run on the 2100 Bioanalyzer (Agilent Technology, Santa Clara, CA) to confirm reduction of 16S 
and 23S rRNA and purified using Agencourt RNAClean XP Kit (Beckman Coulter Inc, Brea, 
CA) prior to preparation of cDNA fragment libraries. The mRNA-enriched fraction was 
converted to indexed RNA-seq libraries with the ScriptSeq v2 RNA-Seq Library Preparation Kit. 
This protocol allows the identification of the specific strand from which each read was generated, 
resulting in a strand-specific analysis of the RNA-seq results. Indexed and purified libraries (8 
libraries including 4 replicates for each CSS and MBHIB) were loaded together onto a flow cell 
without any other samples; sequencing was carried out on a Hiseq 2000 (single-end, 100-bp per 
read). RNA-Seq data is available in the NCBI GEO Short Read Archives (GSE64353). 
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RNA-Seq alignment and coverage. As the H7858 genome has not been completely closed 
(Genbank accession: AADR00000000), the sequence reads were aligned to a H7858 
pseudochromosome. The pseudochromosome was created through alignment of the contigs of 
the H7858 draft genome to the completely closed genome of the L. monocytogenes strain EGD-e 
(GenBank accession: NC_003210) and subsequent concatenation of these contigs in to a 
pseudochromosome. Alignment of reads was carried out using the BWA mem algorithm in 
BWA version 0.7.3a (35). Default parameters were used for the alignment. Coverage at each 
base position along the chromosome was calculated by enumerating the number of reads that 
aligned to a given base for each DNA strand separately. 
Differential expression analysis. Differential expression of genes under the conditions in 
MBHIB and on CSS was statistically assessed using the BaySeq method (36) implemented in the 
BaySeq 1.16.0 package available from Bioconductor. This package implements a full Bayesian 
model of negative binomial distributions to simultaneously assess the likelihood of various 
models, each representing a possible pattern of expression for a given gene. Library sizes were 
normalized using the approach described by Bullard et al. (37). To allow for quantitative 
comparisons among genes and treatments, we used the average normalized RNA-seq coverage 
(NRC) generated by BaySeq for each gene of the four replicates to identify the genes with 
highest average NRC of L. monocytogenes grown on CSS. Genes were considered differentially 
expressed if they showed a false discovery rate (FDR) < 0.05 and a fold change (FC) ≥ 2.5 (for 
genes upregulated on CSS) or FC ≤ 0.4 (for genes downregulated on CSS), where FC = average 
NRC(CSS) ÷ average NRC(MBHIB). To confirm annotation of differentially expressed genes, 
the NCBI BLAST standalone program was used to search the H7858 amino acid sequence for 
each of these genes against the amino acid sequences of the CDS of L. monocytogenes strains 
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EGD-e (GenBank accession: NC_003210), 10403S (GenBank accession: NC_017544) and 
F2365 (GenBank accession: NC_002973), as well as Salmonella enterica Typhimurium LT2 
(GenBank accession: NC_003197) and Escherichia coli K-12 MG1655 (GenBank accession: 
NC_000913). 
GO enrichment analysis. Rather than validating the upregulation of individual genes, we 
focused on identifying the metabolic pathways that contained multiple differentially expressed 
genes, by using the results generated by Gene Ontology (GO) enrichment analysis. This method 
allowed us to statistically confirm the upregulation of specific metabolic pathways that may 
facilitate the survival and growth of L. monocytogenes on CSS. Enrichment of GO terms among 
genes upregulated on CSS was assessed using the GOseq 1.18.0 package (38) available from 
Bioconductor. GO term classification for each gene in H7858 was obtained using the blast2go 
program (https://www.blast2go.com). 
RESULTS 
L. monocytogenes growth parameters are similar on CSS and in MBHIB. L. 
monocytogenes growth parameters, including λ, µmax, N0, and Nmax, did not differ significantly 
between CSS and MBHIB (p>0.05; t-test) (Fig. 4.1). The average λ was 1.78 ± 1.05 and 2.12 ± 
0.35 days for CSS and MBHIB, respectively. The average µmax was 0.35 ± 0.06 log(CFU/g)/day 
and 0.40 ± 0.02 log(CFU/ml)/day for CSS and MBHIB, respectively. The average N0 and 
average Nmax were 6.48 ± 0.16 and 8.68 ± 0.14 log(CFU/g) for CSS, respectively, and 6.35 ± 
0.06 and 8.82 ± 0.07 log(CFU/ml) for MBHIB, respectively.  
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Figure 4.1. Growth of H7858 on cold smoked salmon and in modified BHI broth  
Growth of H7858 on cold smoked salmon (CSS; n) and modified BHI broth (w.p. salt 4.65%, 
pH 6.10) (MBHIB; ) at 7oC. RNA was extracted at the average H7858 cell density of 8.17 ± 
0.16 log(CFU/g) on CSS and 8.28 ± 0.21 log(CFU/ml) in MBHIB (*). 
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Late log-phase H7858 has 88 up- and 61 downregulated genes on CSS compared to in 
MBHIB. RNA-seq was performed on H7858 RNA samples representing four independent 
biological replicates of H7858 grown on CSS or in MBHIB. Samples for RNA isolation were 
collected when H7858 was grown to late log phase under the conditions of these two matrices; 
the average cell density of collected L. monocytogenes samples were 8.17 ± 0.16 log(CFU/ml) 
for CSS and 8.28 ± 0.21 log(CFU/g) for MBHIB (Fig. 4.1). Since the growth parameters of 
H7858 were not significantly different on CSS and in MBHIB, the L. monocytogenes cells from 
both conditions at the time point for RNA isolation were expected to be at the same growth 
phase, indicating that observed differences in transcript levels were not likely to reflect different 
growth phases of H7858. Transcriptome sequencing generated 1.6 to 10.9 million reads per 
sample (Table 4.1). For RNA samples from H7858 grown in MBHIB and on CSS, of the reads 
that mapped to the reference pseudochromosome, ~ 80% and ~82% of them mapped to protein 
coding sequences, respectively. The remaining reads mapped to non-coding RNA, including 
ribosomal RNA and tRNAs. Among the unmapped reads from CSS, 83% on average were found 
to represent sequences that mapped to Atlantic Salmon genomic DNA (GenBank accession: 
AGKD00000000.3), suggesting contamination with residual salmon RNA, and 6% on average 
mapped to the genome of Carnobacterium maltaromaticum LMA28 (GenBank accession: 
NC_019425.2), which is representative of a genus of gram-positive bacteria that is found in food 
products and grows anaerobically (39), and likely represents part of the resident microbiota of 
CSS.  
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Table 4.1. Summary of RNA-seq coverage data 
Sample ID No. of mapped reads No. of reads mapped to CDSc 
Percentage of reads mapped to 
CDS 
MBHIBa-1 1,555,154 1,293,750 83% 
MBHIB-2 2,020,923 1,684,965 83% 
MBHIB-3 6,182,126 4,828,777 78% 
MBHIB-4 6,302,268 4,821,223 76% 
Average MBHIB 4,015,118 3,157,179 80% 
    
CSSb-1 1,611,849 1,314,001 82% 
CSS-2 2,303,793 1,946,859 85% 
CSS-3 3,557,097 2,830,220 80% 
CSS-4 3,204,674 2,684,028 84% 
Average CSS 2,669,353 2,193,777 82% 
aMBHIB, modified brain heart infusion broth, water phase salt 4.65%, pH 6.10; 
bCSS, cold smoked salmon; 
cCDS, coding DNA sequence for protein   
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As RNA-seq allows for absolute quantification, our data allowed us to identify the genes that 
showed the highest transcript levels in H7858 on CSS (Table 4.2). The three genes with the 
highest average NRC were fusA, eno, and tuf, which encodes translation elongation factor G, an 
enolase, and translation elongation factor Tu, respectively. Other genes with well-defined 
functions and high average NRC include gadT2D2 (40), which encode proteins involved in 
glutamate dependent acid resistance, gap, which encodes a NAD-dependent glyceraldehyde-3-
phosphate dehydrogenase involved in glycolysis, and cspLA, which encode cold-shock proteins 
involved in adaptation to atypical conditions (Table 4.2).  
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Table 4.2. Genes with highest average normalized RNA-seq coverage (NRC) 
Gene name in 
H7858 Gene Product 
Average NRC 
rank for 
Average NRCb for 
H7858 EGD-e a 10403S a CSS MBHIB CSS MBHIB 
LMOh7858_2915 lmo2654 
(fusA) 
LMRG_02199 Translation elongation factor G 1 1 3,643,359 3,404,382 
LMOh7858_2604 lmo2455 
(eno) 
LMRG_01793 Enolase (EC 4.2.1.11) 2 3 3,348,509 2,505,110 
LMOh7858_2914 lmo2653 
(tuf) 
LMRG_02198 Translation elongation factor Tu 3 4 3,296,021 2,329,659 
LMOh7858_2506 lmo2363 
(gadD2) 
LMRG_01479 Glutamate decarboxylase (EC 
4.1.1.15) 
4 65 3,186,282 627,851 
LMOh7858_2608 lmo2459 
(gap) 
LMRG_01789 NAD-dependent glyceraldehyde-
3-phosphate dehydrogenase (EC 
1.2.1.12) 
5 15 2,650,840 1,618,077 
LMOh7858_2505 lmo2362 LMRG_01480 Probable glutamate/gamma-
aminobutyrate antiporter 
6 86 2,589,714 490,907 
LMOh7858_1751 lmo1634 LMRG_01332 Alcohol dehydrogenase (EC 
1.1.1.1); Acetaldehyde 
dehydrogenase (EC 1.2.1.10) 
7 8 2,504,749 1,849,977 
LMOh7858_2605 lmo2456 
(gpmI) 
LMRG_01792 2,3-bisphosphoglycerate-
independent phosphoglycerate 
mutase (EC 5.4.2.1) 
8 12 2,229,167 1,648,039 
LMOh7858_2609 lmo2460 LMRG_01788 Central glycolytic genes regulator 9 32 2,197,665 1,008,437 
LMOh7858_2607 lmo2458 
(pgk) 
LMRG_01790 Phosphoglycerate kinase (EC 
2.7.2.3) 
10 15 2,158,721 1,592,390 
LMOh7858_2353 lmo2219 
(prsA2) 
LMRG_01613 Foldase protein PrsA precursor 
(EC 5.2.1.8) @ Foldase clustered 
with pyrimidine conversion 
11 2 1,919,848 2,662,595 
LMOh7858_2899 lmo2638 LMRG_02183 pyridine nucleotide-disulfide 
oxidoreductase family protein 
12 665 1,913,850 1,275,847 
LMOh7858_2708 lmo2556 
(fbaA) 
LMRG_01691 Fructose-bisphosphate aldolase 
class II (EC 4.1.2.13) 
13 1,378 1,892,452 951,955 
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Table 4.2 (Continued) 
LMOh7858_2043 lmo1917 
(pflA) 
LMRG_01064 Pyruvate formate-lyase (EC 
2.3.1.54) 
14 19 1,886,299 1,435,588 
LMOh7858_1070 lmo1003 
(ptsI) 
LMRG_02103 Phosphoenolpyruvate-protein 
phosphotransferase of PTS system 
(EC 2.7.3.9 
15 6 1,810,680 1,933,477 
LMOh7858_1451 lmo1364 
(cspLA) 
LMRG_00814 cold-shock protein 16 67 1,723,202 615,514 
LMOh7858_1331 lmo1250 LMRG_00696 Transporter 17 250 1,711,134 210,841 
LMOh7858_0642 lmo0582 
(iap) 
LMRG_00264 P60 extracellular protein, invasion 
associated protein Iap 
18 5 1,675,726 2,318,702 
NGNc lmo1388 
(tcsA) 
LMRG_00840 Unspecified monosaccharide 
ABC transport system, substrate-
binding compo 
19 9 1,607,769 1,818,968 
LMOh7858_2330 lmo2196 
(oppA) 
LMRG_01636 Oligopeptide ABC transporter, 
periplasmic oligopeptide-binding 
protein O 
20 10 1,603,950 1,694,246 
aStrain EGD-e (GenBank accession no.: NC_003210) and 10403S (GenBank accession no.: 
NC_017544) are L. monocytogenes; 
bNRC, normalized RNA-seq coverage; genes with average NRC >1,500,000 are presented; 
cNGN, no gene name given; in the published version of the H7858 genome (27), this gene was 
not annotated and, therefore, did not receive a locus name; the gene was identified in our 
annotation.  
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Initial analysis of the RNA-seq data identified 88 and 61 genes that showed significantly 
higher and lower transcript levels, respectively, for H7858 grown on CSS compared to in 
MBHIB (see Tables S4.1 and S4.2 for lists of up- and downregulated genes). The 88 upregulated 
genes included genes encoding proteins annotated as being involved in cobalamin biosynthesis 
(26 genes), ethanolamine utilization (8 genes), 1,2-propanediol utilization (7 genes), 
carbohydrate transport and utilization (14 genes), the non-oxidative branch of the pentose 
pathway (5 genes), agmatine deiminase (4 genes), as well as genes regulated by PrfA (5 genes) 
(Tables S4.3-S4.7). The 61 downregulated genes included genes encoding proteins annotated as 
being involved in pyrimidine nucleotide biosynthesis (6 genes) and L-cystine ABC transporter (3 
genes) (Table S4.2). GO enrichment analysis identified 37 GO terms that were overrepresented 
among genes upregulated in L. monocytogenes grown on CSS, as compared to MBHIB (Table 
4.3). No GO terms were found to be enriched among the downregulated genes. 
  
	  	  
	  
96	  
Table 4.3. GO terms enriched among genes upregulated in H7858 grown on CSS compared to in 
MBHIB at 7oC 
GOID GO Term 
Pathways associated with GO term 
cobalamin 
biosynthesis
/transport 
ethanolamin
e/1,2-
propanediol 
utilization 
carbohydrate 
utilization/ 
transport 
GO:0005363 maltose transmembrane transporter activity   Ya 
GO:0006580 ethanolamine metabolic process  Y  
GO:0006766 vitamin metabolic process Y   
GO:0006767 water-soluble vitamin metabolic process Y   
GO:0006778 porphyrin-containing compound metabolic process Y   
GO:0006779 porphyrin-containing compound biosynthetic 
process 
Y   
GO:0006824 cobalt ion transport Y   
GO:0008757 S-adenosylmethionine-dependent 
methyltransferase activity 
Y   
GO:0009110 vitamin biosynthetic process Y   
GO:0009235 cobalamin metabolic process Y   
GO:0009236 cobalamin biosynthetic process Y   
GO:0015151 alpha-glucoside transmembrane transporter activity   Y 
GO:0015157 oligosaccharide transmembrane transporter activity    
GO:0015235 cobalamin transporter activity Y   
GO:0015420 cobalamin-transporting ATPase activity Y   
GO:0015422 oligosaccharide-transporting ATPase activity   Y 
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Table 4.3 (Continued) 
GO:0015423 maltose-transporting ATPase activity   Y 
GO:0015768 maltose transport   Y 
GO:0015889 cobalamin transport Y   
GO:0015994 chlorophyll metabolic process Y   
GO:0016628 oxidoreductase activity, acting on the CH-CH 
group of donors, NAD or NADP as acceptor 
Y   
GO:0022804 active transmembrane transporter activity Y Y  
GO:0033013 tetrapyrrole metabolic process Y   
GO:0033014 tetrapyrrole biosynthetic process Y   
GO:0034311 diol metabolic process  Y  
GO:0034313 diol catabolic process  Y  
GO:0042364 water-soluble vitamin biosynthetic process Y   
GO:0042439 ethanolamine-containing compound metabolic 
process 
 Y  
GO:0042440 pigment metabolic process Y Y  
GO:0044237 cellular metabolic process Y Y Y 
GO:0046483 heterocycle metabolic process Y Y  
GO:0051143 propanediol metabolic process  Y  
GO:0051144 propanediol catabolic process  Y  
GO:0051180 vitamin transport Y   
GO:0051183 vitamin transporter activity Y   
GO:0051186 cofactor metabolic process Y   
GO:0051188 cofactor biosynthetic process Y   
aY, yes.   
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Genes involved in cobalamin synthesis, ethanolamine utilization, and 1,2-
propanediol utilization were upregulated in H7858 growing on CSS. In addition to 
identification of 26 upregulated genes with cobalamin metabolism related annotations (Table 
S4.3), we also found the GO terms “cobalamin biosynthetic process” and “cobalamin transport” 
to be overrepresented among upregulated genes of H7858 on CSS (Table 4.3). We mapped these 
genes to the overall cobalamin biosynthesis pathways (Fig. 4.2) constructed based on the 
metabolic pathway data of EGD-e and 10403S available in the BioCyc database (biocyc.org) 
(41). Among the 21 genes mapped to the cobalamin biosynthesis pathways (Fig. 4.2), 18 were 
found to be upregulated (FC 2.76-12.88).  
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Figure 4.2. Cobalamin biosynthesis, ethanolamine and 1,2-propanediol utilization pathways in H7858 
Pathways were constructed based on information provided in the Biocyc database and previous studies (42-44). H7858 protein 
designations for enzymes involved in these pathways are shown in blue text. Enzymes encoded by genes upregulated in H7858 grown on cold 
smoked salmon (CSS) compared to in modified BHI broth (MBHIB) are designated by display of the fold change (FC) in green boxes. 
Microcompartments are depicted by dotted lines. Purple, orange, and blue boxes mark molecules involved in ethanolamine, cobalamin, and 1,2-
propanediol metabolism, respectively. Solid and dotted orange boxes mark reactions under anaerobic and aerobic conditions, respectively. 
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We also identified eight upregulated genes with ethanolamine utilization related annotations 
(Table S4) and the GO term “ethanolamine metabolic process" as overrepresented among 
upregulated genes in H7858 grown on CSS compared to in MBHIB (Table 4.3). Mapping of 
these genes to the ethanolamine utilization pathway, constructed based on previous studies for S. 
enterica (42-44) and information about the eut operon provided by Staib and Fuchs (42), showed 
that genes encoding eight of the eleven key enzymes mapped to the ethanolamine degradation 
pathway were upregulated (FC 4.97-6.19) (Fig. 4.2). Furthermore, we identified seven 
upregulated genes with 1,2-propanediol utilization related annotations (Table S4.4) and the GO 
term “propanediol catabolic process” as overrepresented among upregulated genes (Table 4.3). 
We mapped these genes to the 1,2-propanediol utilization pathway which was constructed based 
on data from S. enterica (42-44) and information about the pdu operon provided by Staib and 
Fuchs (42). This analysis showed that six of the thirteen genes encoding key enzymes mapped to 
the 1,2-propanediol degradation pathway (Fig. 4.2) were upregulated on CSS (FC 2.88-6.57). 
Genes involved in carbohydrate transport and utilization were upregulated in H7858 
growing on CSS. We identified fourteen upregulated genes with carbohydrate and alcohol 
transport and utilization related annotations (Table S4.5) and the GO terms “alpha-glucoside 
transmembrane transporter activity” and “oligosaccharide-transporting ATPase activity” were 
overrepresented among upregulated genes (Table 4.3). As the fourteen upregulated genes 
represented functions related to transport and metabolism of galactitol, mannose and maltose, we 
diagrammed the galactitol and mannose specific phosphotransferase system (PTS), maltose 
specific ATP-binding cassette (ABC) transporter system, as well as a few catabolism reactions 
for each of these three molecules (Fig. 4.3) to further assess expression of these pathways. For 
the mannose-specific PTS of L. monocytogenes, genes encoding all four components (PTS-
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IIAMan, PTS-IIBMan, PTS-IICMan and PTS-IIDMan ) were upregulated (Fig. 4.3). For the galactitol-
specific PTS, which includes three components, genes encoding two components (PTS-IIBGat 
and PTS-IICGat) were upregulated. For the maltose-specific ABC transporter system of L. 
monocytogenes, genes encoding all three domains of this ABC transporter (MalE, MalF and 
MalG) were upregulated.   
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Figure 4.3. Schematic of galactitol and mannose specific phosphotransferase system (PTS), maltose specific ATP-binding cassette (ABC) 
transporter system, catabolism reactions for each of the three molecules, and the non-oxidative branch of pentose phosphate pathway in H7858 
Pathways were constructed based on information provided in the Biocyc database. H7858 protein designations for enzymes involved in 
these reactions and pathways are shown in blue text. Enzymes encoded by genes upregulated in H7858 grown on cold smoked salmon (CSS) 
compared to in modified BHI broth (MBHIB) are designated by display of the fold change (FC) in green boxes. Pink, red and blue boxes mark 
molecules involved in galactitol and mannose specific PTS and catabolism reactions, maltose specific ABC transporter system and catabolism 
reactions; as well as the non-oxidative branch of pentose phosphate pathway, respectively.  
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Additionally, we found that four of the sixteen genes involved in the non-oxidative branch of 
the L. monocytogenes pentose phosphate pathway were significantly upregulated in H7858 
growing on CSS (Table S4.5); these genes encode enzymes involved in four out of five key 
reactions of this pathway branch based on the 10403S database on BioCyc (Fig. 4.3). Moreover, 
6-phospho-D-gluconate, generated by maltose utilization reactions, and D-glyceraldehyde-3-
phosphate, generated from galactitol utilization reactions, are also found to be the participants of 
the non-oxidative branch of the pentose phosphate pathway in L. monocytogenes (Fig. 4.3), 
which reflect a potential connection between these two carbohydrate utilization pathways and the 
non-oxidative branch of the pentose phosphate pathway. 
Genes involved in agmatine deiminase system were upregulated in H7858 growing on 
CSS. We also identified four upregulated genes with agmatine deiminase related annotations 
(Table S4.6); the fold changes of these genes ranged from 13.67 to 31.36 and were the highest 
among all upregulated genes. To further explore the functions of these genes, we reconstructed 
the reactions involved in the L. monocytogenes agmatine deiminase system, using previous 
studies on L. monocytogenes and other gram-positive bacteria (45-48). All four genes encoding 
the key enzymes involved in breakdown of agmatine to CO2 and NH3 showed higher transcript 
levels in H7858 grown on CSS (Fig. 4.4), indicating upregulation of the overall agmatine 
deiminase pathway.  
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Figure 4.4. Agmatine deiminase system in H7858  
Agmatine deiminase system in H7858 was constructed by connecting reactions 
associated with agmatine deiminase based on previous studies (45-48). H7858 protein 
designations for enzymes involved in these reactions are shown in blue text. Enzymes encoded 
by genes upregulated in H7858 grown on cold smoked salmon (CSS) compared to in modified 
BHI broth (MBHIB) are designated by display of the fold change (FC) in green boxes. Blue 
boxes mark molecules involved in agmatine deiminase system.  
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L. monocytogenes grown on CSS show higher transcript levels of PrfA-dependent 
genes. Five genes known to be regulated by the master regulator of virulence genes, PrfA, were 
found to be upregulated in H7858 grown on CSS. These PrfA-dependent genes include inlB (FC 
2.71), plcA (FC 2.83), hly (FC 2.54), actA (FC 2.86), and plcB (FC 3.19) (Table S4.7). Statistical 
analysis showed that PrfA-dependent genes as a group were significantly enriched among 
upregulated genes (P <0.0001; Fishers exact test). 
DISCUSSION 
In this study we used RNA-seq to explore the transcriptional landscape of L. monocytogenes 
H7858 growing on CSS and in BHIB modified to reflect the pH and water phase salt 
concentration of CSS. Our data indicate that H7858 grown on vacuum-packaged CSS (i) 
upregulates cobalamin biosynthesis pathways as well as ethanolamine and 1,2-propanediol 
utilization pathways, (ii) differentially regulates carbohydrate transport functions, and (iii) 
upregulates arginine deiminase genes, likely facilitating adaptation to anaerobic conditions, 
utilization of nutrients available on CSS and growth in the presence of resident microbiota. 
Limitations of using MBHIB as a reference condition to CSS for studying the gene 
expression profile of L. monocytogenes during growth. A number of previous studies have 
analyzed the transcriptomes of foodborne pathogens under stress conditions commonly present 
on/in food matrices (including hyperosmotic stress, cold stress, hydrostatic pressure stress, 
antimicrobial stress, acid stress and alkali stress), using laboratory media modified to simulate 
these conditions as a model (15-22, 49-63). These laboratory media include BHI broth (18, 20, 
21, 59), BHI agar (19), Luria-Bertani broth (60, 61), tryptic soy broth (62), M9-glucose (63), and 
Listeria minimal medium (22), as references conditions. Key differences between the reference 
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condition we used and CSS were that the CSS was vacuum packaged while the reference 
medium was not anaerobic (though MBHIB was incubated without shaking), L. monocytogenes 
was grown on the surface of CSS, while growth was planktonic in the liquid MBHIB, and CSS 
contains a number of unique components that cannot be easily added to BHIB at comparable 
concentrations (e.g., different phenolics, lipids, trace elements, etc.). In addition, a previous 
study in our lab on the same batch of CSS demonstrated that the resident lactic acid bacteria 
were able to grow to ~ 7 log(CFU/g) by day 10 [with an initial density of ~ 4 log(CFU/g) on day 
0] under the same growth conditions used in the current study (31). Lactic acid bacteria are 
known to be one of the dominant microbes on CSS and may constitute a natural form of 
antimicrobial control via competition for particular nutrients or production of organic acids, 
hydrogen peroxide, and bacteriocins (64-66). Furthermore, Lactobacillus has been demonstrated 
to be able to reshape L. monocytogenes protein-coding genes and sRNA expression profiles (67). 
Even though we modified the laboratory medium to present the same major conditions found in 
CSS, and L. monocytogenes had similar growth patterns under the conditions of both the food 
matrix and laboratory medium, the aforementioned differences between these two conditions add 
limitations to the comparison of the transcriptional profiles. 
The inoculation level of L. monocytogenes in MBHIB and on CSS was high in the present 
study (~ 1 x 106 CFU/g). L. monocytogenes contamination of cold smoked fish is typically at low 
levels (8, 68), and there is the potential for differences in responses of L. monocytogenes when 
inoculated at different levels. However, L. monocytogenes can grow in food products at 
refrigeration temperatures to high levels, and the infection dose in an immune-competent 
individual can be high [up to ~9 log(CFU/g)] (69). While our study does not encompass all 
possible variations in inoculum level, media preparation, and competitive microbes found on 
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some naturally contaminated products, data from previous studies indicate that what we found 
was not unusual. Consistent with our results, studies with lower inoculum levels also found 
similar growth rates (e.g. 0.37 log units/day) and similar final concentrations (e.g. ~8 log 
CFU/ml) for L. monocytogenes on vacuum packed CSS at refrigerated temperatures (e.g. 4oC) (7, 
70). Our results do provide insights into the relative differences in transcriptomes of L. 
monocytogenes at the same growth phase under different complex conditions, and reflect the 
gene expression profile of L. monocytogenes in food at high levels that could cause human 
disease. 
L. monocytogenes grown on vacuum-packaged CSS upregulates cobalamin biosynthesis 
pathways as well as ethanolamine and 1,2-propanediol degradation pathways, likely 
facilitating adaptation to available nutrient sources. Our data showed that L. monocytogenes 
significantly upregulated both cobalamin biosynthesis and transport systems, presumably to 
increase the availability of cobalamin in the bacterial cells. Cobalamin (coenzyme B12 (71)) is 
found in high levels in CSS. Smoked salmon has up to 18.10 µg B12 per 100 g according to the 
USDA National Nutrient Database for Standard Reference (Basic Report: 35190, Salmon, red 
(sockeye), smoked). We found that transcript levels of genes involved in both aerobic and 
anaerobic pathways (72-74) were significantly higher in L. monocytogenes grown on CSS. Roth 
et al. (43) proposed that the primary function of cobalamin in many bacteria is to support 
fermentation of small molecules such as ethanolamine and 1,2-propanediol by catalyzing 
molecular rearrangements. We propose that one of the reasons L. monocytogenes uptakes or 
synthesizes cobalamin more actively on CSS is to facilitate growth under this condition by using 
cobalamin to support the utilization of ethanolamine and 1,2-propanediol. 
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To date, three foodborne bacterial pathogens have been shown to be able to use both 
ethanolamine and 1,2-propanediol as a carbon source (75), and to use ethanolamine as a nitrogen 
source: L. monocytogenes, S. enterica, and Clostridium perfringens (76). Ethanolamine is a 
major constituent of lipids in eukaryotic cells (77) including salmon (78), and thus may become 
available for L. monocytogenes through the breakdown of salmon cells. Broad-range 
phospholipases such as PlcB (plcB was upregulated in CSS) of L. monocytogenes might serve to 
reduce phosphatidylethanolamine to ethanolamine (42). 1,2-propanediol is produced during 
bacterial anaerobic catabolism of the common methylpentoses, rhamnose and/or fucose (42, 79). 
1,2-propanediol may be available for L. monocytogenes through the breakdown of salmon 
mucosal glycoconjugates which contain fucose and rhamnose (80, 81). Moreover, in L. 
monocytogenes, one cobalamin-binding riboswitch is located upstream of the first gene in the eut 
locus; this riboswitch regulates expression of eut in response to cobalamin availability (82). A 
second cobalamin-binding riboswitch is located upstream of the pdu locus; this riboswitch 
maximizes the expression of 1,2-propanediol utilization genes when both 1,2-propanediol and 
cobalamin are present (83). These findings further demonstrate the close relationship between 
ethanolamine and 1,2-propanediol utilization pathways and cobalamin biosynthesis/transport 
pathways. 
Recent research has identified potential roles for ethanolamine and 1,2-propanediol 
utilization in L. monocytogenes and S. Typhimurium during growth in foods and/or in the host 
environment (84-87). Srikumar and Fuchs (88) found that nonpolar deletions of pocR (regulating 
pdu and cob-cbi) and eutR in S. enterica Typhimurium led to significantly reduced proliferation 
in milk and egg yolk. Likewise, Goudeau et al. (84) reported that S. enterica mutants with 
deletions in pduD or cobS show decreased fitness in cilantro soft rot. Archambaud et al. (67) 
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reported that L. monocytogenes shows higher transcript levels of genes encoding functions 
involved in ethanolamine and 1,2-propanediol utilization as well as cobalamin biosynthesis when 
present in the intestine of gnotobiotic mice that contained Lactobacillus spp., as compared to 
mice without Lactobacillus spp.. This suggests that 1,2-propanediol and ethanolamine utilization 
may provide L. monocytogenes a mechanism to effectively co-exist with the resident microbiota, 
which are usually not able to utilize these organic compounds. Overall, our study along with 
other studies suggest that foodborne pathogens including L. monocytogenes may utilize 
ethanolamine and/or 1,2-propanediol to proliferate in food and host environments where these 
molecules are available. Further studies will be needed to confirm this and to identify food 
matrices or growth conditions where ethanolamine and/or 1,2-propanediol utilization by L. 
monocytogenes may occur. 
Listerial physiological adaptation to the end products of ethanolamine and 1,2-
propanediol utilization on CSS may provide targets for novel interventions. Under anaerobic 
conditions, two of the major products of the ethanolamine and 1,2-propanediol utilization 
pathways are acetate (42-44, 89) and propionate (42-44, 90), respectively. We propose that L. 
monocytogenes utilizes the agmatine deiminase system to attenuate the acidification caused by 
these two acids. This is supported by the observation that L. monocytogenes grown in vacuum-
packaged CSS upregulated genes encoding functions involved in the agmatine deiminase system. 
This system has been demonstrated to catalyze arginine and/or agmatine deamination, which 
generates two NH3 molecules, facilitating pH buffering (45-48, 91) and thus possibly buffering 
acid end products (acetate and propionate) created by the ethanolamine and 1,2-propanediol 
degradation. However, the upregulation of genes related to this system have not been found in 
studies on L. monocytogenes growing on/in food matrices such as turkey deli meat (19), skim 
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milk (21), or cut cabbage (22), which may indicate that this transcriptional response is specific to 
the growth conditions tested here. Production of acetate and propionate as byproducts of 
ethanolamine and 1,2-propanediol degradation, suggests that growth inhibitors that include these 
two organic acids may be able to more effectively inhibit L. monocytogenes growth than 
currently used growth inhibitors. This is supported by a recent transcriptomic study in BHIB 
grown L. monocytogenes (17), which showed that exposure of L. monocytogenes to acetate and 
lactate lead to decreased expression of lactate and acetate creating energy pathways, shifting 
ATP production to a less efficient pathway with acetoin, a non-charged molecule, as an end 
product. 
Higher transcript levels of genes encoding specific carbohydrate PTS components and 
ABC transporter domains indicate that L. monocytogenes may uptake and utilize a broad 
range of carbohydrates on CSS. As L. monocytogenes upregulated genes encoding proteins 
involved in utilization and transport of galactitol, mannose and maltose, we propose that L. 
monocytogenes growing on CSS broadens the range of carbohydrates that are utilized to 
compensate for the limited availability of glucose (relative to BHIB, which contains 2g added 
glucose/L). Galactitol is the reduction product of galactose, which together with mannose, may 
be available as components of mucin glycoconjugates at the mucosal tissue of fish (80, 81, 92, 
93). While maltose is found in many processed products that have been sweetened (94), it is 
unclear whether there is a specific maltose source in CSS. Consistent with our findings, genes 
involved in carbohydrate metabolism were identified to be more expressed on cut-cabbage (22) 
and on ready-to-eat turkey deli meat (19), as compared to the growth of L. monocytogenes in 
laboratory media. However, no genes involved in carbohydrate metabolism were found to be 
upregulated in skim milk in Liu and Ream’s study (21), which may be attributed to the 
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abundance of lactose as a carbon source in milk. In the host environment, Toledo-Arana (23) and 
Chatterjee et al. (95) found increased transcript levels of specific PTSs in L. monocytogenes, 
which enabled it to utilize sugars, such as mannose, fructose, and/or their alcohols including 
galactitol, during growth in the intestine of axenic mice (23) or upon entering epithelial cells (95). 
In sum, exploiting a wider range of carbohydrates appears to be a successful strategy of enteric 
pathogens to overcome nutrient limitations or adapt to specific nutrient compositions when 
proliferating under the complex conditions of food matrices such as CSS. 
Our data suggest that L. monocytogenes growing on CSS may use the non-oxidative branch 
of the pentose phosphate pathway for gluconeogenesis, which is plausible since the pentose 
phosphate pathway is more efficient in anabolism compared to glycolysis. Similar to our finding, 
Bae et al. (19) also found the gene LMOf2365_1395 of L. monocytogenes F2365 involved in the 
pentose phosphate pathway was induced on ready-to-eat turkey deli meat (19). Zhou et al. (96) 
found that several key enzymes involved in the pentose phosphate pathway were more prevalent 
in biofilms compared to planktonic-grown cells of L. monocytogenes, and Hefford et al. (97) 
reported that proteins involved in sugar metabolism were highly expressed in biofilms. These 
findings may indicate that upregulation of aforementioned carbohydrate utilization genes, 
especially the pentose phosphate pathway related genes, is due to growth of L. monocytogenes on 
the surface of foods, such as deli meat and CSS. 
Differential regulation of PrfA-dependent genes in vacuum-packaged CSS supports 
that growth conditions can have multifaceted effects on gene expression and cell physiology. 
Interestingly, PrfA-dependent genes showed higher transcript levels in vacuum-packaged CSS, 
which may be triggered by (i) the low level of glucose on CSS, (ii) the oxygen restriction 
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condition presented in vacuum-packaged CSS, and/or (iii) specific signals associated with 
salmon tissue or specific compounds in the BHIB that could suppress the expression/activity of 
PrfA. As the presence of glucose and fermentable carbohydrates can affect expression of the 
PrfA regulon (98-100), the apparent utilization of different carbohydrates by L. monocytogenes 
grown on CSS may affect the transcript level of PrfA-dependent genes in L. monocytogenes 
grown on CSS. The importance of the anaerobic environment is supported by data from Larsen 
et al. (101), who reported higher invasion of Caco-2 cells for L. monocytogenes grown for two 
and four weeks on modified atmosphere-packaged ham at 4oC, as compared to bacteria grown in 
BHIB. Andersen et al. (102) reported that L. monocytogenes grown under oxygen-restricted 
conditions were more invasive to Caco-2 cells and yield higher bacterial loads in organs after 
oral guinea pig challenge compared to bacteria grown without oxygen-restriction. In contrast to 
our findings, Olesen et al. (20) reported that L. monocytogenes strain O57 prfA transcript levels 
were significantly higher in bacteria grown in BHI compared to in liver pâté at 7oC. Possible 
explanations for these observed differences include that the L. monocytogenes was grown on 
liver pâtés under aerobic conditions, as well as differences in the length of incubation. 
Although PrfA-dependent genes represent bona-fide virulence genes (103-105), differential 
regulation of these genes under the complex conditions of food matrices appears to occur, with 
oxygen restricting conditions and carbohydrate availability possibly representing environmental 
cues affecting expression of the PrfA regulon. In addition, a role for PrfA in the survival and 
proliferation of L. monocytogenes outside the human host and on/in specific food matrices 
cannot be excluded, as supported by data that suggest that PrfA contributes to L. monocytogenes 
biofilm formation (106). Along with previously reported studies, our data suggest that growth 
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conditions can have multifaceted effects on gene expression and cell physiology, which reach 
beyond specific adaptations to nutrient availability and stress conditions encountered.  
Increasing evidence supports that food related factors that are not easily simulated in 
laboratory medium likely play important roles in growth and survival of foodborne pathogens in 
different foods. Use of RNA-seq-based transcriptomic profiling allows for detailed assessment of 
the physiological state of pathogens present on/in food matrices and provides novel insights in 
adaptations of foodborne pathogens to the complex conditions on/in specific food matrices and 
environmental conditions. This type of detailed information will open up a number of new 
avenues to improve food safety. For example, the type of information presented here could pave 
the way for developing better detection methods (e.g., methods targeting highly expressed RNA 
molecules) and may even provide for improved risk assessments that account for the fact that 
virulence of a given pathogen may be affected considerably by its physiological state, which 
clearly depends on a number of factors including, but not limited to, food matrix, temperature, 
and packaging strategies. Most importantly, detailed data on pathogen adaptation to different 
complex conditions of food matrices may hold the key to development of more efficient control 
strategies and will move development of control strategies from traditional trial and error 
approaches to a rational design type approaches for the development of new growth inhibitors. 
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CHAPTER 5 
CONCLUSIONS 
 
The ability to survive and grow in nutrient limited food processing environments and 
food products that are stored at low temperatures elevates the risk of food contamination and 
transmission of L. monocytogenes through foods to humans. Our data suggest that, strain 
variability, clonal cluster variability, genetic lineage, matrix (MBHIB versus CSS), and food 
packaging method (anaerobic versus aerobic) may significantly influence the growth rate of L. 
monocytogenes in defined media, the efficacy of antimicrobials against L. monocytogenes, and 
the gene expression profile of L. monocytogenes during late log phase of growth. 
In the first study, we used 10G-MLST, which targets ten housekeeping genes, to 
investigate the diversity and phylogenetic distribution of L. monocytogenes strains with epidemic 
potential. We also compared the classification result based on 10G-MLST scheme to the ones 
based on previously described typing schemes (CCs identified by using 7G-MLST scheme and 
ECs identified by using MvLST), to understand the correlations among them and enable cross 
reference across the phylogenetic classification results of these schemes. The clonal framework 
established by using 10G-MLST allowed us to compare the maximum growth rate of L. 
monocytogenes isolates growing in chemically defined media at 16oC by 10G-TLV-CCs (where 
all STs of the same CC differ from one another in three of the ten alleles). Our findings 
demonstrated that the 124 L. monocytogenes isolates are genetically diverse, and the outbreak-
associated isolates were wide-spread through the diversity of L. monocytogenes. We also 
identified that, among the 105 isolates tested, there was considerable variation in maximum 
growth rate in a nutrient limited growth condition. We found that certain genetic subgroups of 
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lineage II strains could grow faster than some genetic subgroups of lineage I strains under this 
nutrient limited condition, which may facilitate their persistence in non-host environments, thus 
leading to a higher risk of food contamination and transmission of this pathogen through foods to 
humans. 
In the second study, we (i) tested the efficacy of three antimicrobials as well as their binary 
combinations against L. monocytogenes growing on CSS and in MBHIB at 7oC, and (ii) 
investigated that whether the antimicrobial efficacy data generated from studies in laboratory 
medium is able to quantitatively predict efficacy in food matrices. Among all antimicrobial 
treatments, the combination of PL and SDA had synergistic effects and led to the greatest 
increase in λ both on CSS and in MBHIB. Treatments with NI significantly reduced initial cell 
density, the combination of NI and PL led to the greatest reductions in Nmax on CSS, while 
bactericidal effects of NI on L. monocytogenes were highly strain dependent. We observed 
positive correlations between the growth parameters obtained from MBHIB and CSS, indicating 
that growth of L. monocytogenes in broth, to some extent, qualitatively reflected characteristics 
of growth on CSS under antimicrobial stresses. Results from MBHIB could quantitatively 
predict the variability of growth parameters obtained from CSS for lineage II strains, but not for 
lineage I strains. Our data suggest that (i) strain variability, genetic lineage, and matrix (BHI 
versus cold-smoked salmon) can significantly affect the efficacy of NI and organic acids against 
L. monocytogenes, and (ii) data from BHI broth may not be able to accurately predict the 
variability of antimicrobial effects against L. monocytogenes on cold smoked salmon. 
In the third study, we overcame the technical difficulties associated with isolating high 
quality bacterial RNA from the seafood matrix, and took advantage of the probe- and annotation-
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independence of RNA-seq technology to explore the genome-wide gene expression of L. 
monocytogenes grown in a food matrix. We compared the transcriptomes of L. monocytogenes 
strain H7858 grown on CSS and in MBHIB at 7oC, and identified specific transcriptional profiles 
of L. monocytogenes growing on vacuum-packaged CSS. Significant differential transcription of 
149 genes was observed (FDR<0.05, fold change ≥ 2.5), and 88 and 61 genes were up- and down 
regulated in H7858 grown on CSS relative to in MBHIB. Specifically, we found that genes 
encoding proteins involved in cobalamin biosynthesis as well as ethanolamine and 1,2-
propanediol utilization, have significantly higher transcript levels in H7858 grown on CSS 
compared to in MBHIB. The difference between transcriptional profiles of L. monocytogenes 
growing on CCS and in MBHIB highlighted the importance of the investigation of L. 
monocytogenes transcriptome in a real food matrix. Use of RNA-seq-based transcriptomic 
profiling allows for detailed assessment of the physiological state of pathogens present in food 
matrices at an unparalleled resolution and provides novel insights in adaptations of foodborne 
pathogens to specific food matrices and environmental conditions.  
Taken together, our studies in long term may facilitate the surveillance, detection, and control 
of L. monocytogenes strains that are more likely to cause outbreaks and sporadic listeriosis cases. 
Our data highlighted the importance of using molecular typing methods that are amenable to 
evolutionary analysis for a further understanding of the phylogenetic distribution of L. 
monocytogenes isolates and for the phenotypic characterization of genetic subgroups of L. 
monocytogenes. Growth parameter data collected in our studies, when combined with genetic 
and cellular level studies, could provide an improved mechanistic understanding of the cellular 
response and resistance development of L. monocytogenes to different antimicrobials. Detailed 
transcriptional profile data on pathogen adaptation to different food matrices may provide targets 
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for development of novel and improved strategies to control L. monocytogenes growth on this 
RTE food.
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Supplemental Figure 2.1. The 10G-SLV-CCs and singletons generated by eBURST.  
10G-SLV-CCs were identified by using 10G-MLST scheme and eBURST algorithm, 
where all 10G-STs of the same 10G-SLV-CC differ one another in one of the ten alleles, 
singletons were accordingly defined as the 10G-STs that differ from all of the other STs in more 
than one of the ten alleles. The ancestral 10G-ST of a 10G-SLV-CC is represented by a blue dot, 
and the other 10G-STs are represented by black dot. The size of each dot reflects the number of 
isolates within a 10G-ST. Only single-locus-variant links are shown within each 10G-SLV-CCs, 
individual dots represent singletons.  
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Supplemental Table S2.1. Information of L. monocytogenes isolates used 
Strain IDa Alias Lineage Source Sero-
type 
Ribo-
type 
10G
-STb 
10G-
SLV-
CCc 
10G
-
TLV
-
CCd 
7G-
STe 
7G-
CCf 
ECg 
µmaxh 
[log(OD600
/ml)/day] 
Genome 
Accession 
# 
Source 
of 10G-
MLST 
data 
07PF0776 
 
I 
human 
(myocardial 
abscess), 
sporadic  
4b NAi 42 9 12 4 4 NA NA NC_017728.1 (1) 
08_5578 
 
II 
2008, 
Canadian deli 
meat outbreak 
1/2a NA 17 S S 292 8 V NA NC_01376
6.1  
(2) 
08_9523 
 
II 
2008, 
Canadian deli 
meat outbreak 
1/2a NA 17 S S 120 8 V NA NC_013768.1 (2) 
ATCC 19117 
 
I 
animal 
(sheep), 
sporadic 
4d NA 2 2 2 2 2 IV NA FR733643 
(3) 
Finland1998 
 
II 
1998, Finland 
butter 
outbreak 
3a NA 10 S S 155 NA NA NA AART00000000 (4) 
FSL C1-0051 B98-814 II 1998, human sporadic NA 
1053
A 10 S S NA NA NA 0.054 NA CUFSL
j 
FSL C1-0111 B98-4374 II 1998, human, sporadic 1/2a 1039E 77 S 1 NA NA NA 0.037 NA CUFSL 
FSL C1-0115 2006650 II 1998, human, 
sporadic 
3a 1039C 80 S S 370 S NA 0.047 NA CUFSL 
FSL C1-0122 B98-4581 I 1998, human, 
sporadic 
4b 1038B 22 8 8 1 1 NA 0.043 NA CUFSL 
FSL E1-0041 30384/FSL F2-329 I 
2000, animal 
(sheep), 
clinical 
1/2b 1042C 41 S S NA NA NA 0.051 NA CUFSL 
FSL E1-0154 As-6 48h II 2001, soil, environment NA 
1053
A 65 S S NA NA NA 0.048 NA CUFSL 
FSL E1-0201 Cs-4ii 24h I 2001, soil, environment NA 1051C 4 6 6 NA NA NA 0.053 NA CUFSL 
FSL F2-0018 B99-3991 I 1999, human, 
sporadic 
4b 1042B 24 S 9 NA NA NA 0.047 NA CUFSL 
FSL F2-0032 99B08871/BAC9900004653 II 
1999, food 
(smoked 
whitefish) 
1/2a 1045B 66 S S NA NA NA 0.054 NA CUFSL 
FSL F2-0039 B99-4843 II 1999, human, 
sporadic 
1/2a 1030B 63 S S NA NA NA 0.049 NA CUFSL 
FSL F2-0048 NYC99-119G II 1999, human, sporadic 1/2a 
1053
A 70 1 1 NA NA NA 0.063 NA CUFSL 
FSL F2-0091 NYC99-141G I 1999, human, sporadic 4b 
1042
A 2 2 2 NA NA NA 0.055 NA CUFSL 
FSL F2-0141 NYC99-146G II 1999, human, 
sporadic 
1/2a 1053
A 
5 1 1 NA NA NA 0.055 NA CUFSL 
FSL F2-0194 99190247 II 1999, human, 
sporadic 
NA 1030
A 
68 S 3 7 7 NA 0.063 NA CUFSL 
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Supplemental Table S2.1 (Continued) 
FSL F2-0216 99191915 II 1999, human, 
epidemic 
1/2a 1039
A 
10 S S NA NA NA 0.054 NA CUFSL 
FSL F2-0237 99B13372/B0000000265 II 
1999, food 
(smoked 
salmon) 
1/2a 1062D 18 S 1 NA NA NA 0.045 NA CUFSL 
FSL F2-0270 190144 III 1999, human, sporadic 4a 
18007
A 54 S S NA NA NA 0.054 NA CUFSL 
FSL F2-0366 B00-2431 I 2000, human, sporadic 4b 1042B 26 10 9 NA NA NA 0.042 NA CUFSL 
FSL F2-0369 00B04594/BA
C0000002476 
I 
2000, food 
(RTE pasta 
salad) 
1/2b 1042C 1 5 4 NA NA NA 0.043 NA CUFSL 
FSL F2-0405 B00-3127 II 2000, human, 
sporadic 
NA 1053
A 
71 1 1 NA NA NA 0.054 NA CUFSL 
FSL F2-0493 00B07564/BAC0000004013 I 
2000, food 
(raw chunk 
beef patties)  
1/2b 1024A 35 S S NA NA NA 0.047 NA CUFSL 
FSL F2-0515 00B08520/BAC0000004359 II 
2000, food 
(RTE turkey 
deli meat) 
1/2a 1062A 15 12 13 NA NA NA 0.039 NA CUFSL 
FSL F2-0516 B00-4383 II 2000, human, sporadic 1/2a 
1053
A 16 1 1 NA NA NA 0.02 NA CUFSL 
FSL F2-0521 00B08499/BA
C0000004459 
I 
2000, food 
(smoked fish 
salad) 
1/2b 1040
A 
31 3 5 NA NA NA 0.048 NA CUFSL 
FSL F2-0539 EGD-e II 1924 animal 
(rabbit) 
1/2a 1039C 6 11 10 35 9 NA 0.044 NC_00321
0.1 (5) 
FSL F2-0656 NYC01-129g I 2001, human, 
sporadic 
4b 1042
A 
2 2 2 NA NA NA 0.041 NA CUFSL 
FSL F2-0661 B01-1825 I 2001, human, 
sporadic 
4b 1042
A 
2 2 2 NA NA NA 0.041 NA CUFSL 
FSL F2-0693 NYC01-192g I 2001, human, sporadic 1/2b 1042B 60 S S NA NA NA 0.036 NA CUFSL 
FSL F2-0699 NYC02-16g I 2002, human, sporadic NA 
1051
A 14 7 7 NA NA NA 0.049 NA CUFSL 
FSL F3-0566 NYC03-216G II 2003, human, 
sporadic 
NA 1053
A 
73 1 1 NA NA NA 0.066 NA CUFSL 
FSL F3-0631 3191076 II 2003, human, 
sporadic 
NA 1051B 3 4 3 NA NA NA 0.048 NA CUFSL 
FSL F3-0744 M02AE657 II 2002, human, 
sporadic 
NA 1053
A 
3 4 3 NA NA NA 0.058 NA CUFSL 
FSL F3-0757 M02AE1101 I 2002, human, sporadic NA 
1051
A 14 7 7 NA NA NA 0.028 NA CUFSL 
FSL F3-0950 BAC0500005969 I 
2005, human, 
sporadic NA 1051C 4 6 6 NA 6 NA 0.049 NA CUFSL 
FSL F3-0995 BAC06000021
27 
II 2006, human, 
sporadic 
NA 1053
A 
18 S 1 NA NA NA 0.055 NA CUFSL 
FSL F6-0084 nyc04-364G II 2004, human, 
sporadic 
NA 1053
A 
3 4 3 NA NA NA 0.055 NA CUFSL 
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Supplemental Table S2.1 (Continued) 
FSL F6-0095 nyc05-199G I 2005, human, 
sporadic 
NA 1051C 28 6 6 NA NA NA 0.055 NA CUFSL 
FSL F6-0154 J2818 II 
2000, food, 
US turkey 
deli meat 
outbreak 
1/2a 1053
A 
5 1 1 86 11 III 0.053 AARX000
00000 
CUFSL 
FSL F6-0366 H7858 I 
1998-1999, 
US, hot dog 
outbreak 
4b 1044A 4 6 6 6 6 II 0.034 
AADR000
00000 (6) 
FSL F6-0386 07B05187A-1 I 
2007, food 
(smoked 
salmon) 
NA 1051B 20 5 4 NA NA NA 0.049 NA CUFSL 
FSL G2-0003 LO28 II 
human, 
reference 
strain 
1/2c 1056
A 
61 S 10 210 9 NA 0.034 AARY000
00000 
CUFSL 
FSL H5-0804 06B00640D-1 I 
2006, 
environment 
(deli floor 
drain) 
1/2b 1051A 59 7 7 NA NA NA 0.052 NA CUFSL 
FSL J1-0020 DD6609 I 
1987, human, 
Philadelphia 
multiple 
foods 
outbreak 
4b 1042 9 2 2 NA 2 NA 0.052 NA CUFSL 
FSL J1-0022 DD942/NCTC 
4885 
II human 
sporadic 
1/2c 1039C 13 11 10 NA 9 NA 0.052 NA CUFSL 
FSL J1-0049 HO462 I human 
sporadic 
3c 1042C 1 5 4 3 3 NA 0.028 NA CUFSL 
FSL J1-0101 F6900/G3975/
DD6292 
II 1998, human, 
sporadic 
1/2a 1053
A 
5 1 1 86 11 III 0.04 AARU000
00000.2 
(7) 
FSL J1-0108 L4738/TS27/DD6304 I 
1981, human, 
Halifax 
coleslaw 
outbreak 
4b 1038B 8 8 8 1 1 NA 0.059 NA CUFSL 
FSL J1-0110 F2365 I 
1985, food, 
Mexican-
style cheese 
outbreak 
4b 1038B 8 8 8 1 1 I 0.052 NC_002973.6 CUFSL 
FSL J1-0116 TS38/L3306/DD6315 I 
1987-1989, 
human, UK 
and Ireland 
Pâté outbreak 
4b 1042B 2 2 2 2 2 NA 0.062 NA CUFSL 
FSL J1-0125 TS57/L4706/D
D6334 
II human, 
sporadic 
1/2c 1039C 6 11 10 NA 9 NA 0.039 NA CUFSL 
FSL J1-0126 TS60/L4486b/DD6337 I 
1983-1987, 
human, 
Switzerland 
cheese 
outbreak 
4b 1038B 8 8 8 1 1 NA 0.033 NA CUFSL 
FSL J1-0129 TS65/L3238/D
D6342 
I 
1987-1989, 
human, UK 
and Ireland 
Pâté outbreak 
4bx 1042B 2 2 2 NA 2 NA 0.046 NA CUFSL 
FSL J1-0169 B96-1303 I 1996, human, 
sporadic 
3b 1052
A 
7 S S 5 5 NA 0.051 NA CUFSL 
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FSL J1-0175 B97-471 I environment 
(water) 
1/2b 1042
A 
58 7 7 87 S NA 0.052 AARK000
00000 
CUFSL 
FSL J1-0194 B97-904 I 1997, human, 
sporadic 
1/2b 1042B 30 3 5 88 S NA 0.036 AARJ000
00000 
CUFSL 
FSL J1-0208 98-209 III 
1998, animal 
(caprine), 
sporadic 
4a 10142 55 S S 569 NA NA NA AARL00000000 
(den 
Bakker 
et al. 
2012) 
FSL J1-0220 C7942 I 
1979, human, 
vegetable 
outbreak 
4b 1042B 2 2 2 NA NA NA 0.047 NA CUFSL 
FSL J1-0225 Scott A I 
1983, human, 
United States 
outbreak 
4b 1042B 9 2 2 290 2 IV 0.058 CM00115
9.1 
CUFSL 
FSL J2-0003 DL 696073-1A II 
1993,  animal 
(bovine), 
clinical 
1/2a 1039C 79 S S 89 NA NA 0.048 AARM00
000000 
CUFSL 
FSL J2-0045 DL 662205-1A I 
1992, animal 
(sheep), 
clinical 
4b 1042B 25 10 9 NA NA NA 0.044 NA CUFSL 
FSL J2-0054 CU-BR 1/93 II 
1993, animal 
(sheep), 
clinical 
1/2a 1045B 48 S S 412 S NA 0.061 NA CUFSL 
FSL J2-0071 DL 758453-1A III 
1994, animal 
(bovine), 
clinical 
4c 1061A 52 S 11 131 71 NA NA 
AARN000
00000 (4) 
FSL L3-0051 A1-F1-021402 I 2002,food (RTE salmon) 1/2b 1042C 1 5 4 NA 3 NA 0.034 NA CUFSL 
FSL L3-0123 A2-E3-030502 II 
2002, 
environment 
(floor drain) 
NA 1053
A 
72 1 1 NA NA NA 0.061 NA CUFSL 
FSL L4-0096 B1-E1-100702 II 
2002, 
environment 
(fish 
processing 
plant drain) 
NA 1051B 50 4 3 NA NA NA 0.059 NA CUFSL 
FSL L4-0100 B1-E13-100702 II 
2002, 
environment 
(fish 
processing 
floor mat) 
NA 1051B 49 4 3 NA NA NA 0.059 NA CUFSL 
FSL L4-0151 A2-E16-
101502 
II 
2002, 
environment 
(raw salmon 
room floor 
drain) 
1/2a 1062
A 
15 12 13 NA NA NA 0.044 NA CUFSL 
FSL L4-0396 A1-E1-121602 II 
2002, 
environment 
(finished 
product area 
drain) 
1/2a 1039C 67 S S NA NA NA 0.048 NA CUFSL 
FSL M1-0006 B98-506 I 1998, human, 
sporadic 
NA 1051B 19 Si 4 NA NA NA 0.012 NA CUFSL 
FSL M2-0042 B99-1257 I 1999, human, 
sporadic 
4b 1042B 37 2 2 NA NA NA 0.041 NA CUFSL 
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FSL N1-0017 1B-22-1 I 1998, food 1/2b 1042C 21 5 4 3 3 VIII 0.033 AARP000
00000 
CUFSL 
FSL N1-0061 2D-31-2 I 
1998, food 
(salmon 
brine) 
4b 1044A 27 6 6 NA NA NA 0.053 NA CUFSL 
FSL N1-0225 H7550 I 
1998-1999, 
human, US 
hot dog 
outbreak 
4b 1044
A 
29 6 6 6 6 NA 0.05 NA CUFSL 
FSL N1-0260 NYC98-150 I human 1 1051A 33 3 5 NA NA NA 0.031 NA CUFSL 
FSL N3-0165 LS2B II 
2002, 
environment 
(soil) 
1/2a 1045
A 
78 S S 90 90 NA 0.057 AARQ000
00000 
CUFSL 
FSL N3-0692 TS2B I 
2002, 
environment 
(soil) 
4b 1051C 4 6 6 6 6 NA 0.054 NA CUFSL 
FSL N3-0780 TF2C I 2002, animal 
(bovine feces) 
4b 1051C 4 6 6 6 6 NA 0.055 NA CUFSL 
FSL R2-0011 N-7371 II 
2000, food 
(RTE deli 
salad) 
2 1053A 16 1 1 NA NA NA 0.057 NA CUFSL 
FSL R2-0089 N-7432 II 
2000, food 
(RTE deli 
salad) 
NA 1062
A 
62 12 13 NA NA NA 0.047 NA CUFSL 
FSL R2-0154 N-7494 I 
2001, food 
(smoked 
seafood) 
1/2b 1042C 1 5 4 NA 3 NA 0.055 NA CUFSL 
FSL R2-0182 N-7522 I 
2001, food 
(smoked 
seafood) 
1/2b 1043
A 
7 S S NA 5 NA 0.061 NA CUFSL 
FSL R2-0487 N-7817 II 
2001, food 
(RTE bagged 
salad) 
NA 1053
A 
74 1 1 NA NA NA 0.059 NA CUFSL 
FSL R2-0493 N-7823 II 
2001, food 
(RTE deli 
salad) 
NA 1056A 64 S S NA NA NA 0.018 NA CUFSL 
FSL R2-0499  FSL R2-
0603/J0161 
II 
2000, human, 
US turkey 
deli meat 
outbreak 
1/2a 1053
A 
76 1 1 11 11 III 0.059 AARW00
000000.2 
(7) 
FSL R2-0501 J0211 I 
2000, human, 
cheese 
outbreak 
4b 1042B 40 S S 558 S NA 0.043 NA CUFSL 
FSL R2-0502 G6003 I 
1994, food, 
Illinois 
chocolate 
milk outbreak 
1/2b 1051B 1 5 4 3 3 NA 0.04 NA CUFSL 
FSL R2-0557 G3963 I human, sporadic 1/2c 1042B 34 3 5 NA NA NA 0.033 NA CUFSL 
FSL R2-0559 F6854/G3965 II 1998, food, sporadic 1/2a 
1053
A 5 1 1 11 11 III 0.054 
AADQ000
00000 (6) 
FSL R2-0561 G3969 II human, 
sporadic 
1/2c 1039C 6 11 10 9 9 NA 0.053 AARS000
00000 
CUFSL 
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FSL R2-0578 G3996 I 
1983, human, 
Boston milk 
outbreak 
4b 1042B 38 2 2 NA 2 NA 0.05 NA CUFSL 
FSL R2-0583 G4003 I 
1983, human, 
Boston milk 
outbreak 
4b 1042B 9 2 2 NA 2 NA 0.039 NA CUFSL 
FSL R2-0585 L3350 I 
1987-1989, 
food, UK and 
Ireland Pâté 
outbreak 
4b 1042B 2 2 2 NA 2 NA 0.021 NA CUFSL 
FSL R2-0589 G4012/L3334 I 
1987-1989, 
food, UK and 
Ireland Pâté 
outbreak 
4b 1042B 36 2 2 NA 2 NA 0.049 NA CUFSL 
FSL R2-0598 G6055 I 
1994, human, 
Illinois 
chocolate 
milk outbreak 
1/2b 1051B 1 5 4 NA 3 NA 0.06 NA CUFSL 
FSL R2-0763 J1735 I 
2002, human, 
Northeastern 
states sliced 
deli meat 
outbreak 
4b 1044
A 
4 6 6 6 6 NA 0.044 NA CUFSL 
FSL R6-0896 
 
II 
2007, 
environment 
(floor drain) 
NA 1053
A 
3 4 3 NA 7 NA 0.064 NA CUFSL 
FSL R8-0879 
 
II 
2008, 
environment 
(floor drain) 
1/2a 1053
A 
75 S 1 NA NA NA 0.061 NA CUFSL 
FSL R8-5459 
 
I 
2010, 
environment 
(floor) 
NA 1040A 32 3 5 NA NA NA 0.05 NA CUFSL 
FSL S10-630 
 
I 
2010, 
environment 
(produce 
farm) 
NA 1044B 43 S S NA NA NA 0.048 NA CUFSL 
FSL S4-0440 U7-20-1 I 
2002, 
environment 
(sidewalk 
floor) 
1/2b 1042B 23 S S 379 NA NA 0.049 NA CUFSL 
FSL S4-0643 U9-14-3 I 
2002, 
environment 
(bench) 
4b 1044B 11 9 12 NA 4 NA 0.052 NA CUFSL 
FSL S4-0848 U13-31-2 I 
2002, 
environment 
(sidewalk 
floor) 
4b 1042B 39 2 2 2 2 NA 0.034 NA CUFSL 
FSL T1-0073 A2-R4-032601 II 
2001, food 
(raw 
norweigan) 
1/2a 1023C 81 S 1 NA NA NA 0.065 NA CUFSL 
FSL X1-0001 10403S II 1987, human, sporadic 1/2a 
1030
A 69 4 3 85 7 VII 0.047 
AARZ000
00000 CUFSL 
FSL X1-0002 L99 III 1950, food 
(cheese) 
4a NA 12 S S 201 NA NA NA FM211688 
(3) 
HCC23 
 
III animal (healthy 
channel catfish) 
4a NA 12 S S 201 NA NA NA NC_01166
0.1 
(8) 
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HPB2262 
 
I 
1997, Italian 
gastroenteritis 
outbreak 
4b NA 2 2 2 2 2 IV NA AATL00000000 (4) 
L312 
 
I food (cheese) 4b NA 11 9 12 4 4 NA NA FR733642 (3) 
SLCC 2372 
 
II 1935, human, sporadic 1/2c NA 13 11 10 122 9 NA NA FR733648 (3) 
SLCC 2376 
 
III poultry 4c NA 44 S 11 71 71 NA NA FR733651 (3) 
SLCC 2378 
 
I poultry 4e NA 45 8 8 73 1 I NA FR733644 (3) 
SLCC 2479 
 
II 1966, human, 
sporadic 
3c NA 6 11 10 9 9 NA NA FR733649 
(3) 
SLCC 2540 
 
I 1956, human, 
sporadic 
3b NA 46 S S 617 3 NA NA FR733645 
(3) 
SLCC 2755 
 
I 1967, animal 
(chinchilla) 
1/2b NA 47 5 4 66 3 VIII NA FR733646 
(3) 
SLCC 5850 
 
II 1924, animal (rabbit) 1/2a NA 3 4 3 12 7 VII NA FR733647 (3) 
SLCC 7179 
 
II 1986, food (cheese) 3a NA 51 S S 91 NA NA NA FR733650 (3) 
W1-110 
 
III Unknown 4c 1055
A 
53 S S NA NA NA 0.06 NA CUFSL 
W1-111 
 
III Unknown 4c 18036 56 S S NA NA NA 0.05 NA CUFSL 
W1-112   III Unknown 4a 1033A 57 S S NA NA NA 0.052 NA CUFSL 
aIsolates are listed in alphabetical order of the strain IDs.  
b10G-ST, sequence type (ST) identified by using 10-gene multilocus sequence typing (10G-MLST) 
scheme. 
c10G-SLV-CC, single-locus-variant-clonal complex identified by using 10G-MLST scheme and eBURST 
algorithm, where all STs in the clonal complex (CC) differ from one another in one of the ten alleles. 
d10G-TLV-CC, triple-locus-variant-clonal complex identified by using 10G-MLST scheme and eBURST 
algorithm, where all STs in the same CC differ from one another in three of the ten alleles. 
e7G-ST, ST identified by using 7-gene multilocus sequence typing (7G-MLST) scheme. 
f7G-CC, CC identified by using 7G-MLST scheme, where all STs in the same CC differ from one another 
in one of the seven alleles. 
gEC, epidemic clone 
hµmax, growth parameter maximum growth rate of L. monocytogenes isolates growing in defined medium 
(DM) at 16oC. 
iNA, not available.  
jCUFSL, Cornell University Food Safety Lab. 
kS, singleton, (i) for 10G-SLV-CCs and 10G-TLV-CCs, singletons were defined as STs differing from all 
of the other STs in more than one or more than three of the ten alleles, respectively, (ii) for 7G-CCs, 
singletons were defined as STs differing from all of the other STs in more than one of the seven allele 
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Supplemental Table S4.1. Upregulated genes in H7858 grown on CCS as compared to it grown 
in MBHIB at 7oC  
H7858 gene name Gene product FCa 
LMOh7858_0048 Putrescine carbamoyltransferase (EC 2.1.3.6) 31.36 
LMOh7858_0049 Agmatine/putrescine antiporter, associated with agmatine catabolism 19.56 
LMOh7858_0050 Agmatine deiminase (EC 3.5.3.12) 13.67 
LMOh7858_0051 Carbamate kinase (EC 2.7.2.2) 18.29 
LMOh7858_0176 Zinc ABC transporter, periplasmic-binding protein ZnuA 7.64 
LMOh7858_0221 Phosphatidylinositol-specific phospholipase C (EC 4.6.1.13) 2.83 
LMOh7858_0222 Thiol-activated cytolysin 2.54 
LMOh7858_0224 Actin-assembly inducing protein ActA precursor 2.86 
LMOh7858_0225 Broad-substrate range phospholipase C (EC 3.1.4.3) 3.19 
LMOh7858_0311 Multiple sugar ABC transporter, ATP-binding protein 2.54 
LMOh7858_0382 Transketolase (EC 2.2.1.1) 3.39 
LMOh7858_0383 Transaldolase (EC 2.2.1.2) 3.98 
LMOh7858_0384 oxidoreductase, short-chain dehydrogenase/reductase family 3.69 
LMOh7858_0385 Ribose 5-phosphate isomerase B (EC 5.3.1.6) 5.86 
LMOh7858_0396 Fumarate reductase flavoprotein subunit (EC 1.3.99.1) 6.38 
LMOh7858_0499 Internalin B (GW modules) 2.71 
LMOh7858_0536 antigen, putative 17.50 
LMOh7858_0755 Flagellin protein FlaA 3.43 
LMOh7858_0840 FMN-dependent NADH-azoreductase 2.73 
LMOh7858_0957 Sulfate permease 3.95 
LMOh7858_1214 Cob(III)alamin reductase 3.81 
LMOh7858_1215 Propanediol utilization polyhedral body protein PduT 3.72 
LMOh7858_1216 Propanediol utilization polyhedral body protein PduU 4.48 
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LMOh7858_1217 Propanediol utilization protein PduV 6.57 
LMOh7858_1217.1 Predicted alpha-ribazole-5-phosphate synthase CblS for cobalamin 
biosynthesis 
6.36 
LMOh7858_1219 Adenosylcobinamide-phosphate guanylyltransferase (EC 2.7.7.62) 5.02 
LMOh7858_1220 Cobalamin synthase 6.08 
LMOh7858_1221 Alpha-ribazole-5'-phosphate phosphatase (EC 3.1.3.73) 6.78 
LMOh7858_1242 L-threonine 3-O-phosphate decarboxylase (EC 4.1.1.81) 2.77 
LMOh7858_1243 Threonine kinase in B12 biosynthesis 2.88 
LMOh7858_1245 Alcohol dehydrogenase (EC 1.1.1.1) 4.97 
LMOh7858_1249 Ethanolamine ammonia-lyase heavy chain (EC 4.3.1.7) 4.97 
LMOh7858_1250 Ethanolamine ammonia-lyase light chain (EC 4.3.1.7) 5.50 
LMOh7858_1253 Acetaldehyde dehydrogenase, ethanolamine utilization cluster 5.26 
LMOh7858_1254 Ethanolamine utilization protein similar to PduA/PduJ 5.56 
LMOh7858_1254.2 Ethanolamine utilization protein similar to PduL 5.89 
LMOh7858_1258.1 Ethanolamine utilization protein similar to PduT 6.19 
LMOh7858_1260 Ethanolamine permease 5.90 
LMOh7858_1262.1 Substrate-specific component CblT of predicted B12-regulated ECF 
transporter 
8.33 
LMOh7858_1264 Cobyrinic acid A,C-diamide synthase 10.02 
LMOh7858_1265 Adenosylcobinamide-phosphate synthase 12.88 
LMOh7858_1266 Cobalt-precorrin-8x methylmutase (EC 5.4.1.2) 11.84 
LMOh7858_1267 Cobalt-precorrin-6 synthase, anaerobic 11.27 
LMOh7858_1268 Cobalt-precorrin-6y C5-methyltransferase (EC 2.1.1.-) 12.39 
LMOh7858_1269 Cobalt-precorrin-6y C15-methyltransferase [decarboxylating] (EC 
2.1.1.-) 
11.32 
LMOh7858_1270 Cobalt-precorrin-4 C11-methyltransferase (EC 2.1.1.133) 9.70 
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Supplemental Table S4.1 (Continued) 
LMOh7858_1271 Cobalamin biosynthesis protein CbiG 11.54 
LMOh7858_1272 Cobalt-precorrin-3b C17-methyltransferase 10.29 
LMOh7858_1273 Cobalt-precorrin-6x reductase (EC 1.3.1.54) 10.85 
LMOh7858_1274 Uroporphyrinogen-III methyltransferase (EC 2.1.1.107) 12.55 
LMOh7858_1275 Sirohydrochlorin cobaltochelatase CbiK (EC 4.99.1.3) 10.40 
LMOh7858_1276 Cobalt-precorrin-2 C20-methyltransferase (EC 2.1.1.130) 11.76 
LMOh7858_1277 Substrate-specific component CbiM of cobalt ECF transporter 9.95 
LMOh7858_1278 Additional substrate-specific component CbiN of cobalt ECF 
transporter 
9.02 
LMOh7858_1279 Transmembrane component CbiQ of energizing module of cobalt 
ECF transporter 
7.54 
LMOh7858_1280 ATPase component CbiO of energizing module of cobalt ECF 
transporter 
5.30 
LMOh7858_1281 Cobyric acid synthase 2.94 
LMOh7858_1282 Cob(I)alamin adenosyltransferase PduO (EC 2.5.1.17) 2.66 
LMOh7858_1329.1 FIG00774262: hypothetical protein 7.76 
LMOh7858_1331 transporter 8.12 
LMOh7858_2119 PTS system, mannose-specific IIA component (EC 2.7.1.69) 6.31 
LMOh7858_2119.1 Putative glucosamine-fructose-6-phosphate aminotransferase 3.42 
LMOh7858_2121 putative glucosamine-fructose-6-phosphate aminotransferase 3.99 
LMOh7858_2122 PTS system, mannose-specific IID component (EC 2.7.1.69) 5.61 
LMOh7858_2123 PTS system, mannose-specific IIC component (EC 2.7.1.69) 4.78 
LMOh7858_2124 PTS system, mannose-specific IIB component (EC 2.7.1.69) 4.71 
LMOh7858_2253 Maltose phosphorylase (EC 2.4.1.8) 3.45 
LMOh7858_2253.1 Maltodextrose utilization protein MalA 5.71 
LMOh7858_2255 Maltose/maltodextrin ABC transporter, permease protein MalG 6.32 
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LMOh7858_2256 Maltose/maltodextrin ABC transporter, permease protein MalF 7.96 
LMOh7858_2257 Maltose/maltodextrin ABC transporter, substrate binding 
periplasmic protein 
5.74 
LMOh7858_2292.2 FIG00774368: hypothetical protein 5.05 
LMOh7858_2292.3 Inosose dehydratase (EC 4.2.1.44) 4.27 
LMOh7858_2426.4 FIG00775213: hypothetical protein 2.85 
LMOh7858_2503 FIG00774521: hypothetical protein 4.96 
LMOh7858_2504 Rrf2 family transcriptional regulator 4.24 
LMOh7858_2903 serine/threonine protein phosphatase family protein 2.78 
LMOh7858_2922 Transketolase (EC 2.2.1.1) 4.77 
LMOh7858_2925 Galactitol-1-phosphate 5-dehydrogenase (EC 1.1.1.251) 7.62 
LMOh7858_2926 Galactitol-1-phosphate 5-dehydrogenase (EC 1.1.1.251) 5.48 
LMOh7858_2927 PTS system, galactitol-specific IIC component (EC 2.7.1.69) 4.38 
LMOh7858_2928 PTS system, galactitol-specific IIB component (EC 2.7.1.69) 3.17 
LMOh7858_2994 Haloacid dehalogenase-like hydrolase 5.34 
LMOh7858_2995 Transcription regulator, RpiR family 3.11 
LMOh7858_3062 hydrolase, haloacid dehalogenase-like family 7.97 
LMOh7858_3063 PTS system, mannitol-specific IIB component (EC 2.7.1.69) 19.28 
LMOh7858_3064 oxidoreductase, Gfo/Idh/MocA family 9.36 
LMOh7858_3065 N-acetylmannosamine-6-phosphate 2-epimerase (EC 5.1.3.9) 13.04 
aFC, fold change. FC= average normalized RNA-seq coverage (NRC) (CCS) ÷ average NRC 
(MBHIB)  
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Supplemental Table S4.2. Down regulated genes H7858 grown on CCS as compared to it 
grown in MBHIB at 7oC 
H7858 Gene Name Gene Product FCa 
LMOh7858_0107 oxidoreductase, aldo/keto reductase family 0.37 
LMOh7858_0175 Oligopeptide ABC transporter, periplasmic oligopeptide-binding protein 
O 0.38 
LMOh7858_0246 Dihydropteroate synthase (EC 2.5.1.15) 0.16 
LMOh7858_0367 Internalin-like protein (LPXTG motif) Lmo0331 homolog 0.40 
LMOh7858_0506 Cell division protein FtsI [Peptidoglycan synthetase] (EC 2.4.1.129) 0.32 
LMOh7858_0508 Cell envelope-associated transcriptional attenuator LytR-CpsA-Psr, subfa 0.31 
LMOh7858_0625 Imidazoleglycerol-phosphate dehydratase (EC 4.2.1.19) 0.31 
LMOh7858_0655 O-acetylhomoserine sulfhydrylase (EC 2.5.1.49) / O-succinylhomoserine 
sulfhydrylase 0.37 
LMOh7858_0667 Transcriptional regulator, MarR family 0.38 
LMOh7858_0852.2 GTP pyrophosphokinase (EC 2.7.6.5) 0.32 
LMOh7858_0878 acetyltransferase, GNAT family 0.36 
LMOh7858_0940 Putative peptidoglycan bound protein (LPXTG motif) Lmo0880 homolog 0.30 
LMOh7858_1015.1 FIG00774399: hypothetical protein 0.27 
LMOh7858_1015.2 FIG00774456: hypothetical protein 0.39 
LMOh7858_1066.1 FIG00774146: hypothetical protein 0.28 
LMOh7858_1202.1 FIG00774448: hypothetical protein 0.00 
LMOh7858_1289 N-acetylmuramoyl-L-alanine amidase, family 4 0.39 
LMOh7858_1299 Transcriptional regulator, MarR family 0.38 
LMOh7858_1308.2 FIG00774960: hypothetical protein 0.24 
LMOh7858_1321.2 DUF1801 domain-containing protein 0.36 
LMOh7858_1321.3 PhnB protein; putative DNA binding 3-demethylubiquinone-9 3-
methyltransfer 0.28 
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LMOh7858_1339 Trehalose-6-phosphate hydrolase (EC 3.2.1.93) 0.18 
LMOh7858_1340 PTS system, trehalose-specific IIB component (EC 2.7.1.69) / PTS 
system, 0.19 
LMOh7858_1511 FIG00774487: hypothetical protein 0.30 
LMOh7858_1614 Iron-sulfur cluster regulator IscR 0.38 
LMOh7858_1812.1 Hypothetical protein SAV1869 0.38 
LMOh7858_1858 Glutamate synthase [NADPH] small chain (EC 1.4.1.13) 0.30 
LMOh7858_1859 Glutamate synthase [NADPH] large chain (EC 1.4.1.13) 0.29 
LMOh7858_1956 Orotate phosphoribosyltransferase (EC 2.4.2.10) 0.26 
LMOh7858_1957 Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) 0.27 
LMOh7858_1958 Dihydroorotate dehydrogenase, catalytic subunit (EC 1.3.3.1) 0.29 
LMOh7858_1959 Dihydroorotate dehydrogenase electron transfer subunit (EC 1.3.3.1) 0.22 
LMOh7858_1960 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) 0.21 
LMOh7858_1961 Carbamoyl-phosphate synthase small chain (EC 6.3.5.5) 0.22 
LMOh7858_1965.1 FIG00774989: hypothetical protein 0.37 
LMOh7858_1977 Copper chaperone 0.38 
LMOh7858_2167 Cell division protein FtsL 0.37 
LMOh7858_2179 Excinuclease ABC subunit A paralog of unknown function 0.38 
LMOh7858_2262.2 FIG00774113: hypothetical protein 0.37 
LMOh7858_2337 N-acetylmuramoyl-L-alanine amidase, family 4 0.31 
LMOh7858_2343.1 FIG00774091: hypothetical protein 0.18 
LMOh7858_2490 L-Cystine ABC transporter, permease protein TcyM 0.18 
LMOh7858_2491 L-Cystine ABC transporter, permease protein TcyL 0.12 
LMOh7858_2492 L-Cystine ABC transporter, periplasmic cystine-binding protein TcyK 0.31 
LMOh7858_2495 HTH-type transcriptional regulator YtlI, LysR family 0.26 
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LMOh7858_2521 PTS system, IIB component 0.38 
LMOh7858_2566.1 FIG00774101: hypothetical protein 0.23 
LMOh7858_2584.1 FIG00774650: hypothetical protein 0.40 
LMOh7858_2635 FIG00774998: hypothetical protein 0.25 
LMOh7858_2635.1 Hypothetical protein, homolog of fig|393130.3.peg.2627 0.20 
LMOh7858_2717.1 FIG00774295: hypothetical protein 0.13 
LMOh7858_2717.2 FIG00774092: hypothetical protein 0.19 
LMOh7858_2752 lipoprotein, putative 0.30 
LMOh7858_2951 Mg(2+) transport ATPase, P-type (EC 3.6.3.2) 0.27 
LMOh7858_3026.1 hypothetical protein 0.31 
LMOh7858_3027 Beta-glucosidase (EC 3.2.1.21); 6-phospho-beta-glucosidase (EC 
3.2.1.86) 0.24 
LMOh7858_3028 PTS system, cellobiose-specific IIB component (EC 2.7.1.69) 0.12 
LMOh7858_3066.6 hypothetical secreted protein 0.30 
LMOh7858_3076 D-alanyl-D-alanine carboxypeptidase (EC 3.4.16.4) 0.24 
LMOh7858_3082 transporter 0.27 
LMOh7858_3083 Catalyzes the cleavage of p-aminobenzoyl-glutamate to p-aminobenzoate 
and glutamate 0.29 
aFC, fold change. FC= average normalized RNA-seq coverage (NRC) (CCS) ÷ average NRC 
(MBHIB) 
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Supplemental Table S4.3. Genes involved in cobalamin biosynthesis upregulated in H7858 
grown on CSS compared to in MBHIB at 7oC 
Gene name in 
H7858 gene product FCb 
H7858 EGD-e a 10403S a 
LMOh7858_1214 lmo1142 LMRG_00585 Cob(III)alamin reductase 3.81 
LMOh7858_1217.1 lmo1146 LMRG_00589 Predicted alpha-ribazole-5-phosphate synthase 
CblS for cobalamin biosynthesis 
6.36 
LMOh7858_1219 lmo1147 LMRG_00590 Adenosylcobinamide-phosphate 
guanylyltransferase (EC 2.7.7.62) 
5.02 
LMOh7858_1220 lmo1148 
(cobS) 
LMRG_00591 Cobalamin synthase 6.08 
LMOh7858_1221 lmo1149 LMRG_00592 Alpha-ribazole-5'-phosphate phosphatase (EC 
3.1.3.73) 
6.78 
LMOh7858_1242 lmo1169 
(cobD) 
LMRG_00612 L-threonine 3-O-phosphate decarboxylase (EC 
4.1.1.81) 
2.77 
LMOh7858_1262.1 lmo1190 LMRG_00636 Substrate-specific component CblT of predicted 
B12-regulated ECF transporter 
8.33 
LMOh7858_1264 lmo1191 
(cobB) 
LMRG_00637 Cobyrinic acid A,C-diamide synthase 10.02 
LMOh7858_1265 lmo1192 
(cobD) 
LMRG_00638 Adenosylcobinamide-phosphate synthase 12.88 
LMOh7858_1266 lmo1193 LMRG_00639 Cobalt-precorrin-8x methylmutase (EC 5.4.1.2) 11.84 
LMOh7858_1267 lmo1194 
(cbiD) 
LMRG_00640 Cobalt-precorrin-6 synthase, anaerobic 11.27 
LMOh7858_1268 lmo1195 
(cbiE) 
LMRG_00641 Cobalt-precorrin-6y C5-methyltransferase (EC 
2.1.1.-) 
12.39 
LMOh7858_1269 lmo1196 LMRG_00642 Cobalt-precorrin-6y C15-methyltransferase 
[decarboxylating] (EC 2.1.1.-) 
11.32 
LMOh7858_1270 lmo1197 
(cbiF) 
LMRG_00643 Cobalt-precorrin-4 C11-methyltransferase (EC 
2.1.1.133) 
9.70 
LMOh7858_1271 lmo1198 
(cbiG) 
LMRG_00644 Cobalamin biosynthesis protein CbiG 11.54 
LMOh7858_1272 lmo1199 
(cbiH) 
LMRG_00645 Cobalt-precorrin-3b C17-methyltransferase 10.29 
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LMOh7858_1273 lmo1200 LMRG_00646 Cobalt-precorrin-6x reductase (EC 1.3.1.54) 10.85 
LMOh7858_1274 lmo1201 LMRG_00647 Uroporphyrinogen-III methyltransferase (EC 
2.1.1.107) / Uroporphyrinogen 
12.55 
LMOh7858_1275 lmo1202 
(cbiK) 
LMRG_00648 Sirohydrochlorin cobaltochelatase CbiK (EC 
4.99.1.3) 
10.40 
LMOh7858_1276 lmo1203 
(cbiL) 
LMRG_00649 Cobalt-precorrin-2 C20-methyltransferase (EC 
2.1.1.130) 
11.76 
LMOh7858_1277 lmo1204 LMRG_00650 Substrate-specific component CbiM of cobalt 
ECF transporter 
9.95 
LMOh7858_1278 lmo1205 LMRG_00651 Additional substrate-specific component CbiN of 
cobalt ECF transporter 
9.02 
LMOh7858_1279 lmo1206 
(cbiQ) 
LMRG_00652 Transmembrane component CbiQ of energizing 
module of cobalt ECF transporter 
7.54 
LMOh7858_1280 lmo1207 LMRG_00653 ATPase component CbiO of energizing module 
of cobalt ECF transporter 
5.30 
LMOh7858_1281 lmo1208 
(cobQ) 
LMRG_00654 Cobyric acid synthase 2.94 
LMOh7858_1282 lmo1209 LMRG_00655 Cob(I)alamin adenosyltransferase PduO (EC 
2.5.1.17) 
2.66 
aStrain EGD-e (GenBank accession no.: NC_003210) and10403S (GenBank accession no.: 
NC_017544) are L. monocytogenes; 
bFC, fold change, FC= average NRC(CSS) ÷ average NRC(MBHIB); only genes with FDR 
<0.05 are listed.
	  	  
	  
153	  
Supplemental Table S4.4. Upregulated genes involved in ethanolamine and 1,2-propanediol 
utilization in H7858 grown on CSS compared to in MBHIB at 7oC 
Gene name in 
H7858 gene product FCb 
H7858 EGD-e a 10403S a 
Ethanolamine utilization 
LMOh7858_1245 lmo1171 (pduQ)c LMRG_00617 Alcohol dehydrogenase (EC 1.1.1.1) 4.97 
LMOh7858_1249 lmo1175 (eutB) LMRG_00621 Ethanolamine ammonia-lyase heavy chain 
(EC 4.3.1.7) 
4.97 
LMOh7858_1250 lmo1176 (eutC) LMRG_00622 Ethanolamine ammonia-lyase light chain (EC 
4.3.1.7) 
5.50 
LMOh7858_1253 lmo1179 LMRG_00625 
Acetaldehyde dehydrogenase, ethanolamine 
utilization cluster 
5.26 
LMOh7858_1254 lmo1180 LMRG_00626 
Ethanolamine utilization protein similar to 
PduA/PduJ 
5.56 
LMOh7858_1254.2 lmo1182 LMRG_00628 Ethanolamine utilization protein similar to 
PduL 
5.89 
LMOh7858_1258.1 lmo1185 LMRG_00631 Ethanolamine utilization protein similar to 
PduT 
6.19 
LMOh7858_1260 lmo1186 LMRG_00632 Ethanolamine permease 5.90 
1,2-propanediol utilization 
LMOh7858_1214 lmo1142 LMRG_00585 Cob(III)alamin reductase 3.81 
LMOh7858_1215 lmo1143 LMRG_00586 
Propanediol utilization polyhedral body 
protein PduT 
3.72 
LMOh7858_1216 lmo1144 LMRG_00587 Propanediol utilization polyhedral body 
protein PduU 
4.48 
LMOh7858_1217 lmo1145 LMRG_00588 Propanediol utilization protein PduV 6.57 
LMOh7858_1243 lmo1170 LMRG_00613 Threonine kinase in B12 biosynthesis 2.88 
LMOh7858_1245 
lmo1171 
(pduQ)c LMRG_00617 Alcohol dehydrogenase (EC 1.1.1.1) 4.97 
LMOh7858_1282 lmo1209 LMRG_00655 
Cob(I)alamin adenosyltransferase PduO (EC 
2.5.1.17) 
2.66 
aStrain EGD-e (GenBank accession no.: NC_003210) and 10403S (GenBank accession no.: 
NC_017544) are L. monocytogenes; 
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bFC, fold change, FC= average NRC(CSS) ÷ average NRC(MBHIB); only genes with FDR 
<0.05 are listed; 
cAs the gene product Alcohol dehydrogenase of the gene LMOh7858_1245 may participate in 
both of the ethanolamine utilization and the 1,2-propanediol utilization pathways, this gene was 
listed under both categories.  
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Supplemental Table S4.5. Upregulated genes involved in carbohydrate transport and utilization 
in H7858 grown on CSS compared to in MBHIB at 7oC 
Gene name in 
H7858 gene product FCb 
H7858 EGD-ea 10403Sa 
Mannose 
LMOh7858_2119 lmo1997 LMRG_01145 
PTS system, mannose-specific IIA component 
(EC 2.7.1.69) 
6.31 
LMOh7858_2122 lmo2000 LMRG_01148 
PTS system, mannose-specific IID component 
(EC 2.7.1.69) 
5.61 
LMOh7858_2123 lmo2001 LMRG_01149 
PTS system, mannose-specific IIC component 
(EC 2.7.1.69) 
4.78 
LMOh7858_2124 lmo2002 LMRG_01150 
PTS system, mannose-specific IIB component 
(EC 2.7.1.69) 
4.71 
Galactitol 
LMOh7858_2925 lmo2663 LMRG_02208 Galactitol-1-phosphate 5-dehydrogenase (EC 
1.1.1.251) 
7.62 
LMOh7858_2926 lmo2664 LMRG_02209 Galactitol-1-phosphate 5-dehydrogenase (EC 
1.1.1.251) 
5.48 
LMOh7858_2927 lmo2665 LMRG_02210 PTS system, galactitol-specific IIC component 
(EC 2.7.1.69) 
4.38 
LMOh7858_2928 lmo2666 LMRG_02211 PTS system, galactitol-specific IIB component 
(EC 2.7.1.69) 
3.17 
Mannitol 
LMOh7858_3063 lmo2799 LMRG_01898 PTS system, mannitol-specific IIB component 
(EC 2.7.1.69) 
19.28 
Maltose 
LMOh7858_2253 lmo2121 LMRG_01275 Maltose phosphorylase (EC 2.4.1.8) 3.45 
LMOh7858_2253.1 lmo2122 LMRG_01276 Maltodextrose utilization protein MalA 5.71 
LMOh7858_2255 lmo2123 LMRG_01277 
Maltose/maltodextrin ABC transporter, 
permease protein MalG 
6.32 
LMOh7858_2256 lmo2124 LMRG_01278 
Maltose/maltodextrin ABC transporter, 
permease protein MalF 
7.96 
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LMOh7858_2257 lmo2125 LMRG_01279 
Maltose/maltodextrin ABC transporter, 
substrate binding periplasmic protein 
5.74 
Pentose phosphate pathway 
LMOh7858_2922 lmo2660 LMRG_02205 Transketolase (EC 2.2.1.1) 4.77 
LMOh7858_0382 lmo0342 LMRG_00033 Transketolase (EC 2.2.1.1) 3.39 
LMOh7858_0383 lmo0343 
(tal2) 
LMRG_00034 Transaldolase (EC 2.2.1.2) 3.98 
LMOh7858_0384 lmo0344 LMRG_00035 oxidoreductase, short-chain 
dehydrogenase/reductase family 
3.69 
LMOh7858_0385 lmo0345 LMRG_00036 Ribose 5-phosphate isomerase B (EC 5.3.1.6) 5.86 
  
aStrain EGD-e (GenBank accession no.: NC_003210) and 10403S (GenBank accession no.: 
NC_017544) are L. monocytogenes; 
bFC, fold change, FC= average NRC(CSS) ÷ average NRC(MBHIB); only genes with FDR 
<0.05 are listed.  
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Supplemental Table S4.6. Upregulated genes involved in agmatine deiminase in H7858 grown 
on CSS compared to in MBHIB at 7oC 
Gene name in 
H7858 gene product FCb 
H7858 EGD-ea 10403Sa 
LMOh7858
_0048 
lmo0036 
(arcB) 
LMRG_02465 
(arcB) 
Putrescine carbamoyltransferase (EC 2.1.3.6) 31.36 
LMOh7858
_0049 
lmo0037 LMRG_02466 
Agmatine/putrescine antiporter, associated with 
agmatine catabolism 
19.56 
LMOh7858
_0050 
lmo0038 
(aguA1) LMRG_02467 Agmatine deiminase (EC 3.5.3.12) 13.67 
LMOh7858
_0051 
lmo0039 LMRG_02468 Carbamate kinase (EC 2.7.2.2) 18.29 
aStrain EGD-e (GenBank accession no.: NC_003210) and 10403S (GenBank accession no.: 
NC_017544) are L. monocytogenes; 
bFC, fold change, FC= average NRC(CSS) ÷ average NRC(MBHIB); only genes with FDR 
<0.05 are listed   
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Supplemental Table S4.7. Upregulated genes that are regulated by PrfA in H7858 grown on 
CSS compared to in MBHIB at 7oC 
Gene name in 
H7858 gene product FCb 
H7858 EGD-e a 10403S a 
LMOh7858_0499 lmo0434 (inlB) LMRG_00127 Internalin B (GW modules) 2.71 
LMOh7858_0221 lmo0201 (plcA) LMRG_02623 Phosphatidylinositol-specific phospholipase C (EC 4.6.1.13) 2.83 
LMOh7858_0222 lmo0202 (hly) LMRG_02624 Thiol-activated cytolysin 2.54 
LMOh7858_0224 lmo0204 (actA) LMRG_02626 Actin-assembly inducing protein ActA precursor 2.86 
LMOh7858_0225 lmo0205 (plcB) LMRG_02627 Broad-substrate range phospholipase C (EC 3.1.4.3) 3.19 
 aStrain EGD-e (GenBank accession no.: NC_003210) and 10403S (GenBank accession no.: 
NC_017544) are L. monocytogenes; 
bFC, fold change, FC= average NRC(CSS) ÷ average NRC(MBHIB); only genes with FDR 
<0.05 are listed.  
